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The expression of genes in an organism is controlled by many methods. One of 
the most important means of regulation is post-transcriptional control of messenger RNA 
(mRNA). RNA binding proteins (RBPs) are crucial for this process. Here we describe the 
characterization of a functional domain within the Drosophila RBP Pumilio (Pum) and 
examine the effects of Pum on the transcriptome. 
Pum proteins are a highly conserved family of RBPs that control the expression 
of mRNA by binding to specific motifs in the 3’-UTR of transcripts. Through associations 
with other proteins, Pum proteins regulate the fate of an RNA, primarily causing decay of 
the target. Drosophila Pum contains autonomous domains capable of enacting decay 
independently from its RNA binding domain. The most conserved domain is repression 
domain 3 (RD3) which we characterize here. Using conservation analysis, we define 
conserved regions within RD3, and show their importance for the repressive activity of 
RD3. We identify two specific amino acids, F1033 and F1040, which are necessary for 
RD3’s function. Using yeast two-hybrid assays, we show that RD3 contacts several 
members of the CNOT deadenylase complex, the central scaffold unit Not1, and 
subunits Not2 and Not3. In Drosophila cells, we show that RD3 can interact with the 
CNOT complex. We further explore the endogenous targets of Drosophila Pum proteins 
by performing RNA sequencing experiments in which we deplete Pum and members of 
the CNOT complex. This is the first global analysis of the functional regulation of Pum 
targets in Drosophila. From this analysis we find that thousands of genes rely upon the 
regulatory framework provided by Pum. We demonstrate specific regulation of several 
targets of Pum using reporter assays and identify functional Pum binding sites within 
target 3’-UTRs. Finally, we show that regulation by Pum also affects the levels of 
expressed protein for two important targets, Pde11 and Raf. The work shown here 
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Chapter 1: Introduction 
 
The precise regulation of gene products is crucial during an organism’s 
development and entire life. Even small perturbations in the proper level of gene 
expression can result in disease states or developmental abnormalities. Several 
mechanisms exist to maintain the appropriate balance of proteins, such as control of 
gene transcription, spatial and temporal localization of translated proteins, and protein 
degradation. Another important regulatory step is the management of transcribed RNAs, 
in the form of post-transcriptional control.  
Development of all animals is dependent on a system of post-transcriptional 
control. Maturation of a fertilized oocyte into a zygote is a transcriptionally silent process 
that relies on maternally deposited proteins and RNAs. Until transcription of the zygotic 
genome begins, oocyte cell cycle completion, cell division, and localization of cell fate 
determinants must all be regulated post-transcriptionally (Tadros and Lipshitz 2009). 
An organism must also be able to respond to internal and external stimuli, 
sometimes immediately. Most biological processes that occur are carried out by 
proteins, yet the process of making a protein is time and energy consuming. One of the 
ways cells handle this dilemma is by transcribing genes compulsorily then exerting 
control over the product RNA. The RNA can then be translated into protein, stored to 
mount a quicker response at a later time, or transported to a location where the final 
protein will ultimately function. Post transcriptional control allows for exquisite fine tuning 
of cellular responses. 
   
1.1. Making the mRNA  
The first step in the life cycle of all RNA is transcription. DNA transcription in 
eukaryotes is carried out by one of three RNA polymerases (RNA pol), each one 
responsible for transcribing a certain subset of genes. RNA transcripts that are destined 
to become proteins are transcribed by RNA pol II. An extended C-terminal domain (CTD) 
on RNA pol II serves as a scaffold for factors unique to processing pre-mRNAs such as 
capping and splicing complexes. This spatial arrangement allows for RNA processing 
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events to occur co-transcriptionally (Young 1991, Willis 1993, Cho, Takagi et al. 1997, 
McCracken, Fong et al. 1997, Bentley 2002, Dieci, Fiorino et al. 2007). 
Capping of the pre-mRNA occurs immediately after transcription elongation 
begins. The cap consists of a single guanine nucleotide appended to the end of the 
transcript with an unusual 5’ to 5’ triphosphate linkage. A capping complex is recruited to 
the CTD of RNA pol II after the phosphorylation of the RNA pol II CTD (Gonatopoulos-
Pournatzis and Cowling 2014). Capping occurs in 3 stages: removal of the gamma 
phosphate group from the 5’ terminal nucleotide  to yield a 5’ di-phosphate; a guanylyl 
transferase then hydrolyzes GTP to transfer a GMP group to the transcript, finally a 
methyl group is added to the N7 position using s-adenosylmethionine (Banerjee 1980). 
In yeast, three separate enzymes perform these processes, but in metazoans, the 
phosphatase and guanylyl transferase activity are combined into one enzyme- RNGTT 
in humans (Pillutla, Shimamoto et al. 1998, Yamada-Okabe, Doi et al. 1998) and mRNA-
cap in Drosophila. 
Capping of RNA serves several important functions, the first of which is to protect 
the nascent RNA from enzymatic cleavage. The unique triphosphate linkage between 
the cap and the 5’ end of the transcript requires a specialized enzyme for cleavage. 
Uncapped transcripts are rapidly degraded; even viruses have evolved ways of 
stabilizing their own mRNAs with caps or stealing host caps in order to evade 
destruction of their messages. 5’ caps in eukaryotes are often further modified to 
distinguish endogenous RNA from capped viral RNA as well (Ramanathan, Robb et al. 
2016). Capping is also necessary for transcript splicing, as the cap binding complex of 
the splicing machinery must bind to it to initiate splicing (Konarska, Padgett et al. 1984, 
Ohno, Sakamoto et al. 1987). After processing, the cap is necessary for nuclear export 
and for translation initiation. 
As the polymerase extends transcription, the splicing machinery will join with 
RNA pol II and initiate excision of introns. The cap-binding complex (CBC), consisting of 
a heterodimer of CBP80 and CBP20, binds to the 5’ cap and recruits several small 
nuclear ribonucleoproteins (snRNPs) U4, U5, and U6 snRPs to initiate splicing. The 
spliceosome is a very large ribonucleoprotein complex that catalyzes the removal of the 
intron in a two-step process. Recognition of the 5’ splice site is mediated by the snRNP 
U1 (Kondo, Oubridge et al. 2015). Cleavage of the RNA at the 5’ splice site occurs first, 
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forming an intermediate lariat structure of the RNA. After cleavage of the 3’ splice site 
and ligation of the remaining ends of the exon, the intron lariat is released. The 
spliceosome complex dissociates after each splicing event and re-associates 
downstream again for the next event. 
Splicing not only removes introns from a transcript, but it also presents the 
opportunity for the cell to create more than one distinct mRNA from one gene via 
alternative splicing. Using alternative splice sites within the pre-mRNA, a message can 
be “adjusted” by exon skipping, intron inclusion, and extension or reduction of regulatory 
regions. This in turn can lead to changes in RNA stability, localization, and alter the 
resulting protein product. Alternative splicing is a ubiquitous event that allows for the 
creation of unique protein isoforms, and is essential for organismal development and 
responses to stimuli (Baralle and Giudice 2017). 
The polyadenylation sequence (PAS) is a hexameric sequence occurring near 
the end of a gene that serves as a signal for transcription to end. The PAS is recognized 
by cleavage and polyadenylation specificity factor (CPSF), a multi-protein complex 
consisting of four main subunits. CPSF is recruited to the transcription initiation complex 
as transcription begins and follows the elongating polymerase (Dantonel, Murthy et al. 
1997). The PAS sequence, AAUAAA, is specifically recognized by the CPSF30 subunit 
and cleavage of the transcript is initiated by CPSF73 (Ryan, Calvo et al. 2004, Mandel, 
Kaneko et al. 2006, Shimberg, Michalek et al. 2016). Poly-A polymerase (PAP) is 
recruited to the mRNA by an interaction with Fip1 (Factor interacting with Poly(A) 
polymerase), a subunit of CPSF that binds to U-rich elements upstream of the PAS 
(Kaufmann, Martin et al. 2004). Polyadenylation of the transcript results in approximately 
200 to 300 adenosine nucleotides being added onto the end of the transcript (Wahle 
1995, Kuhn, Gundel et al. 2009). The addition of a poly-A tail not only protects the 
transcript from exonuclease decay but serves a binding site for nuclear poly-A binding 
protein (PABPN1), that binds the tail in multimers and accompanies the mRNA out of the 






Figure 1.1: Pre-mRNA processing in the nucleus. RNA polymerase II (RNA pol) transcribes 
mRNA from DNA. A 5’ cap (7mG) is added immediately to the transcript and bound by the cap-
binding complex (CBC). As RNA pol II extends transcription, the spliceosome removes introns. 
Near the end of the gene, cleavage and polyadenylation specificity factor (CPSF) recognizes the 
polyadenylation sequence (PAS) cleaves the RNA and recruits poly(A) polymerase (PAP) to add 
non-templated adenosine nucleotides to the end of the transcript. Poly(A) binding protein (PABP) 
binds to the poly(A) tail. The CBC interacts with the REF subunit of the transcription-export 
complex (TREX), which will interact with the RNA export receptor (TAP) and facilitate transport of 
the mRNA out of the nucleus and into the cytoplasm. 
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Export out of the nucleus requires association of many cofactors, most of which 
accompany the transcript through transcription and pre-mRNA processing. The CBC 
binds to REF, an RNA-binding protein subunit of the transcription-export complex 
(TREX), which in turn will interact with the RNA export receptor, TAP. The spliceosome 
is also responsible for depositing cofactors along the RNA that are essential for its 
export through the nuclear pore, including REF (Le Hir, Izaurralde et al. 2000, 
Rodrigues, Rode et al. 2001, Iglesias and Stutz 2008, Gonatopoulos-Pournatzis and 
Cowling 2014).  
 
1.2. Characteristics of mRNA 
An RNA molecule is never “naked” in the cell. From the moment transcription 
begins until the time it is degraded, it is constantly in contact with other factors - the 
majority of these contacts are mediated through RNA binding proteins (RBPs). The 
processes of transcription, capping, splicing, and polyadenylation are all intricately tied 
together by protein complexes and the interactions between them. Each step in pre-
mRNA processing can be said to serve as checkpoints, where certain proteins are 
deposited as marks that signal a successful processing event. This interplay ensures 
that complete and translation-competent mRNAs are exported to the cytoplasm. 
The mature mRNA has several key features (Figure 1.2). In addition to the 5’ cap 
and poly(A) tail, the mature transcript also contains the coding sequence (CDS) that will 
be translated into the final protein and flanking untranslated regions (UTRs), which do 
not code for part of the protein. These UTRs serve as critical regulatory elements for 
post-transcriptional control.  
 
  
Figure 1.2: The general structure of a mature mRNA. The 5’ cap and poly(A) tail help protect 
the transcript from nucleolytic decay. The 5’ and 3’-UTRs are important regulatory regions. The 
coding sequence (CDS) is the only part of the RNA that will be translated into protein. 
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The 5’ cap protects the transcript from degradation in part by binding proteins 
such as CBC and PABP which compete with decapping enzymes for access to the cap 
structure. Removal of the cap is the first committed step toward transcript decay. In 
addition to its roles in pre-mRNA processing, the cap is also necessary for translation 
and translation-coupled quality control pathways. 
The 5’-UTR of the transcript is the gateway to the coding region for the ribosome 
and many of the regulatory elements positioned here affect translation. In addition to 
sequences within the 5’-UTR that recruit RBPs, the RNA itself can form structures to 
inhibit or promote translation (Hinnebusch, Ivanov et al. 2016, Leppek, Das et al. 2018). 
One of the most important sequences in the 5’-UTR for translation initiation is the Kozak 
sequence, a consensus binding site adjacent to the CDS start codon. Alterations in the 
consensus can dramatically affect the amount of protein translated (Kozak 1986). 
The coding sequence is delineated by start and stop codons, which determine 
the first amino acid and terminate translation, respectively. The start codon, AUG, codes 
for methionine and translation typically ends at the first stop codon, either UAA, UAG, or 
UGA. On some transcripts the ribosome does not stop at the first termination codon and 
continues translation in a process known as readthrough. Although readthrough is not 
common in eukaryotes, it can serve several purposes such as creating C-terminal 
extensions to proteins, suppressing premature stop codons, and incorporating additional 
signal sequences (Dabrowski, Bukowy-Bieryllo et al. 2015). In Drosophila an estimated 
350 genes undergo readthrough and 42 readthrough events have been recorded in 
human cells (Lin, Carlson et al. 2007, Jungreis, Lin et al. 2011, Dunn, Foo et al. 2013).  
The coding sequence itself can also serve as a regulatory mechanism. The 
degenerate protein code allows for several nucleotide triplets to code for the same 
amino acid. As such, there is the potential for some codons to be translated more 
efficiently than others based on the available tRNA pool, in a model known as codon 
optimality. This in turn can effect translation rates and RNA stability (Hanson and Coller 
2018).  
The 3’-UTR of a transcript is a molecular epicenter for regulatory motifs. Most 
miRNAs and RBPs bind in this region which is laden with both sequence and structural 
elements. The length of a 3’-UTR can be controlled by alternative polyadenylation 
(APA), a mechanism by which during transcription an alternative, usually upstream PAS, 
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is used to initiate cleavage and splicing. APA can be used in a tissue-specific manner, 
where the cell type expressing the transcript has need of different regulatory parameters. 
In addition to changing the length of the 3’-UTR, APA can result in the creation of 
proteins with different lengths or domains. (Edwalds-Gilbert, Veraldi et al. 1997, Lutz 
2008). APA is also seen in cancer, where changes in 3’-UTR lengths effectively 
eliminate crucial regulatory elements that might otherwise illicit decay of the transcript 
(Mayr and Bartel 2009, Miles, Tschop et al. 2012). 3’-UTRs can also adopt secondary 
structures that may occlude binding sites for RBPs or miRNAs (Kedde, van Kouwenhove 
et al. 2010, Mayr 2017, Mayr 2019). 
The length of the poly(A) tail added to a nascent transcript in the nucleus is 
controlled by the interaction between CPSF, PAP, and PABPN (Kuhn, Gundel et al. 
2009). During the pioneer round of translation, nuclear PABPN is replaced by 
cytoplasmic PABPCs that cover the poly(A) tail with 25 nucleotide footprints (Smith, 
Gallie et al. 1997, Sato and Maquat 2009). PABPs have no enzymatic activity of their 
own but serve as binding sites for other proteins involved in translation, stability, and 
even decay. Since a long poly(A) tail coated with PABPC would theoretically inhibit the 
activity of a nuclease targeting the transcript, it has classically been believed that the 
longer a poly(A) tail was, the more stable the transcript would be. However, newer 
evidence suggests that transcripts with shorter tails are actively translated while longer 
tails are associated with lower abundance, poorly translated transcripts (Lima, Chipman 
et al. 2017, Nicholson and Pasquinelli 2019). Poly(A) tail length appears to govern 
translational status only during the very early stages of development (Eichhorn, Subtelny 
et al. 2016). Median tail length in the cytoplasm averages about 50 nucleotides in 
Drosophila, but poly(A) tail length is often dynamic and the mechanisms for controlling 
tail length are not well understood (Subtelny, Eichhorn et al. 2014).  
The makeup of RBPs and other associated factors bound to an RNA ultimately 
determine its fate. The oversimplified central dogma that states that genetic information 
flows from DNA to RNA to protein neglects the myriad of other fates that await an RNA 




1.3. Cytoplasmic fates of mRNA  
1.3.1. Translation 
Translation of a transcript in the cytoplasm consists of multiple steps. The first is 
the formation and binding of the 43S preinitiation complex to the RNA. This is a complex 
consisting of multiple initiation factors including the CBC, eIF4F, and the 40S ribosome 
subunit. eIF4F binds the 5’ cap and unwinds the structure of the transcript to allow 
ribosome loading. PABP also binds to this complex, forming what is known as the closed 
loop model of translation, where the 3’ and 5’ ends of the RNA interact (Jackson, Hellen 
et al. 2010). It is likely that this interaction is driven in part by the inherent structure of the 
RNA itself, and natural dynamic 5’-3’ proximity (Vicens, Kieft et al. 2018). The 43S 
complex then scans the RNA in the 5’ to 3’ direction until reaching an initiation codon 
where translation will begin. Binding of the 60S ribosomal subunit and associated factors 
initiates translation.  
Translation elongation and termination require the association of additional 
cofactors. Proteins known as elongation factors (eEFs) associate with amino-acyl tRNAs 
and are brought to the ribosome to join the matching amino acid to the growing peptide 
chain. Hydrolysis of GTP by eEF1A releases the tRNA into the aminoacyl site of the 
ribosome, while eEF2 promotes translocation of the tRNAs into the peptidyl and exit 
sites of the ribosome while the peptide bond is formed (Dever, Dinman et al. 2018). 
When the stop codon is reached, release factors eRF1 and eRF3 promote dissociation 
of the ribosome and the ribosomal subunits and cofactors are recycled for subsequent 
rounds of translation (Hellen 2018). 
Translation is a highly regulated and dynamic process. It is at this step the 
subsequent amplification of gene product occurs. A single mRNA molecule can be 
translated many times, resulting in amplification of protein. On average, 2800 proteins 
are made from one mRNA (Schwanhausser, Busse et al. 2011). Translation can be 
controlled in multiple ways including regulating the activity of initiation factors via 
phosphorylation, controlling the protein levels of translation factors, altering the pool of 
tRNAs, and inhibiting necessary interactions between the initiation machinery and the 
ribosome. Many of the regulatory elements in a mRNA are positioned in the 3’-UTR. A 
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reasonable explanation for this is to allow RBPs to remain bound to the transcript and 
continue to exert their influence even while a transcript is actively being translated. An 
RBP bound to the 3’-UTR is typically inhibitory (with PABP being a notable exception). 
Many RBPs can stymie translation by interfering with the ability of eIF4F to bind to the 
cap. This is typically mediated through interactions with a family of proteins called 4E-
BPs (eIF4E binding proteins) (Sonenberg and Hinnebusch 2009). 
1.3.2. Storage and localization  
An additional consideration of the total protein level derived from a transcript is its 
location. mRNAs often need to be transported to other cellular compartments for several 
reasons. Rather than rely on transport proteins or diffusion to relocate a finished protein 
to its final compartment, it is much more efficient to translate the protein near its ultimate 
site of action. Localization of transcripts can also prevent the accumulation of proteins in 
a given area, or enable rapid protein responses for functions such as signal transduction 
pathways (Blower 2013). Localization is critical during developmental processes, in 
neuron signaling, and co-translational insertion of endoplasmic reticulum (ER) proteins 
into the ER (Walter and Blobel 1981, Bashirullah, Cooperstock et al. 1998, Ohashi and 
Shiina 2020).  
mRNAs can also be localized to sites of ribonucleoprotein (RNP) condensates 
such as processing bodies (p-bodies) and stress granules. It is thought that these 
membrane-less cytoplasmic granules are formed by liquid-liquid phase separation and 
driven by weak RNA-RNA and RNA-protein interactions, especially by aggregate-prone 
domains within the proteins (Mittag and Parker 2018). P bodies are typically enriched in 
proteins that function in the decay pathway, but it is not clear whether they are sites for 
RNA decay or sequestration and storage (Brengues, Teixeira et al. 2005, Luo, Na et al. 
2018, Xing, Muhlrad et al. 2020). Stress granules contain translation initiation factors as 
well as decay proteins, and quickly form as a response to stress, initiating translational 
arrest (Kedersha, Chen et al. 2002, Markmiller, Soltanieh et al. 2018, Wolozin and 
Ivanov 2019). Upon relief of cellular stress the stress granules disassemble. Both stress 
granules and P bodies are highly dynamic and fluid objects and the mechanisms 
governing RNA entry and exit from them are still a matter of intense research. 
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1.3.3. Messenger RNA decay 
The final fate of a mRNA is the decay pathway, which begins with removal of the 
poly(A) tail by a poly(A) ribonuclease. There are several ways in which removal of the 
poly(A) tail leads to the degradation of the transcript. In the absence of a poly(A) tail, 
PABP is unable to bind the mRNA and translation is inhibited. Deadenylation by the 
CCR4-Not (CNOT) complex is coupled to 5’ cap removal and uncapped RNA in the 
cytoplasm are rapidly degraded by Xrn1, a non-specific 5’ > 3’ ribonuclease (Braun, 
Truffault et al. 2012). Transcripts can also be degraded in the 3’ > 5’ direction by the 
exosome. 
In addition to the control of general mRNA levels, the decay machinery is also 
necessary for quality control. Translation of a transcript is monitored closely by cellular 
surveillance mechanisms to ensure product fidelity. Damaged transcripts, stable RNA 
secondary structures, or rare codons can lead to stalling of the ribosome. Translation 
stalling, or no-go decay, leads to endonucleolytic cleavage and subsequent degradation 
by Xrn1 and the exosome (Simms, Thomas et al. 2017). In a similar decay pathway, 
failure of the ribosome to terminate translation at the stop codon triggers non-stop decay 
(Kashima, Takahashi et al. 2014).  Nonsense-mediated decay (NMD) occurs when the 
ribosome encounters a premature stop codon. In mammals, the activity of the 
spliceosome recruits the exon junction complex (EJC) to the RNA transcript. The EJC is 
a four-protein complex that binds to the RNA approximately 20 to 24 nucleotides 
upstream of the splice site and remains with the transcript until it is translated. The 
presence of the EJC downstream of a stop codon enhances NMD. The EJC does not 
seem to be necessary in Drosophila; rather the distance between the stop codon and the 
poly(A) tail determines whether the NMD pathway is initiated (Garneau, Wilusz et al. 
2007, Choudhury, Singh et al. 2016). 
There are multiple enzymes that can catalyze the removal of poly(A) tails in 
eukaryotes; the primary one in all organisms is the CNOT complex. Poly(A) ribonuclease 
(PARN) is also a deadenylase in mammals, but it is not present in Drosophila. 
Additionally, PARN has the ability to interact with the 5’ cap, which can link translation 
directly to decay (Temme, Zaessinger et al. 2004, Godwin, Kojima et al. 2013). In 




The PAN deadenylase complex is composed of the nuclease Pan2, and a 
homodimer of Pan3, which serves as an adaptor protein. PAN activity is dependent on 
PABP, an association mediated by an interaction between PABP and Pan3. The PAN 
complex is poly(A) specific and distributive, and processes poly(A) tails until 
approximately 25 nucleotides remain, believed to be the footprint of a single PABP 
(Wahle and Winkler 2013). The PAN complex appears to function in concert with the 
CNOT complex on certain transcripts, with the PAN complex initiating decay and the 
CNOT complex completing poly(A) tail removal (Yi, Park et al. 2018). 
The CNOT complex is a megadalton cytoplasmic complex conserved in all 
eukaryotes (Figure 1.3). In Drosophila, it consists of 5 to 6 stably associated subunits: 
Not1, Not2, Not3, Caf40 (Not9 in mammals), CCR4, and Pop2. Not4, an E3 ubiquitin 
ligase, is not always detected in immunoprecipitation assays and is not considered to be 
a stable complex member. Two accessory proteins, Not10 and Not11, can be detected 
with the CNOT complex as well (Temme, Zhang et al. 2010, Wahle and Winkler 2013). 
 
  
Figure 1.3: The CNOT deadenylase complex. (A) Depiction of assembled complex. Not1 is 
the largest member and acts as a scaffold for the other subunits. Caf40 has non-specific RNA-
binding activity and Pop2 is the active deadenylase in Drosophila. (B) Linear representation of 




Pop2 (also called CAF1) and CCR4 are the two deadenylase enzymes 
associated with the complex. CCR4 is an exonuclease/ endonuclease/ phosphatase 
(EEP)- family deadenylase and is the primary catalytic deadenylase in budding yeast, 
but it appears to have no activity in Drosophila. Pop2, a DEDD-class nuclease, is the 
primary catalytic subunit in Drosophila (Temme, Zaessinger et al. 2004). Each 
deadenylase has two orthologs in mammals: CNOT6 and CNOT6L for CCR4, and 
CNOT7 and CNOT8 for Pop2. The association between CNOT6/6L with the CNOT 
complex is mutually exclusive, as it is for CNOT7/8. Both CNOT6/6L and CNOT7/8 are 
catalytically active in mammalian cells.  
Not1 is the largest protein of the complex and forms the scaffold that binds the 
other subunits. In Drosophila, Not1 is approximately 2500 amino acids long and 280 
kDa. Not2 and Not3 both bind Not1’s C-terminal domain and together comprise the core 
NOT module. In Drosophila, only the NOT module and Pop2 are required for 
deadenylase activity (Temme, Zhang et al. 2010), however in vitro other human Not 
complex members can stimulate activity (Raisch, Chang et al. 2019). 
The CNOT complex links deadenylation to decapping and other decay pathways 
through multiple interactions with cofactors. The decapping complex, composed of Dcp1, 
Dcp2, and accompanied by decapping enhancers (Edcs), binds to Not1 through an 
interaction with Edc3 and Me31b (DDX6 in humans) (Chen, Boland et al. 2014). Once a 
transcript is decapped, it is rapidly degraded by Xrn1. This is ensured via a direct 
interaction between Xrn1 and Dcp1 (Braun, Truffault et al. 2012) and a direct interaction 
between Xrn1 and the CNOT complex (Chang, Muthukumar et al. 2019). 
Both the PAN and CNOT complexes can be recruited to the mRNA in a non-
specific manner by their interactions with PABP. For CNOT, the interaction is bridged by 
another protein, Tob (Funakoshi, Doi et al. 2007). The CNOT complex member Caf40 
also has intrinsic RNA binding activity (Garces, Gillon et al. 2007, Raisch, Chang et al. 
2019). Targeted recruitment of the deadenylase complex to a transcript can occur 
through interactions with sequence specific RNA binding proteins, or by microRNAs 
(miRNAs). 
miRNAs are ~22 nucleotide-long single-stranded RNAs loaded onto Argonaute 
proteins that can base pair with sequences primarily in a transcript’s 3’-UTR. Argonaute 
proteins are endonucleases, however the miRNA they carry must have near-perfect 
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complementarity to the mRNA target in order for them to cleave the RNA (Elbashir, 
Martinez et al. 2001, Hutvagner and Zamore 2002, Bartel 2009). Since this is rarely the 
case in metazoans, Argonautes and miRNAs mediate gene silencing by recruiting the 
decay machinery via interactions with GW182 proteins (TNRC6A/B/C in vertebrates). 
GW182 proteins contain N-terminal glycine and tryptophan repeats that interact with 
Argonaute proteins, and C-terminal tryptophan repeats that can bind either the CNOT or 
PAN complexes (Behm-Ansmant, Rehwinkel et al. 2006, Braun, Huntzinger et al. 2011, 
Fabian and Sonenberg 2012, Chen, Boland et al. 2014, Gebert and MacRae 2019). 
The CNOT complex interacts with multiple sequence-specific RNA-binding 
proteins to cause deadenylation of targeted transcripts. The TNF-α mRNA regulator, 
Roquin, binds to a conserved stem loop structure in the 3’-UTR and recruits the CNOT 
complex via an interaction with CNOT 9 (Caf40) (Leppek, Schott et al. 2013, Tan, Zhou 
et al. 2014, Sgromo, Raisch et al. 2017). Drosophila Bag of marbles (BAM) also recruits 
the CNOT complex through Caf40 (Sgromo, Raisch et al. 2018). Tristetraprolin (TTP; 
Tis11 in Drosophila) is an RBP that binds to A-U rich sequences. TTP interacts directly 
with Not1 through multiple contacts (Sandler, Kreth et al. 2011, Fabian, Frank et al. 
2013). Nanos, an important developmental morphogen, contains an N-terminal Not1 
interaction motif (NIM) with which it binds to the Not module (Bhandari, Raisch et al. 
2014). Interestingly, Drosophila Nanos does not contain the same motif but it retains the 
ability to contact the Not module including Not3 through an extended Nanos effector 
domain (NED) (Raisch, Bhandari et al. 2016). Most importantly, the PUF (Pumilio and 
FBF) family of RNA binding proteins direct regulation of their targets by recruiting the 
decay machinery. 
 
1.4. Pumilio and PUF proteins 
 
PUF proteins are defined by a characteristic RNA binding domain (RBD), termed 
the Pum-homology domain (Zamore, Williamson et al. 1997). PUF proteins bind 
specifically to sequences called Pumilio response elements (PREs). The founding 
members of the PUF family of proteins, Drosophila Pumilio (Pum), and C. elegans fem-3 
binding factor (FBF) were discovered by their ability to bind and regulate target mRNAs 
14 
 
during development. It is these two proteins that give the family their name. The PUF 
family is conserved in plants and throughout eukaryotes, though the more closely related 
proteins in higher organisms are referred to as Pum proteins. Drosophila has a single 
Pum protein, whereas mammals have two, PUM1 and PUM2. 
Since their initial discovery, many targets of Pum proteins have become known, 
and their roles in important biological functions are beginning to be elucidated. To date, 
Pums have been implicated not only in development, but in cancer (Miles, Tschop et al. 
2012, Naudin, Hattabi et al. 2017, Brocard, Khasnis et al. 2018), germ line maintenance 
(Lin and Spradling 1997, Forbes and Lehmann 1998, Crittenden, Bernstein et al. 2002, 
Chen, Zheng et al. 2012), learning and memory formation (Dubnau, Chiang et al. 2003, 
Baines 2005, Chen, Li et al. 2008), neurogenesis (Fiore, Khudayberdiev et al. 2009, 
Zhang, Chen et al. 2017, Martinez, Randolph et al. 2019), aging (Kopp, Elguindy et al. 
2019), cell cycle control (Lin, Qiang et al. 2019), mitochondrial homeostasis (D'Amico, 
Mottis et al. 2019), neurodegenerative disease (Gennarino, Singh et al. 2015, 
Gennarino, Palmer et al. 2018), cellular signaling (Bermudez, Jouandin et al. 2011), and 
immune response (Narita, Takahasi et al. 2014). RIP-chip (RNA immunoprecipitation-
microarray analysis) data in both human and Drosophila indicate that Pum proteins 
could potentially regulate 15% of the cell’s total transcriptome (Galgano, Forrer et al. 
2008). 
1.4.1. Essential roles of Pum proteins 
 Pum proteins are essential in higher organisms. Pum mutant flies fail to develop 
past the larval stage (Nusslein-Volhard, Frohnhofer et al. 1987). In mammals, double 
knockout Pum mice result in embryonic failure shortly after the blastocyst stage (Lin, 
Zhang et al. 2018). 
 
The first identified Pum targets 
 
In Drosophila, Pum (along with Nanos and Brat) is responsible for the correct 
abdominal segmentation in the embryo by regulating hunchback mRNA, a transcription 
factor that controls patterning genes. Loss of Pum results in improper accumulation of 
hunchback protein in the posterior and embryos fail to develop abdominal segments 
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(Barker, Wang et al. 1992, Murata and Wharton 1995). In C. elegans, the fem-3 mRNA 
is regulated by FBF to mediate the sperm to oocyte switch. C. elegans hermaphrodites 
produce sperm in a larval stage and transition to oocyte production as adults. During 
sperm production, TRA-1, a transcriptional regulator of feminizing genes, is suppressed 
by FEM-3. For the sperm to oocyte switch to occur, FEM-3 must be “turned off”. This is 
accomplished by decay of fem-3 mRNA by FBF proteins (Ahringer, Rosenquist et al. 
1992, Zarkower and Hodgkin 1992, Zhang, Gallegos et al. 1997, Bachorik and Kimble 
2005).  
 
Developmental and signaling roles 
 
Wing vein development in Drosophila is a process under the control of several 
different signaling pathways including epidermal growth factor receptor (EGFR) and 
Notch (Johannes and Preiss 2002). During the larval wing cell differentiation stage, 
enhanced EGFR signaling results in the generation of extra wing veins, a morphology 
phenocopied in Pum mutants (Kim, Kim et al. 2012). Yeast three-hybrid screens 
identified several RNAs in the EGFR pathway as Pum targets: egfr, rolled (human 
homolog MAPK1), the guanine exchange factor sos, and the adapter protein drk (human 
homolog GRB2). In a follow up luciferase reporter assay, overexpression of Pum caused 
repression of these targets, but not when the Pum binding sites were mutated (Johannes 
and Preiss 2002). 
In Drosophila, Pum proteins are necessary to keep migrating germline progenitor 
cells in a state of mitotic arrest. Pum mutants commence mitosis early and fail to migrate 
properly which ultimately leads to germline failure (Asaoka-Taguchi, Yamada et al. 
1999). Pum exhibits this control over the cell cycle by regulating cyclinB RNA in 
partnership with Nanos. Interestingly, Pum’s role in this regard appears to be for 
targeting, since Nanos is capable of repressing cyclinB RNA without Pum if it is tethered, 
and Pum does not bind to this transcript in the absence of Nanos (Kadyrova, Habara et 
al. 2007, Weidmann, Qiu et al. 2016).  
In human B cells infected with Epstein-Barr virus (EBV), Pums contribute to the 
control of poly(A) tail length of another important cell cycle protein, RGCC (Brocard, 
Khasnis et al. 2018). Expression of RGCC is essential for the growth of cells infected 
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with EBV. Depletion of Pum proteins allow an increase in protein levels of RGCC and 
contributes to the proliferation of infected cells. 
Several RIP-chip analyses have identified another cell cycle regulator, p27 (gene 
CDKN1B), as a bound target of both mouse and human PUM1 and PUM2 (Galgano, 
Forrer et al. 2008, Zhang, Chen et al. 2017). In human fibroblasts, knockdown of PUM1 
causes an increase in the levels of p27 protein (Kedde, van Kouwenhove et al. 2010). In 
addition to increased p27 protein levels, depletion of human PUM1 or PUM2 halted cell 
cycle progression and caused a delay of entry into S phase when cells were treated with 
growth factor. 
 
Neuronal roles  
 
Pum proteins have multiple roles in the Drosophila brain and neuromuscular 
system. In the peripheral nervous system, over-expression of Pum (and Nanos) reduces 
the number of high-order dendritic branches in class III and IV neurons (Ye, Petritsch et 
al. 2004). Overexpression of Pum during development of the neuromuscular system 
causes errors in axon guidance and leads to truncations in synapses (Kraut, Menon et 
al. 2001). At the neuromuscular junction (NMJ) Pum is necessary in neurons for proper 
bouton size and number, and in muscle Pum regulates the RNA of the glutamate 
receptor GluRIIa and controls translation of many other genes by targeting translation 
initiation factor eIF4E RNA. Reduction of Pum in this system causes accumulation of 
eIF4E aggregates. Additionally, Pum mutants have a higher frequency of spontaneous 
neurotransmitter release (Menon, Sanyal et al. 2004, Menon, Andrews et al. 2009).  
Neuronal hyperexcitability, observed as prolonged releases in neurotransmitters, 
is seen in Pum mutants, whereas over-expression of Pum can prevent such 
hyperexcitability in the NMJ (Schweers, Walters et al. 2002). This is due to the regulation 
of paralytic, which encodes the sole Drosophila voltage gated sodium ion channel. Over-
expression of Pum protein causes a decrease in the levels of paralytic mRNA. 
Conversely, Pum mutants show two-fold increases in the levels of paralytic (Mee, Pym 
et al. 2004).  
The formation of long-term memory relies heavily on localized translation. RNA 
packaged into neural RNP granules for transport remains in a quiescent state until it is 
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delivered to the active synapse, where translational de-repression commences. Pum 
was implicated as one of the proteins responsible for repressing translation in neural 
granules (Dubnau, Chiang et al. 2003). In a screen for memory formation mutants in 
Drosophila, two different p-element mutations of Pum were identified. These mutants 
show severe defects in one day memory after spaced training. Additionally, levels of 
Pum transcripts were found to increase during memory formation (Dubnau, Chiang et al. 
2003). 
1.4.2. Regulation of Pum 
1.4.2.1. Regulation of Pum RNA 
Little is known about how Pum itself is regulated, although Pum RNA is likely 
auto-regulated by the presence of 2 perfect PREs in the 3’-UTR. In humans, both PUM1 
and PUM2 RNA possess PREs. Pum RNA is frequently identified in RIP-Chip 
experiments as targets of Pum proteins, in Drosophila, mouse, and humans (Gerber, 
Luschnig et al. 2006, Galgano, Forrer et al. 2008, Morris, Mukherjee et al. 2008, Chen, 
Zheng et al. 2012, Laver, Li et al. 2015, Zhang, Chen et al. 2017). Via alternative 
polyadenylation, Drosophila Pum transcripts can be made with three different lengths of 
3’-UTRs, allowing for varying levels of regulation determined by developmental stage or 
other factors. 
Embryonic lethal abnormal visual system (ELAV), an RBP involved in alternative 
polyadenylation in developing neurons, binds to Pum RNA (Hilgers, Lemke et al. 2012). 
By associating with the longer form of Pum RNA near a proximal polyadenylation signal, 
ELAV likely regulates the production of longer Pum mRNA isoforms. In this model, ELAV 
binding to the proximal PAS site promotes transcriptional readthrough and results in the 
longer form 3’-UTR. Since ELAV itself is specific to neural tissues and is both temporally 
and spatially regulated, this model could describe one of many ways in which Pum 
activity is managed in developing neurons.  
Pum RNA is regulated by the RBP RbFox1 protein during Drosophila germline 
development. The 3’-UTR contains four Rbfox1 binding sites, two of which are 
conserved across many Drosophila species. Loss of Rbfox1 resulted in increased levels 
of pum RNA and germline tumor formation (Carreira-Rosario, Bhargava et al. 2016). In 
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addition, mouse Pum1 and Pum2 were identified as Rbfox targets by cross-linking and 
immunoprecipitation followed by high-throughput sequencing (CLIP-seq) in mouse 
neurons (Weyn-Vanhentenryck, Mele et al. 2014). 
A 2016 CLIP-seq experiment in S2 cells identified Pum RNA as a target of Orb2, 
the Drosophila Cytoplasmic polyadenylation element binding protein 2 (CPEB2) 
homolog. The shortest form of the Pum 3’-UTR contains 2 Orb2 binding sites, UUUGU, 
while the longer transcript variants contain a total of 9 Orb2 binding sites. Using a 
luciferase reporter containing the Pum 3’-UTRs, the study showed that Pum RNA is 
repressed by overexpression of Orb2 when compared to overexpression of an Orb2 
RNA-binding mutant (Stepien, Oppitz et al. 2016). 
In Drosophila ovaries, Pum mRNA was also identified in a RIP-seq experiment 
for Hrp38, the fly homolog of hnRNP A1. This was further validated by RIP-RT-PCR. 
Hrp38, best known for its roles in splicing and translation during development, also 
targets and represses Nanos RNA (Borah, Wong et al. 2009, Ji and Tulin 2016). 
Pum RNAs are also targets for miRNA-induced decay. Mammalian Pum2 is a 
direct target of miR134 in hippocampal neurons, where depletion of Pum RNA is 
necessary to promote dendritic outgrowth (Fiore, Khudayberdiev et al. 2009, Fiore, 
Rajman et al. 2014). Although there are no studies directly linking Drosophila miRNA to 
Pum regulation, TargetScan lists several potential miRNA seed sites in the 3’-UTR of the 
transcript, one of which matches the conserved family precursor miR 10. 
Given all of the crucial roles Pum proteins have in development and overall 
homeostasis, it is likely that Pum RNA is regulated by many other RBPs as well. 
1.4.2.2. Regulation of Pum protein 
Pum could potentially be regulated by post-translational modifications, including 
phosphorylation. These modifications could affect Pum’s target specificity, auto-
regulation, or binding partners. During the egg activation stage of embryonic 
development, Pum is regulated by the Pan Gu (PNG) kinase complex, a master kinase 
of oocyte to embryo transition.  This model describes a sequence of events in which 
Pum is bound to cyclin B RNA and thus represses its translation, until phosphorylation 
by PNG triggers de-repression of the transcript (Vardy and Orr-Weaver 2007). Although 
cyclin B is a well-characterized co-target of Pum and Nanos, the effects of 
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phosphorylation on Pum have not been studied. In vitro, a GST-Pum fusion protein is a 
substrate for PNG, but it is unclear whether this interaction occurs in vivo, or if it is 
biologically relevant (Hara, Lourido et al. 2018). In human fibroblasts, phosphorylation of 
PUM1 at serine 714 is rapidly increased following epidermal growth factor stimulation, 
and a phosphomimetic mutation (S714E) increased PUM1’s binding activity (Kedde, van 
Kouwenhove et al. 2010). Similarly, phosphopeptide enrichment in Drosophila embryos 
followed by mass spectrometry identified five phosphorylated serine residues (Zhai, 
Villen et al. 2008). Phoshopep lists an additional two observed phosphorylated Pum 
peptides, but the kinase(s) responsible for any of them have not been identified 
(Bodenmiller, Malmstrom et al. 2007). Another study in human HEK293 cells indicated 
that PUM2 is phosphorylated by the serine/threonine kinase Aurora A, and then 
physically associates with Aurora A to stabilize it against proteasomal degradation. This 
in turn leads to the accumulation of Aurora A protein and kinase activity, which allows 
the cell to enter mitosis (Huang, Wu et al. 2011). Although this model makes no mention 
of the function of Pums as RNA decay factors, the implication of Pums having other 
roles is intriguing.  
Long noncoding RNAs (lncRNAs) are reported to function as microRNA sponges 
to affect the available pool of miRNAs and thus counteract their repressive activities. 
Non-coding RNA activated by DNA damage (NORAD), a lncRNA with 17 PREs, 
functions in this manner against Pum proteins to regulate expression of Pum targets 
(Tichon, Gil et al. 2016). NORAD expression increases upon DNA damage and loss of 
NORAD leads to genomic instability (Lee, Kopp et al. 2016). Presumably this effect is 
due to increased activity of Pum in targeting specific DNA damage response factors 
such as centromere components, DNA replication factors, and proteins involved in 
mitosis (Lee, Kopp et al. 2016). NORAD is highly conserved, but only in mammals. In 
addition to NORAD, HCG11, a pseudogene of NORAD, also contains 17 PREs, 
although its effects on Pum are not known and its expression levels are reported to be 
much lower than NORAD (Chen, Bao et al. 2019). However, in lung cancer patients, 
both NORAD and HCG11 underexpression are associated with poor patient prognosis 
(Stewart, Enfield et al. 2019). It is also unclear if NORAD or HCG11 exist at high enough 




1.4.3. Protein interactors of Pum 
Pum’s mechanism of repressing target RNAs is multi-faceted and mediated 
through interactions with protein partners. During embryonic development, Pum 
associates with the RBP Nanos to control hunchback RNA (Arvola, Weidmann et al. 
2017). A consequence of Nanos binding cooperatively with Pum is enhancement of Pum 
binding and a potential increase of the target pool (Weidmann, Qiu et al. 2016). 
Additionally, the recruitment of Nanos is essential for binding certain targets like cyclin B, 
for which Pum alone has no affinity. A partnership with Nanos might also recruit the 
CNOT complex through Nanos’s NIM or NED.  In addition to Pum and Nanos, the RBP 
Brat also binds and regulates hunchback mRNA, though it remains unclear if Brat 
interacts with Pum or Nanos, or modulates their repressive activity (Arvola, Weidmann et 
al. 2017). 
In Xenopus, Pum interacts with cytoplasmic polyadenylation element binding 
protein (CPEB), a protein responsible for initiating cytoplasmic polyadenylation during 
oocyte maturation. CPEB interacts with poly(A) polymerase (PAP) to lengthen transcript 
poly(A) tails and allow for translation (Richter and Lasko 2011). Depending on the 
context of CPEB binding sites in the 3’-UTR, Pum’s association with CPEB can either 
enhance translation or enact repression (Pique, Lopez et al. 2008). Evidence exists of a 
conserved interface between PUF proteins and CPEBs, and human PUM2 was 
demonstrated to interact with CPEB3 via this interface (Benoit, Papin et al. 2008, 
Campbell, Menichelli et al. 2012).  
C. elegans FBF and human Pum2 interact with AGO proteins and disrupt 
translation elongation by inhibiting the GTPase, eEF1a (Friend, Campbell et al. 2012). 
Although the RBDs of Pum2 and Drosophila Pum interact with AGO in vivo, this 
association is not necessary for translational repression. Rather, repression occurs 
through antagonism of PABP, although the exact mechanism is not clear. Deadenylation 
is enhanced by the RBD, presumably by the recruitment of the CNOT complex 
(Weidmann, Raynard et al. 2014).  
  Mass-spectrometry of human Pum complexes revealed the presence of multiple 
members of the CNOT complex, and subsequent analysis using immunoprecipitation 
assays showed physical associations with the deadenylase subunits in vivo (Van Etten, 
Schagat et al. 2012). In vitro, both the N-terminus and the RBD of Drosophila and 
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human Pums are able to interact with the CNOT complex (Arvola, Chang et al. 2020, 
Enwerem, Elrod et al. 2021). Additionally, the ability of Pums to repress is dependent on 
the deadenylase activity of the CNOT complex although the mechanism of this 
interaction is not clear. 
1.4.4. The structure of Pum proteins 
Between the human and fly proteins, there is 80% identity within the RNA-binding 
domain (RBD) (Goldstrohm, Hall et al. 2018). The RBD, like all PUF family members, is 
composed of 8 alpha-helical repeats. Each repeat consists of ~40 amino acids arranged 
in 3 helix-turn motifs. The overall structure adopts a crescent shape, where the concave 
face binds the RNA using aromatic and basic residues (Wang, Zamore et al. 2001). 
Base-staking and Watson-Crick interactions with the RNA give Pum precise sequence 
specificity to the nucleotides UGUANAUA, with nanomolar affinity (Weidmann, Qiu et al. 
2016). The Pum RBD binds to the RNA in a “backward” orientation, where the C-
terminus of the protein faces the 5’ end of the transcript. The eighth alpha-helical repeat 





Although the RBD is responsible for targeting Pum to a transcript, the RBD alone 
is not sufficient to rescue the segmentation defect of Pum-null Drosophila embryos 
(Wharton, Sonoda et al. 1998). In the Drosophila NMJ, full-length Pum is necessary to 
rescue the neuromuscular defects seen in Pum mutants, and regulation of voltage gated 
sodium channels and paralytic RNA requires full-length Pum (Menon, Sanyal et al. 2004, 
Muraro, Weston et al. 2008). In addition, in a luciferase assay reporter system, the RBD 
alone accounted for only 22% of the repressive activity when compared to the full-length 
Figure 1.4: The structure of Pum. (A) Crystal structure of the RNA binding domain, PDB entry 
5KLA; image generated using PyMOL. Below the structure is shown the PRE sequence that Pum 
binds to. (B) Schematic representation of Drosophila Pum protein, showing repression domains 
(RDs), PCMa and PCMb, and the RBD. Amino acid positions are shown above. 
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protein, indicating that the majority of Pum’s repressive ability is contained in the N-
terminus (Weidmann and Goldstrohm 2012).  
The N-terminus of Pum is predicted to be disordered, and no crystal structures 
have been solved. The N-terminus is divergent between human and Drosophila, 
however two regions of conserved residues exist, PCMa and PCMb (Weidmann and 
Goldstrohm 2012). PCMa, located at residues 379 to 547, shares 38% identity with 
human Pums, and PCMb, residues 777 to 847, shares an average of 65%. The 
intervening areas between PCMa and PCMb of the N-terminus can be divided into three 
unique repressive domains (RDs): RD1 (amino acids 1 to 379), RD2 (aa 547 to 777), 
and RD3 (aa 847 to 1090). In a tethered luciferase assay reporter system, each 
individual RD maintains the ability to affect decay, with RD2 and RD3 having the highest 
levels of activity (Weidmann and Goldstrohm 2012). The PCMs have little to no 
repressive activity on their own and appear to have auto-regulatory functions. 
Expressing PCMb as a fusion construct to the RDs can counteract the repression 
conferred by an RD, and PCMa appears to counteract PCMb. It is not clear how these 
disparate regions of Pum function together to bring about target mRNA decay. 
Much has been learned about Pum proteins since their discovery over thirty 
years ago, but many questions remain. One aspect yet to be fully explored is the 
mechanism by which Pums cause decay of target transcripts. Pum proteins effect decay 
through an association with the CNOT complex, but the residues or regions responsible 
have not been identified. In this work we seek to understand how RD3 contributes to the 





Chapter 2: Structure-function analysis of RD3 
2.1. Introduction 
Pum enacts decay by recruiting the CNOT deadenylase complex. Both 
Drosophila and human Pums interact with the complex (Van Etten, Schagat et al. 2012, 
Arvola, Chang et al. 2020, Enwerem, Elrod et al. 2021) and Pum’s activity is severely 
diminished when Not1 or Pop2 are depleted (Arvola, Chang et al. 2020).  
We hypothesized that Pum directly recruits the CNOT complex through short 
interaction motifs. We sought to identify those regions within Pum that are responsible 
for recruiting the CNOT complex and to define which members of the complex were 
necessary for the interaction. 
The functional redundancy of human PUM1 and PUM2 makes it difficult to 
evaluate their mechanism of action. With only a single Pum protein, Drosophila Pum is 
well-suited to functional and biochemical characterization. Drosophila cells are simple to 
maintain in culture, and highly amenable to manipulation. We employed this system to 
interrogate the method of Pum repression.  
The three repression domains (RDs) in the N-terminus of Pum exhibit functional 
redundancy and removal of a single RD has little effect on the activity of the protein 
(Weidmann and Goldstrohm 2012). Because of this, it was necessary to focus on a 
single RD in order to examine the mechanism of repressive activity. RD3 was chosen for 
several reasons. First, in human Pums, RD3 contains the most activity (Weidmann and 
Goldstrohm 2012). Human RD3 also interacts with the CNOT complex in vitro, whereas 
RD1 and RD2 do not (Enwerem, Elrod et al. 2021). Second, RD3 is the only RD present 
in all annotated protein isoforms. The shortest isoforms in Drosophila contain only a 
small portion of RD2, followed by PCMb, RD3, and the RBD. The spatial and temporal 
expression levels of the different Pum isoforms have not been studied in detail. It is 
therefore possible that in certain developmental contexts, RD3 will have the highest 
biological significance. Third, RD3 is the most conserved of the three RDs. Human 
PUM2 does not have a functional RD1, and RD2 has 16% amino acid identity between 
Drosophila and human Pums, whereas RD3 has 23% identity. 
In Drosophila, the Pum gene has nine annotated transcripts (A-H, illustrated in 
Figure 2.1) and encodes five unique protein isoforms. Isoform A is considered the 
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canonical protein and is 1533 amino acids in length. This form is approximately 160 kDa 
in size (Thurmond J 2019). The shorter isoforms are predicted to make proteins around 
98 kDa (isoforms E, F, and H) or 130 kDa in size (isoform B). In adult flies, ovaries and 
embryos, both the 160 and 130 kDa isoforms are present (Parisi and Lin 1999). It is not 
known under which conditions the shorter isoforms are expressed. Dmel2 cells express 
both 130 and 160 kDa forms, but only the 160 kDa form is detected in Dl1 cell lines via 




Figure 2.1: Drosophila Pum isoforms. Isoform A is considered the canonical isoform. The 
transcripts that encode isoforms A, C, D, and G differ in their UTRs. Note that in isoforms E, F, 
and H, RD3 is the only complete RD. Human PUM1 and PUM2 are also shown for comparison. 
Drosophila Pum is most closely related to human PUM2, despite PUM2’s lack of RD1.  
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2.2. Overall structure of RD3 
In Drosophila, RD3 is comprised of amino acids 847 to 1090 (Figure 2.1). This 
area lies between PCMb on the 5’ end and is immediately followed by the RBD 
(Weidmann and Goldstrohm 2012). RD3 contains many stretches of sequence 
dominated by a single amino acid, specifically alanine and/or glutamine. It has been 
proposed that similar stretches in other proteins might play a role in forming protein 
aggregates or serve as spacer regions between functional motifs (Laughon, Carroll et al. 
1985, Macdonald 1992). For RD3, these intervening regions show very little 
conservation, even in other insect species. The entire Pum N-terminus contains 
numerous low complexity areas that are not amenable to structural analysis. For this 
reason, our approaches were limited to functional analyses of the conserved regions. 
 
2.3. Identification of conserved residues in RD3 
Using an alignment of 82 Pum proteins across 45 different species, we sought to 
identify regions of conservation that could indicate functional residues. The alignment 
was generated with Clustal Omega and ConSurf using Pum proteins from species 
including insects, reptiles, birds, and mammals. This alignment highlighted several 
interesting features of Pum proteins, including several conserved glutamine-rich regions 
and multiple regions of alanine stretches present in insects. From this alignment, five 
regions of conservation were annotated in RD3: Q-P/N-rich region, CR1, CR2, CR3, and 




The Q-P/N-rich region spans from aa 857 to 876 (Figure 2.3). This stretch of 
twenty amino acids contains seven glutamine and seven proline residues, interspersed 
with small hydrophobic and uncharged amino acids. In humans, ten of these residues 
are identical, with small changes in position. Several other Q-rich regions are present in 
the N-terminus of Pum as well and can form aggregates in yeast cells and amyloid fibrils 
(Macdonald 1992, Salazar, Silverman et al. 2010). Due to the rapid evolution of 
aggregate-forming glutamine-rich areas of proteins, the overall amino acid compositions 
tend to be conserved, even if the positions are not. Both human Pum proteins also retain 
multiple areas rich in glutamine residues, and mouse Pum2 can form aggregates in 
neurons (Vessey, Vaccani et al. 2006). 
Figure 2.2: Location of conserved regions (CRs) in RD3 of Drosophila Pum. Full-length Pum 
is shown at top, with an expanded view for RD3 below. The amino acid positions for each CR 




CR1 lies within aa 895 to 913 of Drosophila Pum (Figure 2.4). Of these 19 amino 
acids, 13 are identical in human Pums. Serine 902 is a known phosphorylated residue 
and is one of the conserved residues (Bodenmiller, Malmstrom et al. 2007). Serine 
residues make up 32% of CR1, making CR1 relatively serine-rich. This feature could 
have functional significance, as both human Pums are enriched in serine residues as 
well.  
 
Figure 2.3: The Q-P/N region. A selection of ten different Pum proteins from a ConSurf 
alignment of 45 different species is shown. Relative conservation for each amino acid position is 
shaded according to the ConSurf color scheme. Residues with insufficient data to reliably call 
position are underlined. Amino acid positions for Drosophila Pum are listed. 
Figure 2.4: Conserved region 1. A selection of ten different Pum proteins from a ConSurf 
alignment of 45 different species is shown. Relative conservation for each amino acid position is 
shaded according to the ConSurf color scheme. Residues with insufficient data to reliably call 
position are underlined. Amino acid positions for Drosophila Pum are listed. 
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CR2 is separated from CR1 by an intervening region comprised of 43% alanine 
residues. In human Pums, CR1 and CR2 are only about 13 aa apart. In Drosophila Pum, 
CR2 spans from aa 969 to 984 (Figure 2.5). In humans and many other species, an 
additional nine amino acids are inserted just before I-979. Apart from this divergence, 
69% of Drosophila CR2 residues are identical to human.  
 
CR3, (Drosophila Pum aa 992 to 1002), is the most invariant region in all 45 
species (Figure 2.6). The initial seven residues, with the exception of R993, are 
absolutely conserved in both composition and position. For CR3, Drosophila appears to 
be the unusual species in that it harbors the most deviation in the latter half of CR3. Of 
all aligned species, only Drosophila lacks the A/T-K-Y residues. Instead, Drosophila Pum 
uses S-R-Q.  
Figure 2.5: Conserved region 2. A selection of ten different Pum proteins from a ConSurf 
alignment of 45 different species is shown. Relative conservation for each amino acid position is 
shaded according to the ConSurf color scheme. Residues with insufficient data to reliably call 





The space between CR3 and CR4 is another region rich in alanine residues, 
including a stretch of 6 glutamines. In higher organisms, this intervening region is 
absent, making CR3 and CR4 essentially one longer conserved region.  
In flies, CR4 begins at aa1030 and spans 11 residues (Figure 2.7). CR4 is 
followed by another alanine-rich region that is also absent in most other species, 
including other insects. In Drosophila, CR4 contains several asparagine residues that 
have evolved into serines in higher organisms. There are two invariant phenylalanine 
residues as well. 
Figure 2.6: Conserved region 3. A selection of ten different Pum proteins from a ConSurf 
alignment of 45 different species is shown. Relative conservation for each amino acid position is 





2.4. Functional activity of conserved regions 
To test the functional relevance of these conserved regions and identify the 
area(s) of RD3 responsible for activity, a tethered luciferase assay system was 
employed. Full-length RD3 or deletion constructs were expressed as fusions to N-
terminal bacteriophage MS2 coat protein. MS2 coat protein specifically recognizes and 
binds as a homodimer to RNA MS2-stem loop structures. A plasmid encoding 
Nanoluciferase (NLuc) enzyme followed by a set of two MS2 stem loops served as the 
target substrate. This system is an established and reliable readout for measuring the 
repressive activity of Pum (Weidmann and Goldstrohm 2012, Arvola, Chang et al. 2020). 
In this way we were able to direct RD3 constructs to the NLuc reporter target (Figure 
2.8). Plasmids were co-transfected with firefly luciferase (FFLuc) as an internal control 
and fold change was determined as the ratio of NLuc to FFLuc. Repressive activity was 
determined relative to MS2-eGFP negative control (Figure 2.8 A). Normalizing activity to 
tethered MS2-eGFP accounts for the natural repressive effect seen when directing any 
tethered protein to an MS2 stem loop reporter. 
Figure 2.7: Conserved region 4. A selection of ten different Pum proteins from a ConSurf 
alignment of 45 different species is shown. Relative conservation for each amino acid position is 





In this system, WT RD3 repressed the reporter an average log(2) fold change 
of -0.663 when normalized to eGFP. As a positive control, we included the decapping 
factor Dcp1, which resulted in an average log(2) fold change of -1.82 when tethered 
(Figure 2.8 C). After establishing the effectiveness of this system, we used a dual 
approach consisting of truncations of RD3 and internal deletions of the CRs. 
2.4.1. Truncations of RD3 
The first constructs tested were simple divisions of RD3, including halves and 
thirds (Figure 2.9 A). Consideration was taken in ensuring no CR was interrupted in the 
design of these truncations. The first half consisted of 121 amino acids (847 to 967): the 
Q-P/N region and CR1, while the second half retained CR2, CR3, and CR4 and 
comprised 123 amino acids (968 to 1090). The thirds of RD3 were divided into aa 847 to 
926 (1/3), aa 927 to 1009 (2/3), and aa 1010 to 1090 (3/3). The 1/3 area of RD3 
contained the Q-P/N region and CR1, the 2/3 contained CR2 and CR3, and the last 3/3 
contained only CR4. Very little activity remained when RD3 was divided into small 
regions (Figure 2.9 B). The first half exhibited only about 40% of WT RD3 activity, while 
Figure 2.8: The tethered luciferase system. (A) Fold change is calculated by dividing the 
ratio of Nano luciferase (NLuc) reporter to Firefly luciferase (FF) control for the effector 
condition to the NLuc:FF ratio for the control condition. FF is used to control for transfection 
efficiency and general cell health and viability. (B) Schematic representation of the NLuc 
tethered reporter. The 3’ UTR of the NLuc transcript contains 2 MS2 stem loop structures 
which are recognized by the MS2 viral coat protein. Each RD3 effector is expressed as an 
MS2 protein fusion, which serves to convey RD3 to the transcript in the absence of an RBD. 
The FF internal control has a minimal 3’-UTR and is not regulated. (C) Representation of 
repression. DCP1, a decapping factor, is a positive control for decay of the NLuc reporter. RD3 
also causes decay of the reporter. Both effectors are normalized to eGFP. Repression is 
shown as log(2) fold change. 
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the second half had about 20%. This could have been due in part to a lower level of 
expression of these constructs when compared to RD3 (Figure 2.9 C). 
 
Figure 2.9: Repressive activity of RD3 truncations. (A) Schematic representation of 
truncations made of RD3. Heavy lines separate where divisions were made for halves and thirds 
of RD3. Amino acid positions are listed above the diagram which correspond to the numbering of 
truncations in the graph. (B) Log(2) fold change data showing the mean activity level of RD3 and 
the truncations tested, with standard error of the mean (SEM) indicated (n ≥ 16). Significance 
compared to eGFP is shown along the x-axis, while significance compared to WT RD3 is shown 
at the bottom of the graph. Significance calling is as follows: * = p < 0.05, ** = p < 0.01, 
*** = p < 0.001. (C) Western blot showing protein expression levels of all tested constructs. 
Tubulin is used as a loading control. 
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A titration of RD3 was done to determine if a slight decrease in expression level 
could account for the poor activity seen with the truncations (Figure 2.10). RD3 still 
exhibited nearly full function even at 10 ng transfected DNA with 44% of the protein level 
compared to RD3 (29% repression at 10 ng, compared to 36% for 100 ng; 81% of WT). 
At 5 ng transfected only 20% as much protein was expressed and RD3 had 69% activity 
of WT. The small thirds of the protein, despite having adequate protein expression, had 
no activity. This indicated that the CRs represented in each truncation were not enough 
in this context to enact repression.  
 
Figure 2.10: Titration of RD3. (Top) Differing amounts of plasmid DNA encoding RD3 were 
titrated to determine the effective concentration of DNA to protein expression level (n = 4, 4 
biological replicates of one experiment). Mean values are plotted with SEM. Significance 
compared to eGFP is shown along the x-axis, while significance compared to 100ng transfected 
RD3 is shown at the bottom of the graph. Significance calling is as follows: * = p < 0.05, 
** = p < 0.01, *** = p < 0.001. (Bottom) Western blot showing expression level of RD3 with tubulin 
used as a loading control. 
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 Other truncations of RD3 were tested and results are summarized in Figure 2.11. 
One of the observations made was that the stretch of amino acids between CR4 and the 
RBD was not necessary for function since the truncation had 100% activity (aa 847 to 
1042). The region of RD3 encompassing CR2 and CR3 also did not appear crucial for 
repression although we did not test removing them without the upstream aa 913 to 969. 
Curiously, this region of RD3 with no CRs did appear to have an impact on activity when 
we compared aa 847 to 967 to aa 847 to 926, and aa 927 to 1090 to aa 968 to 1090 
(Figure 2.11). There is very little sequence conservation in this area, although there are 




Figure 2.11: Summary of RD3 truncations. Schematic representation of the tested truncations 
of RD3, with CR positions and amino acid positions shown. The average activity of each 
construct is shown as a percentage of WT RD3. n ≥ 12 for all constructs. 
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2.4.2. Deletions of conserved regions 
 
Next, we tested deletions of the conserved regions. Individual deletions of the 
CRs had varied effects on the repressive activity of Pum RD3 (Figure 2.12). Deleting the 
Q-P/N region resulted in a relatively small but significant decrease in repression. ∆Q-P/N 
retained about 84% of wild type RD3 activity. Deleting CR1 had a greater impact on 
activity- removing this CR resulted in 72% of WT activity. Interestingly, deleting CR2 did 
not seem to have much of an impact on repression at all. When CR3 was removed, RD3 
retained 66% of its wild type activity. The largest effect on activity was seen when CR4 
was removed- only 21% of RD3 activity remained. These results indicated that more 
than one CR might be necessary for RD3’s activity. Without structural information, it was 
not possible to determine if internal deletions were affecting folding or other potential 
structural motifs RD3 might have. Because RD3 is predicted to be unstructured, we 
hypothesized the lack of activity was due to the missing amino acids affecting RD3’s 




Since the deletion of any single CR was insufficient to completely abrogate 
function, we next tested deletions of two or more conserved regions. Deleting the Q-P/N 
region or CR2 with other CRs did not have an appreciable effect on repression over the 
single CR deletions, so further analysis was focused on CR1, 3, and 4. However, double 
deletions involving CR2 had an unexpected effect in that deleting CR2 with another CR 
mitigated the loss of repression seen with a single CR deletion (Figure 2.13). With the 
exception of CR4, when any CR was deleted in conjunction with CR2, there was no loss 
of activity. Removing CR2 with CR4 restored activity over ∆CR4 alone to approximately 
Figure 2.12: Deletions of the conserved regions of RD3. (Top) Graph showing mean 
relative activity level of RD3 and single truncations of the CRs, with SEM (n ≥ 12). Significance 
compared to WT RD3 is shown. Significance calling is as follows: * = p < 0.05, ** = p < 0.01, 
*** = p < 0.001. (Bottom) Western blot showing protein expression of all tested constructs, with 
tubulin used as a loading control. 
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50% of WT RD3. However, as our main focus was determining which areas of RD3 
contribute to repression, this phenomenon was not explored further. 
 
  
Since CR1, CR3, and CR4 appeared to contribute the most to RD3’s repressive 
activity, we focused on double deletions involving these CRs. Deletions of CR4 with CR1 
were highly effective in alleviating repression by RD3, and reduced activity to 
Figure 2.13: Double CR deletions involving CR2. (Top) Mean relative activity of single CR 
deletions compared to double deletions. Single deletions are labeled and shown in red. Double 
deletions involving CR2 are labeled and shown in purple (n ≥ 12). Error bars represent SEM. 
Significance between pairs of comparisons is shown. Significance compared to WT RD3 is shown 
at the bottom of the graph. Significance calling is as follows: * = p < 0.05, ** = p < 0.01, 
*** = p < 0.001. (Bottom) Western blot showing protein expression of all tested constructs, with 
tubulin used as a loading control. 
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approximately 4 percent of wild type RD3 (Figure 2.14). Although ∆CR3+CR4 was also 
striking, it was not statistically different than deleting CR4 alone. In addition, deleting 
CR1 in conjunction with CR3 did not have an additive effect on repression. This 
indicated that CR3 was not as important as CR1 and CR4 for RD3’s repressive function. 
We hypothesized that CR4 could be a main point of contact with a protein partner and 
that CR1 might also contact a partner in a secondary fashion or strengthen CR4’s 




Figure 2.14: The effects of double CR deletions on RD3 activity. (Top) Graph showing mean 
relative activity of deletions involving 2 CRs of RD3 (n ≥ 12). Error bars represent SEM.  
Significance compared to ∆CR1 and ∆CR4 is shown. Significance calling is as follows: 
* = p < 0.05, ** = p < 0.01, *** = p < 0.001. (Bottom) Western blot showing protein expression of 
all tested constructs, with tubulin used as a loading control. 
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2.4.3. Alanine scanning of conserved regions 
To identify the important residues within CR1 and CR4, an alanine scanning 
strategy was employed. We reasoned that if a group of mutations were to cause an 
equal loss of activity as deleting the entire CR, it would indicate that one or more of the 
amino acids in the group could be a site of protein interaction. Since CR1 is 19 amino 
acids in length, groups of 3 to 4 residues were mutated to alanine (Figure 2.15 A), while 
groups of 2 to 3 residues were used for CR4 (Figure 2.16 A).  
When alanine mutations in CR1 were tested, the results were similar for all 
groups. Every group reduced repressive activity, and none of the mutants were 
significantly different from ∆CR1. Three groups showed statistical difference from WT 
RD3: RRD>AAA, SAF>AAA, and SPS>AAA. These results indicated that any of the 




Five groups of alanine mutations in CR4 were tested (Figure 2.16). Interestingly, 
the first set of two asparagine residues caused an increase in activity when mutated to 
alanine, increasing repression from 31%, when compared to eGFP, to 43%. In most 
Figure 2.15: Alanine scanning of CR1. (A) Diagram of groups of alanine mutations. The sets of 
mutations tested are indicated by boxes. (B) Mean relative activity level of CR1 alanine mutations 
is shown compared to WT RD3 and ∆CR1 (n ≥ 11). Error bars represent SEM. Significance 
compared to WT RD3 is shown. Significance calling is as follows: * = p < 0.05, ** = p < 0.01, 
*** = p < 0.001. (C) Western blot showing protein expression of all tested constructs, with tubulin 
used as a loading control. 
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species, these two amino acid positions are serine residues (Figure 2.7). The sets 
GS>AA and NS>AA had no effect on activity. The last two sets, MF>AA and SIF>AA 
both showed a substantial loss of repression compared to WT RD3. To test whether the 
loss of activity was due to mutating the serine residue, and to avoid the potential for 
neighboring serines to “compensate” for its loss, all three serines in CR4 were mutated 
to alanine. This resulted in a slight increase in activity when compared to the group 
mutation of SIF>AAA (Figure 2.16 B). This implied that the serine residue was not the 






Since an isoleucine to alanine change is a conservative mutation, as is 
methionine to alanine, we reasoned that the two phenylalanine residues present in both 
groups were important. Additionally, phenylalanine residues are often seen at protein-
protein interfaces due to their bulky and hydrophobic nature. Mutating each 
Figure 2.16: The effects of CR4 alanine mutations on RD3 activity. (A) Diagram of groups of 
alanine mutations. The sets of mutations tested are indicated by boxes. (B) Mean relative activity 
level of CR4 alanine mutations is shown compared to WT RD3 and ∆CR4 (n ≥ 12). Error bars 
represent SEM. Significance compared to WT RD3 is shown. Significance calling is as follows: 
* = p < 0.05, ** = p < 0.01, *** = p < 0.001. (C) Western blot showing protein expression of all 
tested constructs, with tubulin as a loading control. 
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phenylalanine residue separately resulted in a loss of approximately half of RD3’s 





The effects of deleting CR1 alone were minimal to RD3’s repressive activity, yet 
when CR4 was deleted in combination with CR1, repression was lost entirely. We 
sought to identify the residues in CR1 which appeared to work in conjunction with CR4. 
Since mutating both phenylalanine residues in CR4 eliminated repression, we focused 
on mutations involving F1033 with CR1 groups where we could observe any effect of 
synergism. Each single CR1 mutation was compared to the combined mutations with 
Figure 2.17: Mutations of the phenylalanine residues in CR4. (Top) Mean relative activity 
level of phenylalanine mutations compared to the first mutation sets tested, with SEM (n ≥ 12). 
Significance compared to ∆CR4 is shown. Significance calling is as follows: * = p < 0.05, 
** = p < 0.01, *** = p < 0.001. (Bottom) Western blot showing protein expression of all tested 
constructs, with tubulin used as a loading control. 
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F1033A (Figure 2.18). The expected combined additive effect of the loss of functional 
residues with RRD>AAA and F1033A would be about 33% activity of WT RD3. With 
20.5% activity remaining, only the RRD>AAA + F1033A group appeared to exhibit 
synergism. The RRD>AAA group was also an important group when mutated in WT RD3 




Figure 2.18: Effects of alanine mutations involving CR1 and CR4 F1033A. (Top) Mean 
relative activity of CR1 alanine mutations either alone (purple) or in combination with CR4 
F1033A (red). n ≥ 11. Error bars represent SEM.  Significance compared to the single mutation of 
CR4 F1033A is shown. Significance calling is as follows: * = p < 0.05, ** = p < 0.01, 
*** = p < 0.001. (Bottom) Western blot showing protein expression of all tested constructs, with 
tubulin used as a loading control. 
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2.4.4. Sufficiency of CR1 and CR4 
Having established that CR1 and CR4 are necessary for RD3’s activity, we next 
asked if they were sufficient. Multimers of CR1 and CR4 were cloned as MS2-eGFP 
fusions with the eGFP being added to improve protein expression levels. Each set of 
CR1+4 was separated by a flexible serine-glycine linker 28 amino acids in length, with 
the same linker between CR1 and CR4 (Figure 2.19).  
 
 
Multimers of CR1+4 are sufficient to repress a reporter mRNA (Figure 2.20). A 
small amount of activity was seen with a single set of CR1+4, however the construct was 
not expressed well. As the number of CR1+4 repeats was increased, repression also 
increased, up to a level that surpassed WT RD3 activity, with 5x CR1+4. 6x CR1+4 also 
had more repressive activity than WT RD3, but it was not expressed as well as the 5x 
construct.  
Figure 2.19: The CR1+4 constructs. (A) Schematic representation of the luciferase assay 
reporter with MS2 stem loops, and the MS2-eGFP CR1+4 multimer constructs. (B) Amino acid 
sequence identity of the multimer constructs. Following the MS2-eGFP sequence is a flexible 28 
amino acid linker preceding CR1, represented by dashes. The same linker separates CR1 and 
CR4. Brackets denote the repeating unit considered one unit of the multimer. The identity of the 




To demonstrate the importance of the phenylalanine residues in these 
constructs, a 5x CR1+4 mutant was made in which both phenylalanine residues were 
mutated to alanine (5x CR1+4 FF mut). Although the mutant constructs retained a 
significant amount of repressive activity, it was due in part to their higher expression 
levels. To determine how much activity could be attributed to the higher expression level 
of the mutant, we used western blots normalized to tubulin to determine relative 
expression levels between the 5x CR1+4 and its mutant. The relative expression levels 
Figure 2.20: Repressive activity of the multimers of CR1 and CR4. (Top) Mean relative 
activity level of CR1+4 multimers compared to WT RD3 (n ≥ 12). Error bars represent SEM. 
Significance compared to WT RD3 is shown. Significance calling is as follows: * = p < 0.05, 
** = p < 0.01, *** = p < 0.001. (Bottom) Western blot showing protein expression of all tested 
constructs, with vinculin used as a loading control.  
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from three independent titrations were averaged to give an overall equivalency estimate. 
By this calculation, 100 ng of the 5x CR1+4 construct expressed at the same level as 24 
ng of the 5x CR1+4 FF mutant. At an equivalent level of protein expression, the 5x FF 
mutant had very little activity (Figure 2.21). This further established the importance of the 
phenylalanine residues in CR4. 
 
 
Figure 2.21: Titration of the 5x CR1+4 FF mutant. (Top) Mean relative activity level of 
increasing amounts of transfected 5x CR1+4 FF mut DNA, compared to WT RD3 and 5x 
CR1+4 (n ≥ 12). Error bars represent SEM. Significance compared to eGFP is shown along the 
x axis. Significance calling is as follows: * = p < 0.05, ** = p < 0.01, *** = p < 0.001. (Bottom) 




2.5. Summary and discussion 
In this study, we found that RD3 has several conserved regions. The most 
important areas for RD3 repressive function were CR1 and CR4, specifically two 
phenylalanine residues within CR4, F1033 and F1040. Using a tethered reporter system, 
we were able to demonstrate that these two phenylalanine residues are necessary for 
RD3’s activity. We were also able to show that CR1 and CR4 were sufficient for activity. 
Deleting CR1 alone had a small effect on activity and reduced RD3 function to 65% of 
WT RD3. Removing both CR1 and CR4 eliminated RD3 activity. Activity was also lost 
when CR4 was deleted, or when both phenylalanine residues were mutated.  
Curiously, mutating both phenylalanines in CR4 had a more detrimental effect 
than deleting CR4 entirely. If the position of CR4 is important to its function, it is possible 
that the deletion of CR4 brings other residues into proximity that may fractionally 
compensate for its loss.  The N-terminal side of CR4 is alanine rich with several 
glutamines, and this stretch of residues was absent in the other 41 species we 
examined. The C-terminal side of CR4 is not conserved in amino acid position, but most 
species contain serine, proline, and tyrosine or threonine interspersed with small 
hydrophobic residues. A truncation of RD3 which removed all the amino acids following 
CR4 retained full activity (aa 847 to 1042, Figure 2.11), although this construct was not 
tested with a CR4 deletion. 
Equally intriguing is the observation that deleting CR2 in combination with other 
CRs appeared to restore activity over the single deletion alone. This implies that CR2 
has an auto-regulatory function. There is precedence for this behavior in full-length Pum 
where PCMa and PCMb exhibit regulatory activity (Weidmann and Goldstrohm 2012). 
Weidmann and Goldstrohm showed that expressing a construct of PCMb-RD3 alleviates 
repression by RD3.  However, the mechanism of auto regulation remains unexplored. A 
simpler explanation could be that removing CR2 allows RD3 to adopt a conformation 
that improves contacts with a binding partner. Alternatively, CR2 might contact another 
regulatory protein. If this were the case, however, one would expect that removing only 
CR2 would improve RD3’s repressive activity over that of WT, which the data does not 
show. It also does not appear that RD3’s activity is saturated since the NN>AA mutation 
in CR4 enhances activity to 137% of WT. In the case of the NN>AA mutation, it is 
possible that removing the larger asparagine residues could allow for the nearby 
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phenylalanines to better contact the co-repressor protein(s). Evolution may have already 
accomplished this, as higher species have serine residues in these positions. If CR2 is 
exerting auto-regulatory behavior, it could help to explain why the 5x CR1+4 construct 
surpassed WT RD3 activity. With no regulatory domain, 5x CR1+4 may be able to 
function at their full potential. 
In the native RD3, CR1 and CR4 are separated by 135 amino acids. In the 5x 
CR1+4 construct, they are 28 residues apart. Even though 2x CR1+4 was adequately 
expressed, it has only 65% of WT RD3 activity. It was only when 4 or more groups of 
CR1+4 were expressed that repression reached the level of WT RD3. This could 
indicate that the spacing between the CRs is important. It is also possible that the other 
CRs that contribute to repressive activity in the context of WT RD3 are needed for full 
function in a minimal construct such as CR1+4. Indeed, both the Q-P/N region and CR3 
had significant effects on WT RD3 when they were deleted, although they were not 
essential. 
The observation that RD3’s repressive ability did not depend upon CR3 was 
curious given the high level of conservation seen between species in CR3. Drosophila is 
the only species we examined using ConSurf with an extensive stretch of alanine and 
other residues separating CR3 and CR4. It may be that the importance of CR3 evolved 
alongside the elimination of this stretch of amino acids. Alternatively, perhaps the unique 
amino acids S-R-Q in Drosophila CR3 diminished its functionality in fly and other species 
escaped this mutation. 
Although the Q-P/N region is not as relevant for RD3’s activity, intrinsically 
disordered regions (IDRs) such as this can have roles in oligomerization, granule 
formation, or function as flexible spacer regions (van der Lee, Buljan et al. 2014). One 
study used similar regions present in RD1 and RD2 to show that these Q-rich domains 
along with the N-terminus of Pum can form aggregates in yeast (Salazar, Silverman et 
al. 2010). Pum has also been identified as a component in P-bodies, the formation of 
which are driven by protein aggregation-prone domains and RNA interactions (Barbee, 
Estes et al. 2006). It is possible that the Q-P/N region in RD3 functions in a similar 
manner and that the decrease in activity seen when it was deleted was caused by the 
lack of an additional Pum molecule to help enact decay. 
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Additionally, it is not known whether the mutations or deletions are affecting the 
localization or storage or overall folding of the protein. RD3 is predicted to be disordered 
but it may adopt a structure upon interaction with a protein partner. Such induced folding 
is common with unstructured and intrinsically disordered proteins (Uversky 2019). 
Another, perhaps simpler explanation for the dispensable nature of individual 
conserved regions is that each one may be only partially responsible for a larger 
interface of multiple contacts with protein partners. This is a common theme for proteins 
interacting with large complexes, and is seen with human Pum proteins in their 




2.6. Materials and methods 
 
Cell culture 
Drosophila Dmel2 cells (Invitrogen) were cultured in Gibco SF-900III media with no 
additional supplements. Cells were passaged every 3 to 4 days and discarded once they 
reached passage 30. Drosophila Dl1 cells were a gift from Eric Wagner. Dl1 cells were 
cultured in Schneider’s Drosophila media (SDM, Gibco) containing additional glutamine 
(1x GlutaMAX, Gibco), 1x anti-microbial/anti-fungal (Anti/anti, Thermo Fisher), and 10% 
heat inactivated fetal bovine serum (FBS, GenClone). FBS was heat inactivated by 
incubating at 56 to 60°C for 30 minutes. DL1 cells were passaged every 3 to 4 days and 
discarded after passage number 40. All Drosophila cell lines were cultured at 25°C in a 
humidified incubator. DL1 cells were frozen from 80% density in 10-cm dishes, collected 
and centrifuged in 15 mL tubes at 800 x g for 3 minutes. 2 mL of used media was 
reserved; 500 µL DMSO and 2.5 mL of complete SDM were added to the tube and cells 
were resuspended. Cells were aliquoted into 3 cryogenic storage tubes, placed in a 




100 µL of Drosophila cells were seeded in 96-well plates at a density of 1.5 x 
10^6 per mL. Four wells in each condition served as biological replicates for luciferase 
measurements, while three wells in each condition were reserved for protein analysis. 
Transfection master mixes were set up using 1 ng of Firefly Luciferase (FF) per well (5 
ng for Dmel2), 1 ng of Nano Luciferase (NLuc) reporter (5 ng for Dmel2), and 98 ng of 
either effector plasmid or balanced with empty pIZ plasmid (90 ng for Dmel2). FuGene 
HD transfection reagent (Promega) was used at a 4:1 ratio (0.4 µL/well) and serum free 
media was added to master mixes to bring the level of master mix transfected per well to 
10 µL. Master mixes were incubated for 5 to 10 minutes before adding to wells of plated 
cells. Plates were incubated for 48 to 72 hours before harvest and analysis. For analysis, 
100 µL of OneGlo Firefly reagent (Promega) was added to each well, mixed and 
incubated at room temperature for 10 minutes. Luminescence was measured on a Glo-
Max instrument under default settings. 100 µL of NanoGlo Stop-n-Glo reagent 
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(Promega) was then added to each well, mixed and incubated at room temperature for 
15 minutes before reading luminescence. 
 
Data analysis 
Luciferase assays: Samples were normalized for potential variation in transfection 
efficiency by calculating the ratio of NLuc to FF. The repression activity of each effector 
was calculated as fold change by dividing each sample well NLuc:FF ratio by the 
average NLuc:FF ratio of the control condition (eGFP, R7 RNA binding mutant, or ACA 
mutant reporter). Repression activity was then graphed as log(2) fold change. Statistics 
for luciferase assays were performed using Student’s unpaired T test with either equal or 
unequal variance as dictated by F-test results. Significance calling was based on the 
convention p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***. Each experiment consisted of 3 to 
4 biological replicates and each experiment was repeated at least 3 individual times. 
 
Westerns 
Three wells of each condition were harvested by pipette-mixing and transferring 
cells to 1.5mL Eppendorf tubes. Cells were centrifuged at 900 x g for 4 minutes, media 
was removed, and cells were resuspended in RIPA buffer (25 mM Tris pH 7.6, 1 mM 
EDTA, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) with additional 2x protease 
inhibitors (Roche). Lysate was collected by centrifuging at 21,000 x g for 10 minutes and 
removing the supernatant. Protein concentration was measured using the Bio-Rad DC 
protein assay kit according to manufacturer’s directions. 
10 µg of total protein extract was incubated with an equal volume of 2x SDS 
loading buffer at 85°C for ten minutes. Samples were loaded on 12% SDS-PAGE gels 
(either laboratory-made or purchased precasted from BioRad) and electrophoresed at 
120 to180 volts until the dye front reached the bottom of the gel. Gels were transferred 
to PVDF membranes (Millipore) for either 1.5 hours at 65 volts or overnight at 35 volts. 
Following transfer, membranes were either blocked in blotto (1x PBS, 0.1% Tween, 5% 
dried milk) for 1 hour or allowed to dry completely, then primary antibodies were applied 
for one hour at room temperature, or incubated overnight at 4°C. Membranes were 
washed three times for 10 minutes in blotto, then secondary antibodies were applied for 
1 hour at room temperature. Membranes were washed three times for ten minutes each 
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in blotto, then rinsed with 1x PBS before applying chemiluminescent substrate (Pierce- 
Thermo Fisher, or Immobilon- Millipore) Blots were imaged using the auto exposure 
setting on a ChemiDoc touch (BioRad). 
 
Plasmids 
Archive number Plasmid name Creator 
CAW061 pIZ MS2CP-GFP V5H6 Chase Weidmann 
RMA0053 pIZ MS2-Dcp1 V5H6 Rene Arvola 
CAW314 pIZ MS2 Pum RD3i V5H6 Chase Weidmann 
CAW313 pIZ MS2 Pum RD3ii V5H6 Chase Weidmann 
RMA0008 pIZ Dm Pum RD3-RBD Rene Arvola 
pBA017 pAc5.4 NLuc 2xMS2 BS Brian Alzua 
CAW023 pAc5.1 FFLuc2 minimal 3’-UTR Chase Weidmann 
RJH63 pIZ MS2 RD3 ▲FA2 Rebecca Haugen 
RJH64 pIZ MS2 RD3 ▲Q+FA2 Rebecca Haugen 
RMA0001 pIZ MS2-RD3 -QN Rene Arvola 
RJH66 pIZ MS2 RD3 ▲FA1+CR3 Rebecca Haugen 
RJH67 pIZ MS2 RD3 ▲FA2+CR3 Rebecca Haugen 
RJH68 pIZ MS2 RD3 ▲FA4+CR3 Rebecca Haugen 
RJH72 pIZ MS2 RD3 ▲1/3 Rebecca Haugen 
RJH73 pIZ MS2 RD3 ▲2/3 Rebecca Haugen 
RJH77 pIZ MS2 RD3 ▲FA1 Rebecca Haugen 
RJH78 pIZ MS2 RD3 ▲FA4 Rebecca Haugen 
RJH80 pIZ MS2 RD3 1/3 alone, 1-79 Rebecca Haugen 
RJH81 pIZ MS2 RD3 3/3 alone, 163-243 Rebecca Haugen 
RJH82 pIZ MS2 RD3 ▲3/3 Rebecca Haugen 
RJH87 pIZ MS2 RD3 ▲FA2+1 Rebecca Haugen 
RJH88 pIZ MS2 RD3 ▲FA2+4 Rebecca Haugen 
RJH98 pIZ MS2 RD3 2/3 alone, 80-162 Rebecca Haugen 
RJH101 pIZ MS2 RD3 ▲FA1+4 Rebecca Haugen 
RJH115 pIZ MS2 RD3 1-195 Rebecca Haugen 
RJH116 pIZ MS2 RD3 73-195 Rebecca Haugen 
RJH135 pIZ MS2 RD3 CR4 NN184-185AA Rebecca Haugen 
RJH136 pIZ MS2 RD3 CR4 MF186-187AA Rebecca Haugen 
RJH137 pIZ MS2 RD3 CR4 GS188-189AA Rebecca Haugen 
RJH138 pIZ MS2 RD3 CR4 NS190-191AA Rebecca Haugen 
RJH139 pIZ MS2 RD3 CR4 SIF192-194AAA Rebecca Haugen 
RJH146 pIZ MS2 RD3 CR4 F187A Rebecca Haugen 
RJH147 pIZ MS2 RD3 CR4 F194A Rebecca Haugen 
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Archive number Plasmid name Creator 
RJH148 pIZ MS2 RD3 CR1 SLTG-A's Rebecca Haugen 
RJH149 pIZ MS2 RD3 CR1 RRD-A's Rebecca Haugen 
RJH150 pIZ MS2 RD3 CR1 SFD-A's Rebecca Haugen 
RJH151 pIZ MS2 RD3 CR1 RST-A's Rebecca Haugen 
RJH152 pIZ MS2 RD3 CR1 SAF-A's Rebecca Haugen 
RJH153 pIZ MS2 RD3 CR1 SPS-A's Rebecca Haugen 
RJH158 pIZ MS2 eGFP MCS Rebecca Haugen 
RJH161 pIZ MS2 RD3 CR4 F187+194A Rebecca Haugen 
RJH162 pIZ MS2 RD3 CR4 SSS-A's Rebecca Haugen 
RJH163 pIZ MS2 RD3 CR1 SLTG+CR4 F187A Rebecca Haugen 
RJH164 pIZ MS2 RD3 CR1 RRD+CR4 F187A Rebecca Haugen 
RJH165 pIZ MS2 RD3 CR1 SFD+CR4 F187A Rebecca Haugen 
RJH166 pIZ MS2 RD3 CR1 RST+CR4 F187A Rebecca Haugen 
RJH171 pIZ MS2 RD3 49-195 Rebecca Haugen 
RJH172 pIZ MS2 RD3 CR1 SPS+CR4 F187A Rebecca Haugen 
RJH173 pIZ MS2 RD3 CR1 SAF+CR4 F187A Rebecca Haugen 
RJH240 pIZ MS2-eGFP-link-CR1-link-CR4 (1x) Rebecca Haugen 
RJH241 pIZ MS2-eGFP-link-CR1-link-CR4 (2x) Rebecca Haugen 
RJH242 pIZ MS2-eGFP-link-CR1-link-CR4 (3x) Rebecca Haugen 
RJH243 pIZ MS2-eGFP-link-CR1-link-CR4 (4x) Rebecca Haugen 
RJH184 pIZ MS2-eGFP-link-CR1-link-CR4 (5x) Rebecca Haugen 
RJH185 pIZ MS2-eGFP-link-CR1-link-CR4 (6x) Rebecca Haugen 
RJH186 pIZ MS2-eGFP-link-CR1-link-CR4 (5x) 
FF mut 
Rebecca Haugen 
RJH187 pIZ MS2-eGFP-RD3 Rebecca Haugen 
Table 2.1: Plasmids used in Chapter 2. A full list of plasmids can be found in Appendix C. 
 
Antibodies 
All antibodies used in this work are listed in Appendix B. Antibodies used in this 
section are as follows: Mouse anti-V5 primary antibody (Invitrogen, Cat# R960-25) was 
diluted 1:5000 in blotto. Mouse anti-Tubulin (CST, Cat# 3873) was diluted 1:1000 in 
blotto. Rabbit anti-Vinculin (Thermo Fisher Cat# 700062) was diluted 1:1000 in blotto. 
Goat anti-rabbit-HRP secondary antibody (CST, Cat# 7074P2 or Sigma Cat# AP187P) 
was diluted 1:5000 in blotto. Goat anti-mouse-HRP (Thermo Fisher Cat# 31430) was 
diluted 1:5000 in blotto.   
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Chapter 3: Interactions of RD3 with the CNOT complex 
3.1. Introduction 
The CNOT complex has a long-standing role as a mediator of decay, and as 
such, is known to interact with several other decay factors. Through Not9, the CNOT 
complex interacts with GW182 proteins and is thus recruited to decay transcripts 
targeted by micro RNAs (Braun, Huntzinger et al. 2011, Fabian, Cieplak et al. 2011, 
Chen, Boland et al. 2014). Tis11, an RBP that binds to AU-rich elements in the 3’-UTR 
of targets, interacts directly with the Not1 N-terminus (Fabian, Frank et al. 2013). The 
CNOT complex also recruits the RNA helicase Me31b (DDX6 in humans), a necessary 
factor for unwinding RNA structures preceding decay (Mathys, Basquin et al. 2014, 
Ozgur, Basquin et al. 2015). Through Me31b, the CNOT complex is additionally linked to 
the decapping complex members Dcp1, Dcp2, and decapping enhancers Edc3 and Ge-
1 (EDC4) (Fromm, Truffault et al. 2012, Sharif, Ozgur et al. 2013). In turn, Dcp1 directly 
couples decapping to 5’ exonucleolytic decay through a direct interaction with the 
ribonuclease Xrn1 (Braun, Truffault et al. 2012). The CNOT complex can also interact 
directly with Xrn1 (Chang, Muthukumar et al. 2019). 
Early research in the developing fly embryo showed that regulation of hunchback 
RNA by Pum and nanos occurred through poly(A) tail shortening, implicating a 
deadenylase complex (Wreden, Verrotti et al. 1997). Subsequent studies in yeast 
demonstrated that PUF proteins also relied on the presence of Ccr4 and Pop2 and that 
Puf5f could directly bind to Pop2 (Goldstrohm, Hook et al. 2006, Goldstrohm, Seay et al. 
2007). Drosophila Pum RBD was shown to interact in vitro with Pop2, and the human 
homologs CNOT7 and CNOT8 (Kadyrova, Habara et al. 2007). The RBD also promotes 
deadenylation (Weidmann and Goldstrohm 2012). Additionally, CCR4 interacts with Pum 
in vivo (Joly, Chartier et al. 2013). Human Pum proteins depend on the CNOT complex 
for activity, and associate with CNOT 7/8 and CNOT 6/6L in vivo (Van Etten, Schagat et 
al. 2012). Finally, it was demonstrated recently that Drosophila Pum could interact in 
vitro with multiple members of the human CNOT complex. This interaction is likely 
strengthened by multiple points of contact, since each one of Pum’s RDs was able to 
interact with the CNOT complex modules (Arvola, Chang et al. 2020). 
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The activity of Pum RD3 is also dependent on the CNOT complex, and depletion 
of either Not1 or Pop2 eliminates repression by RD3 (Arvola, Chang et al. 2020).  
Additionally, immunoprecipitation experiments with overexpressed Flag-tagged Pum N-
terminus were able to pull down endogenous Not1. This interaction was not disrupted by 
the addition of RNase, indicating that it could be due to a direct protein contact. In vitro 
assays using MBP-tagged RD3 were able to pull down the human CNOT complex 
members, but it is unclear if the interaction is direct with a single complex member, or via 
multiple subunits (Arvola, Chang et al. 2020). 
Pum activity has also been tied to decapping. Yeast Puf5p interacts with Eap1p, 
a 4E-BP, which interferes with translation and recruits the decapping protein Dhh1 
(Blewett and Goldstrohm 2012). In Drosophila and human cells, the repressive activity of 
the Pum N-terminus is reduced when decapping is inhibited (Arvola, Chang et al. 2020, 
Enwerem, Elrod et al. 2021).  
We hypothesized that RD3 was directly recruiting the decay machinery through 
conserved motifs. We set out to test the interactions between RD3 and individual CNOT 
complex members and interactions between RD3 and other decay factors. 
 
3.2. Interaction screens - Y2H assays 
To determine the CNOT complex members that RD3 may be associating with, 
we turned to the yeast 2-hybrid system (Y2H). RD3 was expressed as a Gal4 binding 
domain fusion (BD-RD3) on a plasmid carrying the gene for leucine synthesis (pGBK), 
and all potential interactors were cloned as activating domain fusions (AD-Nots) with the 
gene for tryptophan synthesis (pGAD). Both plasmids were co-transformed into Y2H 
gold strain yeast, auxotrophic for adenine, histidine, leucine, and tryptophan. Adenine 
and histidine synthesis occurred only when the tested proteins were able to functionally 
interact. Additionally, interactions activate transcription of the MEL1 gene, which 
encodes the protein alpha-galactosidase, and enables synthesis of the chromogenic 
substrate x-alpha-gal, turning the colonies blue. These three reporter genes are under 
the control of the GAL4 UAS promotor. Co-transformants in which the proteins do not 
interact also produce a red pigment due to accumulation of an intermediate in the 




Since knockdown of Not1 and Pop2 had the greatest effect on repression by 
RD3 (Arvola, Chang et al. 2020), we began by testing if Not1 could interact with RD3 in 
vivo in yeast. The large size of Not1 necessitated the creation of 3 separate regions: the 
N-terminal region (Not1-N, residues 1 to 1148), the MIF4G region (Not1-M, residues 
1147 to 1717), and the C-terminal region (Not1-C, residues 1710 to 2503) (Figure 3.2). 
Each separate region of Not1 is capable of adopting stable structures in vivo and 
associating with its respective complex members (Petit, Wohlbold et al. 2012, Bawankar, 
Loh et al. 2013).  
 
 
Figure 3.1: The yeast two hybrid system. RD3 constructs are fused to the DNA binding domain 
(BD) and Not1 or other proteins are fused to the activation domain (AD). The plasmids expressing 
these constructs allow yeast transformed with both to grow on media lacking tryptophan and 
leucine. When the two proteins interact, transcription of reporter genes begins, allowing growth on 
media also lacking adenine and histidine. Transcription of the MEL1 gene allows yeast to 
synthesize a chromogenic substance which turns the colonies blue. 
Figure 3.2: The arrangement of CNOT complex modules and Not1 subdivisions. Not1 
serves as a scaffold for the other subunits to bind. The subdivisions of Drosophila Not1 used in 
this work are shown above the diagram with corresponding amino acid positions. Each 
subdivision of Not1 is capable of associating with the respective subunits in each module (Petit, 
Wohlbold et al. 2012). Figure adapted from (Chang, Muthukumar et al. 2019). 
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RD3 interacted with Not1-N, but not Not1-M or Not1-C (Figure 3.3). This was not 
due to auto-activation of either RD3 or Not1, as neither construct was capable of growth 
when transformed with empty vector. 
 
  
Other CNOT complex members that affected RD3 activity were Not2 and Not3 
(Arvola, Chang et al. 2020). These two subunits, along with the C-terminal region of 
Not1, form the primary Not module. The Not module mediates complex assembly in cells 
and serves as an interaction platform for multiple regulatory proteins including Nanos 
(Maillet, Tu et al. 2000, Boland, Chen et al. 2013, Bhandari, Raisch et al. 2014). Since 
the Pum RBD binds to and interacts with Nanos (Weidmann, Qiu et al. 2016), it was 
reasoned that RD3 might also interact with the Not module as well. Since an interaction 
between RD3 and Not1-C was not seen, we tested Not2 and Not3. Full-length Not3 (aa 
1 to 844) tested with RD3 was negative (data not shown), so we instead tested a 
Figure 3.3: RD3 interacts with Not1-N in yeast. (Left) Co-transfected plasmids are listed. The 
binding domain (BD) is expressed with RD3 proteins or empty vector expressing only the BD. The 
activating domain (AD) is expressed with the Not1 constructs, or alone (vector). Vector controls 
ensure the fusion protein is not capable of either binding or activating without a protein interaction 
with the other domain fused to the tested protein (auto-activation). (Middle) Photograph of yeast 
serial dilutions (104 to 101) plated on media lacking leucine and tryptophan (DDO). DDO media 
selects for colonies containing both AD and BD plasmids. (Right) Photograph of yeast serial 
dilutions duplicate plated on media lacking leucine, tryptophan, histidine, and adenine, (QDO) and 
supplemented with the chromogenic substrate X-α-gal. Colony growth on this plate indicates a 
positive interaction between the tested proteins. All Y2H figures in this chapter are illustrated in 
this manner. n ≥ 3. 
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truncation of Not3 encompassing the C-terminal NOT box domain, aa 522 to 844 (Not3-
C), and observed that RD3 can interact with Not2 and Not3-C (Figure 3.4). 
Pop2 is also necessary for RD3’s activity (Arvola, Chang et al. 2020). 
Surprisingly, there was no detectable interaction between RD3 and Pop2 (Figure 3.4). 
This implies that RD3’s reliance on Pop2 for repressive activity is due solely to the 
enzymatic function of Pop2, since CCR4, the second deadenylase of the CNOT 
complex, is believed to be inactive in Drosophila. Additionally, RNAi depletion of CCR4 
in Dmel2 cells did not affect the function of RD3 or any other RD of Pum (Arvola, Chang 




The other main CNOT complex members in fly were also tested for interactions 
with RD3: Caf40 (Not9), Not10, and Not11. Caf40 binds to the Not1-M region of Not1 
(Bawankar, Loh et al. 2013). Neither Caf40 nor Not1-M appeared to interact with RD3. 
Not10 and Not11 both bind together at the Not1 N-terminus (Bawankar, Loh et al. 2013), 
which had shown a positive interaction with RD3, however neither protein appeared to 
stably interact with RD3 (Figure 3.5).  
Figure 3.4: RD3 interacts with Not2 and Not3-C. BD and AD fusion proteins are listed, along 
with the negative controls, BD-vector with Not2 and Not3. As seen in the QDO plate on the right, 




Our initial assays provided evidence for a positive interaction between Not11 and 
Pum RD.  However, through experimental replication this observation proved to be 
inconsistent. When multiple independent colonies from freshly transformed yeast were 
tested, the Pum RD3 – Not11 interaction was not reproducible (Figure 3.6).  Not11 
expression in these tests remained consistent, ruling out variability in expression levels 
of Not11. We also considered the possibility that variability might arise if Drosophila 
Not11 could associate with the endogenous yeast CNOT complex. Two facts argue 
against this notion. First, yeast do not possess a Not11 homolog. Second, yeast Not1 
lacks the N-terminal region responsible for Not11 binding (Basquin, Roudko et al. 2012, 
Bawankar, Loh et al. 2013). The preponderance of evidence indicates that the RD3 and 
Not11 interaction in our initial two-hybrid assay represented a false positive. 
Figure 3.5: RD3 does not interact with Caf40, Not10, or Not11. BD and AD fusion proteins are 
listed, along with the assay positive control p53+T7 antigen. As seen in the QDO plate on the 




Given the complex interplay of decay factors involving the CNOT complex, we 
decided to test if RD3 could interact with any potential accessory proteins as well. In 
addition, the positive interaction seen between RD3 and Not1-N also made us question 
whether RD3 could interact with Tis11. Tis11 is an ARE-binding protein and recent 
evidence shows enrichment of AREs surrounding functional PREs (Wolfe, Schagat et al. 
2020). Me31b, Dcp1, and Tis11 were cloned into the pGAD vector and tested for 
interactions with RD3. All these results appeared negative, however the level of protein 
expression for Dcp1 and Tis11 were low. It is unclear if this level of protein would be 
enough to activate the transcription of genes if there were a positive interaction with 
RD3. Expression of all Y2H constructs is shown in Figure 3.14. 
Figure 3.6: RD3 false positive interaction with Not11. (Top) A positive interaction was seen 
with Not11, but tests of multiple colonies (below) failed to grow. (Bottom) Western blot showing 
even expression of all Not11 constructs extracted from yeast. Total protein from Sypro Ruby stain 





Using the known structures of Not1 homologs, we decided to make truncations of 
Not1-N to determine where the interaction with RD3 was occurring (Figure 3.8). The first 
412 residues of Not1 are involved in Not10/11 binding (Bawankar, Loh et al. 2013), and 
residues 908 to 1065 bind the RBP Tis11 (TTP in human) (Fabian, Frank et al. 2013). 
The N-terminus also contains multiple regions of HEAT repeats (Basquin, Roudko et al. 
2012, Petit, Wohlbold et al. 2012, Fabian, Frank et al. 2013). We first divided the N-
terminus into amino acids 1 to 788 and 789 to 1148. The first 788 residues did not 
interact with RD3, however, 789 to 1148 showed a positive interaction. Narrowing down 
the interaction further, we next tested amino acids 789 to 1064 and 1061 to 1148, then 
further subdivided the positive interaction between 789 to 1064 into 789 to 908, and the 
region of Tis11 binding, 908 to 1064. RD3 also interacted with the same region of Not1 
that had been demonstrated to bind to Tis11 (Figure 3.8). This region for both human 
proteins TTP and CNOT1 is highly conserved in Drosophila. Interestingly, Fabian et al. 
also demonstrated that mutation of a single phenylalanine residue (F319) of TTP 
involved in binding to CNOT1 disrupted the interaction altogether in vitro. We further 
divided this 156 peptide-long region into 908 to 1047, 908 to 1016, and 908 to 995, 
however these smaller fragments were not expressed as well. Still, there was a positive 
interaction with all three fragments. 
Figure 3.7: RD3 does not interact with Me31b, Tis11, or Dcp1. RD3 interactions tested with 
decay pathway accessory proteins fail to grow on QDO plates. The positive assay control p53+T7 





Figure 3.8: RD3 interactions with Not1 truncations. (A) Full-length RD3 was tested for 
interactions with truncations of Not1, shown by their amino acid numbers at left. The smallest 
regions of Not1 with a positive interaction are in the bottom panel. n ≥ 3. (B) Schematic 
representation of Not1 truncations tested for interaction with RD3. (C) Crystal structure of human 
Not1 aa 820 to 999 from (Fabian, Frank et al. 2013). Equivalent amino acid positions and 
numbering for Drosophila are shown as diamonds. The residues responsible for interaction with 
human TTP peptide are highlighted in red. Image generated with PyMOL, PDB 4J8S. 
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We employed the same strategy of protein truncations to determine which 
domain of Not2 RD3 was interacting with. Not2 is 585 amino acids in length and the 
structure for the C terminal region where it associates with the NOT module (Not1-Not2-
Not3) is known for the human proteins (Boland, Chen et al. 2013, Raisch, Bhandari et al. 
2016). This region is referred to as the NOT box domain, a feature that is shared 
between Not2 and Not3. In solution, both Not2 and Not3 adopt a similar fold and form a 
heterodimer that forms the binding interface with the C terminal region of Not1 (Figure 
3.9). This crystallized region in human NOT2 corresponds to amino acids 399 to 585 in 
Drosophila.  
 
Figure 3.9: The components of the NOT module. (A) Cartoon representation of the NOT 
module structure shown in B. The C-terminal regions of Not1, Not2, and Not3 are shown. Not2 
and Not3 have conserved C-terminal domains referred to as NOT boxes. A short peptide 
sequence called the connector sequence (CS) mediates the interaction between Not2 and 
Not3. The Not1 anchor region (NAR) on each protein binds to Not1. All three proteins have N-
terminal regions that are not shown in A and B. (B) Crystal structure generated with PyMOL 
from PDB 5FU7 (Raisch, Bhandari et al. 2016). Proteins are colored as in A; Not1-C grey, Not2 
purple, Not3 blue. Not2 and Not3 N-termini have not been crystallized. (C) Stick diagrams of 
Not2 and Not3 with amino acid positions for tested truncations shown above. Colored shading 




We tested Not2 constructs of aa 1 to 399 and 399 to 585 for interaction with RD3 
in the Y2H system. A positive interaction was seen for the C terminal area of Not2 (399 
to 585, Figure 3.10), therefore we further divided this area into aa 399 to 475 and aa 465 
to 585. The area chosen for the division falls within the connector sequence, the region 
of interaction between Not2 and Not3 (Boland, Chen et al. 2013). This effectively divided 
Not2 into a section that binds to Not1 (Not1 anchor region, aa 399 to 475) and the 
remaining Not box domain (aa 465 to 585). RD3 interacted with Not2 aa 465 to 585 
(Figure 3.10). 
A similar truncation was made for Not3-C. The region of aa 522 to 844 was 
divided in the CS region to isolate the NOT box domain, aa 740 to 844. However, this 
peptide did not interact with RD3 in yeast (data not shown). 
 
 
Having identified the CNOT complex subunits that interact with RD3, we next 
tested if the phenylalanine mutations in CR4 would disrupt those associations in yeast. 
Mutating F1033 was enough to eliminate the interaction between RD3 and Not1-N 
(Figure 3.11). Additionally, the F1040A mutation also abolished the interaction between 
RD3 and Not1-N. Deleting CR1 affected the interaction with Not1-N as well, but this 
deletion alone was not enough to completely disrupt it. 
Figure 3.10: The interactions of Not2 subdivisions with RD3. The Not2 
truncations are listed by their amino acid numbers at left. The C-terminal Not box 




To test which areas of RD3 were responsible for the interaction with Not2 and 
Not3, we again tested the CR1 deletion and CR4 phenylalanine mutations. Deletion of 
CR1 had no effect on the Not2 interaction or Not3, nor did the single phenylalanine 
mutations (Figure 3.12). When both CR4 phenylalanines were mutated, the interactions 
with Not2 and Not3 were impacted. This data indicated that Not2 and Not3 were not 
contacting RD3 through CR1, but might be contacting CR4. 
Figure 3.11: The effects of RD3 mutations on the interaction with Not1-N. The RD3 
phenylalanine mutations and CR1 deletion are shown with Not1-N. Any single phenylalanine 




Since deleting CR4 did not completely disrupt the interaction with Not2, next we 
screened deletions of the other CRs, since several of them showed a decrease in RD3’s 
activity when deleted in our luciferase assay system. However, none of the other CRs 
appeared to be responsible for the interaction with Not2 (Figure 3.13). We tested the 
same RD3 deletions with Not3, and observed that deleting both CR1 and CR4 together 
disrupted the interaction between RD3 and Not3 (Figure 3.13). 
Figure 3.12: The effects of RD3 mutations on the interaction with Not2 and Not3-C. 
RD3 mutations were tested for interactions with Not2. Removing CR4 or mutating both 





We attempted to determine if the 5x CR1+4 constructs interact with Not1-N or 
Not2 using the Y2H system. However, the 5x CR1+4 construct auto-activated the 
reporter genes, so we were not able to test this interaction. Curiously, the 5x CR1+4 FF 
mutant did not show auto-activation, but did not interact with either Not1-N or Not2 (data 
not shown). 
Figure 3.13: The effects of RD3 deletions on the interaction with Not2 and Not3. 
Deletions of all the CRs of RD3 were tested for interactions with Not2 (Top). None of the 
deletions completely disrupt the interaction. (Bottom) RD3 deletions tested with Not3. The 




Figure 3.14: Expression data for Y2H constructs. Western blots showing expression of all 
tested activation domain (AD) and binding domain (BD) fusion proteins. Sypro Ruby stain was 
used as a loading control for total protein. (A) Myc- tagged BD-RD3 constructs. (B) HA-tagged AD 
constructs. Tis11 and Dcp1 were not expressed well. (C) HA-tagged AD-fusion CNOT complex 
members. The Not3 (522 to 844) construct is used in interaction tests with RD3. Not3 full-length 
was still expressed. (D) Truncations of HA-tagged Not2 and Not1-N AD fusions. Molecular weight 
marker (MWM) can be seen in the center of the gel. 
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3.3. Immunoprecipitation assays in Drosophila cells 
 
To corroborate our findings from the Y2H system, we turned to 
immunoprecipitation assays (IP) in Drosophila cells. First, we tested the ability of RD3 
and the CR4 double phenylalanine mutant, F1033A+F1040A (RD3 FF mut) to interact 
with Not1. We used a DL1 cell line expressing Flag-tagged Not1 which we generated 
with CRISPR-Cas9. For negative controls, we expressed RD3 constructs with wild-type 
DL1 cells (WT), and HaloTag (HT)-V5 with Not1-Flag. Our positive control was Not11-
V5. Additionally, all samples in these experiments were treated with RNase One and 
RNase A. RD3 co-immunoprecipitated with endogenous Not1 whereas HT-V5 did not 
(Figure 3.15). As expected, Not11-V5 interacted with Not1. Intriguingly, the RD3 FF mut 




Figure 3.15: Immunoprecipitation assay with RD3 and endogenous Not1 in Drosophila 
cells. V5-tagged RD3 or RD3 F1033+F1040A mutant (RD3 FF mut) were transfected into Dl1 
cells expressing endogenous Flag-tagged Not1, or WT DL1 cells. V5-HaloTag and Not11-V5 
served as negative and positive controls, respectively. Expression of all samples is shown in the 
Input at left. (Right) Anti-Flag IP was used to capture interactions with RD3 and RD3 FF mut, and 
the positive control Not11. n ≥ 3. 
72 
 
Next, we co-expressed Flag-tagged Not1-N with wild type or mutant versions of 
V5-tagged MS2-RD3 in Dmel2 cells. HT-V5 served as a negative control and Not11-V5 
was included as a positive control. The tested RD3 constructs were transfected with 
empty vector to rule out nonspecific interactions between RD3 and the Flag resin. RD3 
co-immunoprecipitated with Flag-tagged Not1-N (Figure 3.16). The RD3 FF mut also co-
immunoprecipitated with Not1, whereas the HT negative control did not. 
 
 
   
Since our yeast data also indicated that RD3 can associate with Not2, we tested 
this interaction in Dmel2 cells as well. Using the same IP strategy of overexpressed V5 
and Flag-tagged constructs, we were able to show that RD3 can interact with Not2. In 
this experiment Pop2 was used as a positive control with Not2 (Figure 3.17). The RD3 
FF mutant also associated with Not2, in agreement with our observations in the Y2H 
system. 
Figure 3.16: Immunoprecipitation assay with RD3 and Not1-N in Drosophila cells. V5-
tagged RD3 or RD3 F1033+F1040A mutant (RD3 FF mut) were co-transfected with Flag-tagged 
Not1-N or an empty vector control. V5-HaloTag and Not11-V5 served as negative and positive 
controls, respectively. Expression of all samples is shown in the Input at left. (Right) Anti-Flag IP 




 We next asked if the 5x CR1+4 construct could associate with the Not complex in 
Drosophila cells. Since the RD3 FF mutant could still interact with Not1 in cells, we 
expected that both the 5x CR1+4 and its mutant would be able to as well. We 
overexpressed the V5- tagged MS2-eGFP-5x CR1+4 construct (MG-5xCR1+4) and its 
mutant (MG-5xCR1+4 FF) with Flag-Not1-N in Dmel2 cells. We also included the same 
positive and negative controls as used previously. Both the 5x CR1+4 construct and its 
mutant interacted with Not1-N in cells (Figure 3.18 A).  
One complication in this assay is the fact that the 5x CR1+4 FF mutant is more 
highly expressed than the WT version. We attempted to compensate for this discrepancy 
by transfecting less 5x CR1+4 FF mutant DNA, however, even at a 7.5:1 ratio of 
transfected plasmid (3 µg WT: 400 ng FF mut), the mutant version was still more 
abundant. Nonetheless, both constructs interacted with Not1-N.  
We also tested whether the 5x CR1+4 multimer could interact with Not2 in Dmel2 
cells (Figure 3.18 B). The 7.5:1 ratio of transfected DNA for the 5x CR1+4 constructs 
was used again. Both the 5x CR1+4 and the mutant co-immunoprecipitated with Not2. 
Figure 3.17: Immunoprecipitation assay with RD3 and Not2 in Drosophila cells. V5-tagged 
RD3 or RD3 F1033+F1040A mutant (RD3 FF mut) were co-transfected with Flag-tagged Not2 or 
empty vector control. V5-HaloTag and Pop2-V5 served as negative and positive controls, 
respectively. Expression of all samples is shown in the Input at left. (Right) Anti-Flag IP was used 




Figure 3.18: The 5x CR1+4 construct interacts with Not1-N and Not2 in Drosophila cells. 
The 5x CR1+4 construct and its mutant (5xCR1+4 FF mut) were overexpressed with Not1-N-Flag 
(A), Not2-Flag (B), or empty vector control (A, B). HaloTag-V5 served as the negative control as 
before. Not11 served as the positive control for Not1-N interactions, and Pop2 for Not2 
interactions. n = 3. 
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Finally, we tested the interaction between 5x CR1+4 and its mutant in Dl1 cells 
expressing endogenous Not1-Flag. Because the protein expression levels of the 5x 
CR1+4 construct were extremely low in DL1 cells, we used three times the amount of 
total protein in both the WT and Not1-Flag IPs. The 5x CR1+4 FF mutants were still 
highly expressed in these cells, and we transfected 400 ng as in Dmel2 cells. Due to the 
inequality of total protein loaded into each IP we were unable to make comparisons 
between the 5x CR1+4 construct and its mutant, however, both the 5x CR1+4 and its 




Figure 3.19: The 5x CR1+4 and 5x CR1+4 FF mutant interact with Not1 in Drosophila cells. 
The 5x CR1+4 construct and its mutant (5xCR1+4 FF mut) were overexpressed in either WT or 
Not1-Flag cells. HaloTag-V5 served as the negative control as before. Not11 served as the 
positive control for Not1 interactions. n = 3. 
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3.4. Summary and discussion 
 
In this chapter, we set out to identify the protein interactions of Pum RD3 with the 
CNOT complex. We found that RD3 interacts with multiple members of the CNOT 
complex: Not1, Not2, and Not3. We also tested interactions between RD3 and other 
decay factors, Me31b, Tis11, and Dcp1, but did not detect any interactions. We mapped 
the regions of Not1 and Not2 that are necessary for these interactions. We found that 
RD3 interacted with Not1 in the N-terminal region, specifically, amino acids 908 to 1016. 
This is also the same region involved in TTP binding in humans (Fabian, Frank et al. 
2013). RD3 interacted with Not2 in the conserved NOT box domain, aa 465 to 585. RD3 
also interacted with Not3 in the C-terminal region, aa 520 to 844. We tested the effect of 
several mutations and deletions in RD3 that caused loss of function. For Not1-N, 
mutation of either phenylalanine residue in CR4 of RD3 destroyed the interaction. The 
interaction between RD3 and Not2 was resistant to the deletions of RD3’s CRs, however 
the interaction between Not3 and RD3 was effected by deletion of CR1 with CR4. 
Using co-IP, we demonstrated that RD3 interacted with the CNOT complex in 
Drosophila cells. RD3 co-immunoprecipitated endogenous Not1, and overexpressed 
Not1-N and Not2. This interaction was not disrupted by the CR4 double phenylalanine 
mutation for any of the CNOT members tested. We further demonstrated that the 5x 
CR1+4 multimer construct is sufficient to interact with the CNOT complex in Drosophila 
cells, and that mutating the phenylalanine residues in this construct also did not 
eliminate the interaction. 
This was a surprising result since the phenylalanine mutations in CR4 destroyed 
RD3’s repressive ability. A robust interaction between RD3 and the CNOT complex is 
assured through multiple contacts with Not1, Not2, and Not3. This interaction is 
evolutionarily conserved: in pull-down experiments with human proteins, RD3 interacts 
directly with all three subunits of the NOT module (Enwerem, Elrod et al. 2021). Since 
the physical interaction is not perturbed by the phenylalanine mutations, another 
mechanism must be responsible for the loss of RD3’s activity.  
 RD3 might possess the ability to stimulate the CNOT complex’s activity in 
addition to recruiting it to a transcript. The contacts with Not2 and Not3 might stabilize 
the interaction, while the functional phenylalanine residues might be responsible for a 
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stimulatory effect. There is precedence for fine-tuning of the CNOT complex’s activity 
through RBPs. Other proteins that are known to affect the activity of the CNOT complex 
include Roquin (Sgromo, Raisch et al. 2017), Bag of Marbles (BAM) (Sgromo, Raisch et 
al. 2018), and Not4 (Raisch, Chang et al. 2019).  
In vitro, a Roquin peptide inhibits deadenylation of a poly(A) substrate by 
competing with the substrate for binding to Caf40 (Raisch, Chang et al. 2019). In the 
proposed model, in vivo Roquin may block Caf40 binding to RNA and thus direct the 
CNOT complex deadenylase activity to the Roquin-bound transcript, therefore promoting 
specific target deadenylation versus non-specific “bulk” decay.  
A similar mechanism may occur with RD3, where RD3 binds CNOT through Not2 
and Not3 and directs the complex to decay the Pum-bound target RNA. While the RD3 
FF mutant still associates with the complex via multiple contact sites with Not2 and Not3, 
without the stimulatory effect provided by the phenylalanines associating with Not1-N, 
decay is limited. An additional facet of this interaction between RD3 and Not1-N could be 
the exclusion of other RBPs such as Tis11 (TTP) which binds to Not1-N in the same 
region as RD3. This would provide a way for RD3 (and Pum) to compete with other 
RBPs for specific and rapid degradation of their own targets.  
The only known structures of the entire complex come from yeast (Nasertorabi, 
Batisse et al. 2011, Ukleja, Cuellar et al. 2016). These electron microscopy structures 
depict the complex as L-shaped and lack the resolution needed to determine how RD3 
might span the molecular distance between Not1-N and Not2. This structural prediction 
depicts the TTP binding face and the NOT module approximately 100 Å apart (Ukleja, 
Cuellar et al. 2016) and yet RD3 is predicted to be 43 Å in length. This implies that either 
RD3 does not contact both proteins simultaneously or that in cells, the CNOT complex 
adopts a very flexible structure. Indeed, it has been suggested that the CNOT complex 
does not form one single conformation, but rather multiple conformations, with each 




3.5. Materials and methods 
Yeast two-hybrid assays 
Yeast strain Y2H Gold from the Clonetech Matchmaker Gold kit (Takara Bio) 
were grown on YPAD (yeast extract peptone dextrose + adenine) agar plates. (Yeast 
genotype MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2 : : 
GAL1UAS–Gal1TATA–His3, GAL2UAS–Gal2TATA–Ade2 URA3 : : MEL1UAS–Mel1TATA). 
Transformations of yeast were made using 1 µg total of both pGBK vector and 
pGAD vectors. Co-transformed yeast were grown on double dropout media (-Leu, -Trp, 
DDO) for 3 days at 30°C to select for co-transformants. For plate spotting, colonies from 
each DDO plate were struck into 5 mL DDO SD media and grown overnight at 30°C. 
The following day, 1 mL of culture was taken and grown in 4 mL YPAD media until the 
OD600 was approximately 1.0. Each culture was serially diluted from 2 x 10^6 cells/mL to 
2 x 10^3 cells/mL and 5 µL of each dilution was duplicate plated on DDO and quadruple 
dropout (-Leu, -Trp, -His, -Ade, QDO) plates supplemented with 100 µL of 4 µg/mL 
alpha-x-gal substrate. Plates were incubated at 30°C for 3 to 5 days, then photographed. 
Each interaction was tested in at least three experimental replicates.  
 
Western blotting for Y2H expression 
For western blot detection, each co-transformant was grown overnight in 5 mL 
YPAD media as described. When cell density became ~OD600 0.7, 10 million cells were 
harvested. Samples were prepared using 75 µL RIPA buffer (25 mM Tris pH 7.6, 1 mM 
EDTA, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) with 4x Roche cOmplete 
protease inhibitors (Sigma) and bead-bashed with glass beads on ice five times at 1 
minute intervals. Additional 100x PMSF was added every 15 minutes. Sample lysate 
was cleared by centrifugation, 20 µL of 5x SDS loading dye was added, samples were 
incubated at 85°C for ten minutes, then 10 µL was loaded on a 12% SDS-PAGE gel, or 
5-20% SDS-PAGE gradient gel (BioRad). Gels were electrophoresed at 120 to 150 volts 
until the dye front reached the bottom, then transferred to PVDF membranes 
(Immobilon). Total protein was detected by Sypro Ruby stain (Thermo Fisher) following 
the manufacturer’s directions and imaged on a Chemidoc touch (BioRad). Primary 
antibodies were applied for one hour at room temperature or incubated overnight at 4°C. 
Membranes were washed three times for 10 minutes in blotto (1x PBS, 0.1% Tween, 5% 
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dried milk), then secondary antibodies were applied for 1 hour at room temperature. 
Membranes were washed three times for ten minutes each in blotto, then rinsed with 1x 
PBS before applying Pierce chemiluminescent substrate (Thermo Fisher). Blots were 
imaged using the auto exposure setting on a ChemiDoc touch (BioRad). 
 
Co-immunoprecipitation assays 
Dmel2 cells were seeded in 6 well plates at a density of 1.5 x 10^6 cells/mL in 2 
mL SF900III media (Gibco). Transfection mixes were set up using 150 µL media, a total 
of 3 µg plasmid DNA (1.5 µg each for co-transfection; 3 µg for single transfection), and 
12 µL FuGene HD (Promega). Transfection mixes for 5x CR1+4 differed in DNA amount 
as follows: for 5x CR1+4 FF mut, 400 ng 5x CR1+4 FF mut was transfected with empty 
pIZ vector balance to equal 1.5 µg total for co-transfection, or 3 µg total for single 
transfection in Not1-Flag cells. For 5x CR1+4, 4 µg total DNA was transfected with 16 µL 
FuGene HD for single transfection in Not1-Flag cells. Co-transfections in Dmel2 cells 
used 3 µg 5x CR1+4 and 1 µg Not1-N or Not2. Transfection mixes were incubated for 10 
minutes before applying to cells. Cells were incubated at 25°C for 3 days before 
harvesting for co-IP assays. 
Cells were collected and washed once with PBS, then incubated on ice for 10 
minutes in lysis buffer containing 50 mM Tris pH 8.0, 500 nM NaCl, 1 mM EDTA, 0.2% 
Triton, and 2x protease inhibitors (Roche). Samples were mechanically disrupted with 
pestles for 20 seconds each, then lysates were cleared by centrifugation at 21,000 x g 
for 10 minutes. Lysate was passed through biospin columns (Millipore) and 35 µL of 
lysate was reserved for input analysis. Samples were then applied to prepared Flag 
resin.  
20 µL of Flag resin suspension (EZview Red ANTI-FLAG M2 Affinity Gel, Sigma) 
was used per sample. Resin was prepared by washing four times in wash buffer 
containing 50 mM Tris pH 8.0, 500 nM NaCl, 1 mM EDTA, and collected by 
centrifugation at 4,000 x g between washes. Prior to binding, resin was resuspended in 
700 µL per sample of lysis buffer with 1 µL per sample of both RNaseONE (Promega) 
and RNaseA (Promega.) Binding was performed with end-over-end rotation at 4°C for 2 
to 3 hours. 
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After binding, the flowthrough was reserved and the samples were washed six 
times for 5 minutes each with end-over-end rotation at 4°C. The first three washes were 
performed with lysis buffer without protease inhibitors and the last three with wash 
buffer. After the final wash, approximately 20 µL volume remained of buffer and resin per 
sample.  
 
Western blot imaging of IP assays 
ELUATE: 20 µL of 2x SDS loading dye was added to each eluate sample and 
samples were incubated at 85°C for 10 minutes prior to loading on an SDS-PAGE gel. 
For dual over-expression samples, 10 µL of eluate was loaded for each sample, with the 
exception of positive CNOT controls, in which case 4 µL of eluate was loaded. For 
endogenous Not1 samples, 15 µL of eluate was loaded for all samples except positive 
controls, for which 5µL was used. 
INPUT: Protein concentration of input samples was determined by Lowry DC 
protein assay (BioRad) and 5 µg of total protein (10 µg for endogenous Not1 samples) 
was loaded on either 12% or 5-20% gradient SDS-PAGE gel (BioRad). Gels were 
electrophoresed for approximately 1 hour at 150 to 180 volts, then transferred to PVDF 
membranes (Immobilon) at 4°C for 1.5 hours at 65 volts or overnight at 35 volts. 
Western blotting was performed by allowing the membrane to dry, then applying primary 
rabbit anti-V5 antibody for 1 hour with rocking at room temperature. Membranes were 
washed 3 times briefly in blotto (1x PBS, 0.1% Tween, 5% dried milk) then secondary 
goat anti-rabbit -HRP conjugated antibodies were applied for one hour. Membranes 
were washed twice for ten minutes each, then washed once with PBS before imaging. 
Chemiluminescent substrate was applied briefly (Pierce ECL, Thermo-Fisher or 
Immobilon, Sigma) and blots were imaged on the auto optimal exposure setting of a 
Chemidoc Touch (BioRad.) To image bait proteins, membranes were washed 3 times for 
ten minutes each in PBS, then primary rabbit anti-Flag antibody was applied to eluate 








Archive number Plasmid name Creator 
RJH188 pGBK RD3 Rebecca Haugen 
RJH189 pGBK RD3 ∆Q Rebecca Haugen 
RJH190 pGBK RD3 ∆CR1 Rebecca Haugen 
RJH191 pGBK RD3 ∆CR2 Rebecca Haugen 
RJH192 pGBK RD3 ∆CR3 Rebecca Haugen 
RJH193 pGBK RD3 ∆CR4 Rebecca Haugen 
RJH194 pGBK RD3 ∆CR1+4 Rebecca Haugen 
RJH195 pGBK RD3 F1033A Rebecca Haugen 
RJH196 pGBK RD3 F1040A Rebecca Haugen 
RJH197 pGBK RD3 FF Rebecca Haugen 
CAW038 pIZ MS2CP-DmPop2 V5H6 Chase Weidmann 
ACG544 pIZ GFP Marzluf Lab 
ACG272 pGADT7  CloneTech 
ACG1036 pGADT7 T CloneTech 
ACG1037 pGBKT7 p53 CloneTech 
RJH198 pGAD Not1-N Rebecca Haugen 
RJH199 pGAD Not1-C Rebecca Haugen 
RJH200 pGAD Not1-M Rebecca Haugen 
RJH201 pGAD Dcp1 Rebecca Haugen 
RJH202 pGAD Me31b Rebecca Haugen 
RJH203 pGAD Tis11 Rebecca Haugen 
RJH204 pGAD CCR4 Rebecca Haugen 
RJH205 pGAD Pop2 Rebecca Haugen 
RJH206 pGAD Not10 Rebecca Haugen 
RJH207 pGAD Not11 Rebecca Haugen 
RJH208 pGAD Not2 Rebecca Haugen 
RJH209 pGAD Caf40 Rebecca Haugen 
RJH210 pGAD Not3 Rebecca Haugen 
RJH211 pGAD Not1-N 1-788 Rebecca Haugen 
RJH212 pGAD Not1-N 789-1148 Rebecca Haugen 
RJH213 pGAD Not1-N 789-1064 Rebecca Haugen 
RJH214 pGAD Not1-N 1061-1148 Rebecca Haugen 
RJH215 pGAD Not1-N 789-908 Rebecca Haugen 
RJH216 pGAD Not1-N 908-1064 Rebecca Haugen 
RJH217 pGAD Not1-N 908-1016 Rebecca Haugen 
RJH218 pGAD Not1-N 908-995 Rebecca Haugen 
RJH219 pGAD Not2 1-399 Rebecca Haugen 
RJH220 pGAD Not2 399-585 Rebecca Haugen 
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Archive number Plasmid name Creator 
RJH221 pGAD Not2 399-475 Rebecca Haugen 
RJH222 pGAD Not2 465-585 Rebecca Haugen 
RJH223 pGAD Not3 522-844 Rebecca Haugen 
RJH224 pGAD Not3 740-844 Rebecca Haugen 
pBA041 pGADT7 RD3 Brian Alzua 
CAW018 pIZ HT-V5H6 Chase Weidmann 
RJH175 pIZ Not1-N-Flag Rebecca Haugen 
RJH227 pIZ Not2-Flag Rebecca Haugen 
RJH228 pIZ Not11-V5 Rebecca Haugen 
RJH184 pIZ MS2-eGFP-link-CR1-link-CR4 
(5x) 
Rebecca Haugen 
RJH186 pIZ MS2-eGFP-link-CR1-link-CR4 
(5x) FF mut 
Rebecca Haugen 
 
pIZ MS2-RD3 V5 H6 Chase Weidmann 
RJH161 pIZ MS2 RD3 CR4 F187+194A Rebecca Haugen 
Table 3.1: Plasmids used in Chapter 3. A full list of plasmids can be found in Appendix C. 
 
Antibodies 
All antibodies used in this study are also included Appendix B. Mouse anti-V5 
primary antibody (Invitrogen, Cat# R960-25) was diluted 1:5000 in blotto. Rabbit anti-V5 
(CST Cat# 13202S) was diluted 1:5000 in TBST. Mouse anti-Tubulin (CST, Cat# 3873) 
was diluted 1:1000 in blotto. Rabbit anti-Myc primary antibody (CST Cat# 2278S) was 
diluted 1:5000 in TBST. Rabbit anti-HA tag (CST Cat# 3724s) was diluted 1:5000 in 
TBST. Rabbit anti-Flag antibody (Sigma Cat# sab4301135) was diluted 1:5000 in blotto. 
Mouse anti-Flag (Sigma Cat# F3165-1MG) was diluted 1:5000 in blotto. Goat anti-rabbit-
HRP secondary antibody (CST, Cat# 7074P2 or Sigma Cat# AP187P) was diluted 
1:5000 in blotto. Goat anti-mouse-HRP (Thermo Fisher Cat# 31430) was diluted 1:5000 
in blotto. 
3.5.1. CRISPR generation of Not1-Flag Dl1 cells 
Design of CRISPR guides  
For all CRISPR workflows, the NCBI database was used to determine the ideal 
placement for CRISPR-tagging or gene knockout. If available, the N-terminus of each 
protein was chosen so that indels were more likely to result in a knockout. Benchling 
software (2019) was used to identify CRISPR sites with the highest potential efficiency 
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for Cas9 cleavage with the lowest potential off-target effects. Gene-specific primers 
(listed in Appendix G) were used to amplify the region of interest and TA-cloned into the 
pGEM T-easy vector to generate a library. Ten clones from each library were mini-
prepped using Promega Mini-prep kits and sequenced to verify the targeted region 
matched the NCBI sequence and that the PAM sites were correct. Single-stranded DNA 
oligos were ordered to match the sgRNA sequence with additional BspQI overhangs for 
cloning into the pAc-sgRNA-Cas9 vector (Bassett, Tibbit et al. 2014). Oligos were 
prepared for cloning by taking 50 pmol of each forward and reverse strand, briefly 
heating them at 90°C, and then slowly cooling them. The annealed oligos were then 
phosphorylated using T4 polynucleotide kinase (PNK, NEB) and used in a ligation 
reaction with a BspQI-digested vector.   
Not1 has six annotated transcript variants, with three different potential 
translation start sites. All but one transcript (variant F) code for proteins with the same C-
terminus. The intron that gives rise to variant F shows very low inclusion in NCBI 
annotated RNA-seq data, so it is was assumed that most or all expressed isoforms of 
Not1 would harbor a tag placed at the C-terminus. This work refers to transcript variant 
and isoform D when using amino acid or nucleotide positions. Exon 10 was targeted for 
an insertion in WT Dl1 cells and primers were made to amplify a 597 bp region 
surrounding the stop codon. A 200 bp Ultramer containing a TEV site followed by a 3x-
Flag tag was designed and ordered from IDT.  Two individual homozygous knock-in 





Generation of CRISPR-tagged Not1 cell lines 
Dl1 cells were plated at a density of 1 x 10^6 per mL in 2 mL complete 
Schneider’s Drosophila Medium (SDM) in a six-well dish. Transfection mixes were set up 
using 4 µL FuGene HD (4:1 ratio)(Promega), 1 µg sgRNA-Cas9 plasmid DNA, 40 pmol 
homologous recombination (HR) template, and 100 µL serum free SDM. After a 10 
minute incubation at room temperature, transfection mixes were applied dropwise to 
wells. One well remained untransfected to measure efficacy of Puromycin treatment. 
Cells were incubated at 25°C for 48 hours, then media was removed and replaced by 
media containing 5 µg/mL Puromycin (Gibco). After 48 to 72 hours, when untransfected 
cells had died, selective media was removed and replaced with complete SDM. When 
cells became confluent, they were passaged up to a 10-cm dish and allowed to continue 
growing to 80% density again. At this stage, cells were collected as a polyclonal 
population and approximately half were frozen and stored in liquid nitrogen. The 
remaining cells were diluted to isolate clones in two ways: a limiting dilution was made 
and cells were plated at a density of 1 to 2 cells per 100 µL into 3 to 6 96-well plates, 
Figure 3.20: Characterization of Not1-Flag lines. (Top) DNA agarose gels showing amplicon 
sizes for both Not1-Flag clones (left) and WT Dl1 cells (right). (Bottom) Aligned chromatogram of 
sequenced amplicon for the clone used in this study (C4) using SnapGene v5.0.4. The inserted 
tags are shown. 
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and 10 µL of this dilution was plated into 10-cm plates. Once visible colonies grew in the 
10-cm plates, they were carefully pipetted out and transferred to single wells of a 24-well 
plate. For all wells of clonal isolates, once cells had achieved 80% density, they were 
passaged up sequentially to larger wells. Once cells had reached confluency in a 12-well 
plate, a portion were harvested for genomic analysis. Genomic analysis was performed 
by isolating genomic DNA (gDNA) from the sample using the Wizard gDNA isolation kit 
(Promega) and using gene-specific primers to amplify the region of intended template 
insertion. PCR products were analyzed on a 1% agarose gel for correct size, then 
purified using the Zymo DNA Clean & Concentrator 25 kit, and verified by DNA 
sequencing. If contamination of wild type cells was observed, cells underwent isolation 
procedures again until the remaining population appeared to be homozygous for the 





Chapter 4: Endogenous targets of Pum proteins 
4.1. Introduction 
One of the crucial remaining questions in our understanding of Pum function is 
how does RD3 contribute to Pum regulation of target mRNAs? To begin to answer this 
question, we first needed to identify endogenous targets that we could analyze in detail 
in our cell system. As described in Chapter 1, several targets are well known and have 
important roles in development, however, little is known about target regulation in the 
adult cell and Pum’s day-to-day role in homeostasis.  
In this chapter we sought to identify Drosophila Pum targets that are conserved 
in mammals. We hypothesized that deleting RD3 or mutating F1033 and F1040 would 
result in a reduction of Pum’s repression on these targets. 
 RNA immunoprecipitation assays coupled with micro-arrays (RIP-Chip) have 
shown that Pum binds to hundreds of transcripts in both adult Drosophila and embryos, 
and these experiments provided a starting point for identifying potential Pum targets. A 
2006 RIP-Chip study expressed TAP-tagged (tandem affinity purification) Pum RBD in 
both Drosophila embryos and adult ovaries (Gerber, Luschnig et al. 2006). Over 1,000 
genes were enriched in ovaries (FDR < 1%), including four well-known targets, bicoid, 
hunchback, eIF4E, and cyclinB. High background in the embryo dataset limited the 
identification to 192 genes. Further analysis of these data sets revealed only 31 genes 
shared between adult Drosophila ovaries and embryos, which could indicate distinct 
Pum targets at different developmental stages.  
Another study in 2015 used Drosophila embryos to identify transcripts associated 
with full-length Pum using synthetic Pum antibodies (Laver, Li et al. 2015). With a 1.5-
fold enrichment over negative control and FDR < 5%, 641 genes were identified as Pum 
targets, 300 of which were also identified in the Gerber et al. study in ovaries.  
In addition, our laboratory performed an RNA-seq experiment in Dmel2 cells to 
identify targets that are increased under conditions of Pum depletion via RNAi versus 
LacZ (unpublished data). Although the knockdown efficiency was sub-optimal, the data 




More data is available concerning Pum targets in human or mouse cells. A 2008 
RIP-chip study using human PUM1 in HeLa cells identified 726 genes as PUM1 targets 
(Morris, Mukherjee et al. 2008). This study also sought to compare the level of 
conservation of targets between yeast Puf3, Drosophila Pum, and human PUM1. They 
found that although there is no significant target conservation between Puf3 and PUM1, 
502 Drosophila Pum targets from ovaries had human orthologs, 73 of which are also 
human PUM1 targets.  
A similar RIP-chip experiment was performed in human HeLa S3 cells for both 
PUM1 and PUM2 (Galgano, Forrer et al. 2008). This study identified 1421 genes as 
PUM1 targets and 575 genes for PUM2, with 507 genes as targets of both Pum proteins. 
The authors noted that the apparent lack of identified targets for PUM2 could be due to 
protein degradation present in the PUM2 samples, and not necessarily indicative of a 
smaller binding repertoire. Comparing their results to the 2006 Gerber et al study, they 
found that 17% of Drosophila targets overlapped with human PUM1, and about 7% were 
shared with PUM2.  
In a study designed to investigate germline homeostasis in mice, a Pum1 RIP-
chip experiment was performed using mouse testes (Chen, Zheng et al. 2012). In this 
study, Pum1 bound to over 1500 genes with significant enrichment in gene ontology 
categories for p53 regulation and mitogen-activated protein kinase (MAPK) signaling. In 
addition, many of the target genes also showed changes in protein level when Pum1 
was depleted. 
In mice, Zhang et al. performed CLIP-seq to compare targets between neural-
specific conditional Pum knock out and wild type mouse brains (Zhang, Chen et al. 
2017). Their results also showed a limited pool of targets for Pum2 when compared to 
Pum1: Pum1 bound to 1874 genes compared to 875 for Pum2. There was significant 
overlap between the binding for both proteins however, with 694 targets in common. 
 
4.2. Identification of endogenous Pum targets 
Using the datasets described above, we searched for targets that could meet the 
following criteria: First, the targets are expressed in DL1 cells (Eric Wagner, personal 
communication). Second, each target has at least one PRE. Third, there is evidence of 
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direct binding of the target from the afore-mentioned RIP-Chip experiments. Fourth, the 
target has a known function. Finally, the target has a mammalian homolog. An additional 
consideration was whether there is a disease state associated with dysregulation of the 
target. From this criteria, an initial 23 targets were chosen to study, listed below in Table 
4.1. 
 
Gene FlyBase ID # PREs Human homologs binding data 
disease 
state 
Baboon FBgn0011300 3 
TGFBR1, 
ACVR1B+C 
(1), (2), (3), (6) yes 
Ccm3 FBgn0038331 1 PDCD10 (3), (5), (6) yes 
Ches-1L FBgn0029504 3 FOXN2+N3 (1), (3), (6) none 
Chico FBgn0024248 1 IRS1,2,4 (3), (5), (6) yes 
CoA7 FBgn0039965 2 COA7 (1) yes 
CycK FBgn0025674 5 CCNK (1) yes 
E(Pc) FBgn0000581 4 EPC1+2 (1), (3), (6) none 
Fs(1)h FBgn0004656 4 BRD2, 3, 4, BRDT (1), (2), (5), (6) yes 
Larp4B FBgn0035424 4 LARP4, 4B (1), (2), (6)  none 
Msi FBgn0011666 4 MSI1+2 (2), (4), (5), (6) none 
Myc FBgn0262656 6 MYC (2), (6) yes 
Nrg FBgn0264975 1 
NRCAM, L1CAM, 
NFASC, CHL1 
(3), (5), (6) yes 
Nrv1 FBgn0015776 1 ATP1B1-4, ATP4B (3), (5), (6) yes 
Pan FBgn0085432 9 
TCF7, TCF7L1+2, 
LEF1 
(1), (2), (3), (4), (6) yes 
Pde11 FBgn0085370 3 
PDE:2A, 4A, 4D, 
5A, 6A-C, 7A, 7B, 
10A, 11A  
 (3), (4), (5), (6) yes 
Pten FBgn0026379 5 PTEN (1), (2), (3), (6) yes 
Raf FBgn0003079 2 
BRAF, ARAF, 
RAF1 
(1), (2), (3), (6) yes 
Skd FBgn0003415 2 MED13+13L (2), (3), (6) yes 
Spoon FBgn0263987 3 AKAP1 (2), (3), (5), (6) none 
Strica FBgn0033051 3 CASP3,6,7 (1), (3), (4) none 
Tis11 FBgn0011837 4 
TTP (ZFP36), 
ZFP36L1+L2 
(1), (2), (3), (6) none 
Tob FBgn0028397 15 TOB1+2, BTG1+3 (1), (2), (3), (5), (6) none 
upSET FBgn0036398 6 KMT2E, SETD5 (2), (6) yes 
Table 4.1: Potential endogenous targets. Binding data from (1) Gerber et al. 2006, (2) Laver et 




For these experiments, we used CRISPR-Cas9 to place a Myc tag on 
endogenous Pum at the C-terminus. To measure the effects of Pum on the targets, we 
employed a knockdown strategy using RNAi. dsRNA was used to target Pum, and a 
non-targeting control dsRNA corresponding to E.coli LacZ was used for normalization. 
RNA was extracted from the cells and reverse-transcription and qPCR (RT-qPCR) was 
used to measure the target levels. Knockdown of Pum was efficient at depleting Pum 
protein below the level of detection for a western blot (Figure 4.1 A). Pum RNA level 
showed a 0.18-fold change, indicating robust depletion at the RNA level as well (Figure 
4.1 B). Each experiment was performed with biological triplicates and repeated in three 
separate experiments. Fold changes for all tested targets are listed in Appendix E. 
A 1.2-fold change cutoff (log(2) ≈ 0.263) was used to narrow our focus to targets 
with the highest biological significance. The expected level of repression seen in a 
minimal mRNA construct with one PRE is 1.3-fold in human cells (Bohn, Van Etten et al. 
2018), however we chose to be more lenient in this definition to accommodate for other 
regulatory elements present in endogenous 3’-UTRs that might otherwise dampen 
Pum’s effects. Nine targets met this criterion: Chico, Nervana1 (Nrv1), Pten, Pangolin 
(Pan), Phosphodiesterase 11 (Pde11), Raf, Enhancer of Polycomb (E(Pc)), Tob, and 
Tis11. In addition to measuring RNA levels of targets, we also measured the RNA levels 
of two non-targets, that is, genes that have no known PREs and are not predicted to be 
regulated by Pum. These non-targets served as a baseline for the effects of Pum 
knockdown in cells: wee augmin (wac) and Pgk. Depletion of Pum caused a decrease in 
the levels of non-targets, which could be interpreted as a global effect (Figure 4.1 C). 
However, when Pum was depleted, the levels of the PRE-containing targets increased 
significantly. Since these targets all have PREs and there is evidence of Pum binding to 
the RNA, it is probable that the observed effects were a direct result of Pum binding and 






Figure 4.1: RNAi depletion of Pum increases the RNA levels of endogenous targets. (A) 
Western blot confirming depletion of Pum-Myc. Tubulin and total protein (Sypro Ruby) are both 
shown as loading controls. (B) Mean RT-qPCR measurement of Pum RNA and quantification of 
Pum protein level demonstrating efficient depletion of Pum. (C) Mean target RNA levels as 
measured by RT-qPCR under depletion of Pum using RNAi (n = 9). RT-qPCR experiments are 
normalized to ribosomal protein RPL32 and Pum RNAi compared to LacZ. Significance calling is 




4.3. Validation of Pum targets  
To demonstrate that Pum regulation of these targets is dependent on the PRE, 
we cloned the 3’-UTRs of Raf, Pde11, Nrv1, and Chico into luciferase reporters. Mutant 
reporters of each target were made by mutating each PRE sequence from UGUANAUA 
to ACAANAUA (Figure 4.2). These experiments were performed in Dl1 cells, using 
endogenous Pum to measure the effect of mutating the PRE on the target reporters. As 
a positive control, we included a PRE reporter consisting of 3 PREs in a minimal 3’-UTR 
(3x min). Each reporter was normalized to its respective mutant. Experiments were 
carried out in biological quadruplicates and repeated three times. Pum repression of the 





4.4. Contribution of RD3 to repression of endogenous targets 
Having established PRE-dependent repression of our target reporters, we next 
asked what contribution RD3 has on regulating the target reporters. Previous 
Figure 4.2: Pum repression of target reporters is PRE-dependent. (A) Representation of 
target reporters. Each 3’-UTR was cloned into a NanoLuc reporter with WT sequence or mutated 
PREs. FFLuc is an internal control. (B) Mean log(2) fold change of target reporters showing SEM 
(n = 12). Each WT 3’-UTR (x PRE) is normalized to the respective mutant PRE (x mut). 
Significance against mutant reporters is as follows: * = p < 0.05, ** = p < 0.01, *** = p < 0.001. 
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experiments in Dmel-2 cells had shown that redundancy among the Pum RDs can 
compensate for the deletion of a single RD (Weidmann and Goldstrohm 2012), however 
these experiments were performed using minimal 3’-UTR reporters.  
To test this, we overexpressed full-length Pum constructs in DL1 cells or Pum 
with RD3 removed (Pum ∆RD3). These effectors were normalized to overexpressed 
eGFP. As a negative control, we included a Pum R7 mutant. This mutant has amino acid 
substitutions in repeat 7 of the RBD (S1342A, N1343A, E1346A), rendering it incapable 
of binding RNA (Weidmann and Goldstrohm 2012). As such, its effects on the target 
reporters should be minimal. Experiments were carried out in biological quadruplicates 
and repeated three times. Overexpression of full-length Pum or Pum ∆RD3 effectively 
repressed the reporters over the endogenous amount of Pum, but the R7 mutant had 
minimal effect (Figure 4.3). 
Additionally, the effects of deleting RD3 were different for certain targets. There 
was no significant difference between Pum and Pum ∆RD3 on the Chico reporter, and a 
small difference on the Nrv1 reporter (Figure 4.3 A, B). Removing RD3 appeared to 
enhance repression on the Pde11 target reporter (+7%), while it was detrimental on the 





To further explore the contribution of RD3 to repression and the effect of 
mutating F1033 and F1040, we switched to using a Pum-null cell line that we created 
using CRISPR-Cas9 gene editing. Since the RBD is necessary for binding of Pum to the 
Figure 4.3: Overexpression of Pum represses target reporters. (A-D) Mean log(2) fold 
change relative to eGFP is shown for all reporters with SEM (n = 12). Significance against eGFP 
is shown along the x axis. Significance between Pum and Pum ∆RD3 is shown below the graph. 
Significance calling is as follows: * = p < 0.05, ** = p < 0.01, *** = p < 0.001. (E) Western blot 
showing expression of V5-tagged effectors with tubulin as a loading control. 
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target reporter, we overexpressed either the RBD alone, or the contiguous region RD3-
RBD with its mutant, RD3-RBD F1033A+F1040A (RD3-RBD FF). As a positive control 
for the luciferase assays, we included a reporter with a minimal 3’-UTR, consisting 
simply of 3 PRE sites (3xPRE), and its corresponding mutant, 3xACA. The Pum RBD 
has a small amount of activity when expressed alone (Weidmann and Goldstrohm 
2012), so we normalized these experiments to the RNA binding R7 mutant RBD (RBD 
R7). Experiments were carried out in biological quadruplicates and repeated three times. 
RD3 enhanced repression over the RBD alone, but this additional repressive activity was 
abrogated when both phenylalanines were mutated (Figure 4.4). The effects of the FF 
mutation on the Nrv1 and 3x min reporters were especially striking. The RD3-RBD FF 





Figure 4.4: Overexpression of RD3 represses target reporters. (A-D) Mean log(2) fold 
change relative to RBD R7 mutant is shown for all reporters with SEM (n = 12). Significance 
against RBD R7 is shown along the x axis. Significance between RBD, RD3-RBD, and RD3-
RBD FF is shown below the graph. Significance calling is as follows: * = p < 0.05, ** = p < 0.01, 




4.5. Pum depletion causes an increase in target protein levels 
RNA level does not always correlate with protein level. To demonstrate that the 
effects of Pum depletion on the targets were biologically relevant, we asked if we could 
also detect a change in the protein levels of targets when Pum was depleted. This is 
especially important for signaling molecules and other proteins that the cell keeps under 
tight regulation. The targets Raf and Pde11 are two such proteins. 
Using CRISPR-Cas9 editing, we placed V5 tags on the endogenous Raf and 
Pde11 proteins in our Pum-Myc cell line. RNAi was used to knock down Pum in these 
cells and quantitative western blotting was used to measure the resulting protein levels 
of the targets. Each knockdown experiment was performed in triplicate and repeated 
three times for reproducibility. The average change in protein level for both Pde11 and 
Raf was then assessed and compared to the change in RNA level (Figure 4.5 A). For 




Figure 4.5: Pum depletion causes an increase in target protein levels. Results of quantitative 
western blotting for V5-Raf and V5-Pde11. (A) Mean log(2) fold change for RNA levels as 
measured previously by RT-qPCR, and protein levels. Error bars represent standard error of the 
mean. Significance calling is as follows: * = p < 0.05, ** = p < 0.01, *** = p < 0.001. n = 9 for RNA 
data; n = 9 for protein data. (B) Representative western blot showing depletion of Myc-tagged 
Pum with Tubulin as a loading control. (C, D) Representative western blots of V5-Pde11 (C) and 
V5-Raf (D) with total protein staining by Sypro Ruby. Titrations of total protein are loaded for the 
LacZ NTC condition and Pum RNAi condition. Band density is normalized to total protein as 
described in Methods. (E, F) Standard curve for Pde11 (E) and Raf (F). Normalized band volume 
for the LacZ condition is plotted against total protein loaded (as measured by Lowry DC assay). n 
= 9 for each data point. 
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4.6. Not1 as the effector of Pum-mediated decay of endogenous targets  
Having established that Pum uses the CNOT complex for repression, we next 
asked if our Pum targets were also affected similarly when Not1 is depleted. Although 
we expected global changes when knocking down a major deadenylase, not all mRNAs 
are regulated by the CNOT complex. Since there is no evidence of Pum interacting with 
the Pan complex, we expected that all of Pum’s targets would be specifically affected by 
Not1 depletion.  
We tested the RNA levels of the nine previous targets by using RNAi to knock 
down Not1 in our Not1-Flag Dl1 cells. Target levels were measured by RT-qPCR and 
compared to a LacZ non-targeting control. Most of the tested Pum targets were affected 





Figure 4.6: RNAi depletion of Not1 increases the RNA levels of endogenous Pum targets. 
(A) Western blot confirming depletion of Not1-Flag. Tubulin and total protein (Sypro Ruby) are 
both shown as loading controls. (B) Mean RT-qPCR measurement of Not1 RNA and 
quantification of Not1 protein level demonstrating depletion of Not1. (C) Mean target RNA levels 
as measured by RT-qPCR under depletion of Not1 using RNAi (n = 9). RT-qPCR experiments 
are normalized to Act5c and Not1 RNAi compared to LacZ. Significance calling is as follows: 




4.7. Summary and discussion 
Much of our understanding of Pum targets comes from developmental or tissue 
specific analysis. Our experiments demonstrate the importance of Pum-mediated decay 
outside of these contexts and show that regulation by Pum is relevant in a cell-based 
system. Furthermore, RD3 contributes to the repression of endogenous targets. 
We identified at least nine endogenous targets of Pum and showed that their 
RNA levels were affected by Pum depletion. We further verified Pum-mediated 
repression by demonstrating that regulation of four of these targets (Pde11, Raf, Nrv1, 
and Chico) was dependent on the Pum binding sites present in the 3’-UTRs. 
Additionally, overexpression of Pum caused a decrease in the target reporter levels. We 
also showed that RD3 can repress these target reporters, and that mutating the 
phenylalanine residues F1033 and F1040 severely impacted the repressive ability of 
RD3. We also showed that depletion of Not1 affected Pum targets, as the effector of 
Pum-mediated decay. Finally, we demonstrated that in addition to affecting RNA levels 
of endogenous targets, depletion of Pum caused an increase in the protein levels of both 
Raf and Pde11. 
One of the observations worth noting is the fact that the number of PREs in a 
target’s 3’-UTR does not correlate to repression level by Pum. Presumably, the presence 
of a single PRE is enough to enact decay by Pum, and the presence of multiple PREs 
serves only to increase the odds that Pum will bind to the transcript (Bohn, Van Etten et 
al. 2018, Wolfe, Schagat et al. 2020). Even so, several of the genes we tested did not 
change appreciably under Pum depletion regardless of PRE number. There are several 
explanations for this. One is the presence of other cis regulatory elements in the 3’-UTR. 
Pum is but one of many regulatory proteins bound to a target RNA at any given moment. 
Other RBPs might sterically block the PRE and prevent Pum binding or force the 
transcript toward a different fate. Pum might also be bound to the PRE, but otherwise be 
prevented from recruiting the CNOT complex by associations with other proteins, or by 
autoregulation. A recent study of transcripts regulated by human PUM1 and PUM2 
identified an enriched motif present in genes that were downregulated when PUM1/2 
were depleted (Bohn, Van Etten et al. 2018). This could indicate a mode of combinatorial 
control or the unknown protein(s) that bind to this motif may supersede Pum’s activity. 
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The position of the PRE could also be a factor. The most active PREs tend to be 
located in the 3’-UTR versus the CDS or 5’-UTR (Bohn, Van Etten et al. 2018, Wolfe, 
Schagat et al. 2020). The reasons for this are unclear, but given the known mechanisms 
of Pum action involving recruiting deadenylases and inhibiting PABP (Van Etten, 
Schagat et al. 2012), proximity to the poly(A) tail could be a contributing factor.  
The inherent structure of the RNA itself might inhibit Pum binding. The common 
depiction of RNA as a linear molecule is grossly misleading, as RNA forms many 
structures in vivo. These include cis base pairing, G-quadruplex structures, 
pseudoknots, hairpins and helices (Ganser, Kelly et al. 2019). Any of these structures 
can form to occlude an RBP binding site. 
The dynamic interplay of RNA regulatory factors can be seen in the target 3’-
UTR reporter assays for Pde11, Raf, Chico, and Nrv1. All other conditions being equal, 
each reporter had a different response to Pum independent of PRE number (Figure 4.2). 
Additionally, overexpressing Pum or Pum ∆RD3 affected the reporters differently. For 
the Pde11 reporter, the loss of RD3 resulted in an increase in repression by Pum, while 
the opposite was true for the Raf reporter (Figure 4.3). Furthermore, the effects of 
mutating the phenylalanine residues in RD3 were much more pronounced for the Nrv1 
reporter (Figure 4.4).  
One of the top targets identified in our RNAi screen was Tob, a target that has 15 
PREs. Tob has a very long 3’-UTR (5,000+ bp) and we were not able to clone it fully into 
our reporter assay system. Instead, we cloned an area that covered 5 of the PRE sites. 
However, this reporter did not show PRE-dependent repression, nor did a reporter made 
from the Ccm3 3’-UTR with 2 PREs (data not shown). It is unknown what other factors 
might contribute to regulation of these targets or whether Pum is acting on them at all.  
The data presented here illustrates the complexity surrounding the modality of 
Pum repression. The larger question of what makes a PRE functional still remains a 
mystery and a topic of great interest. 
4.7.1. Biological significance of targets 
The Pum targets identified in this chapter have many different cellular functions. 
This set of Pum targets, while just a small sampling of the potential hundreds of genes 
regulated by Pum, demonstrates the importance and scope of the regulatory power of 
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Pum proteins. The Pum targets described here function in multiple cell-signaling 
pathways, regulate development, and control cell growth and tumor progression. Here 
we summarize what is known about these targets in Drosophila and mammals. 
Cyclic GMP and AMP (cAMP and cGMP) are important cytoplasmic signaling 
molecules that regulate diverse cellular functions. Levels of cAMP and cGMP are tightly 
controlled by their interconversion from linear and cyclic forms by adenyl or guanyl 
cyclases and phosphodiesterases (PDEs). PDEs are responsible for catalyzing the 
conversion from cGMP and cAMP to 5’ GMP and 5’ AMP. In humans, there are ten 
families of PDEs, with most members exhibiting distinct tissue localization, substrate 
specificity, allosteric activators and regulation.  Because of their roles in signal 
transduction pathways, PDEs are important drug targets. Pde11 is one of six PDEs in 
Drosophila, exhibiting dual specificity for both cGMP and cAMP. Of the fly PDEs, Pde11 
shows the highest affinity for cGMP (Day, Dow et al. 2005).  
Pde11 has been best studied in human and mouse systems, where PDE11 is 
important for male testicular function and controlling cAMP levels (Wayman, Phillips et 
al. 2005, Levy, Szarek et al. 2021). PDEs are often implicated in adrenal tumors, where 
levels of cAMP are dysregulated (Szarek and Stratakis 2014). In humans, mutations of 
Pde11 were discovered in patients with idiopathic Cushing syndrome. These mutations 
resulted in decreased protein levels of PDE11 in adrenal tumor tissues, increased levels 
of cyclic nucleotides, and increased phosphorylation of cAMP-responsive element 
binding protein (CREB) (Horvath, Boikos et al. 2006). In mouse brain, Pde11a KO also 
affects societal learning and memory formation (Makhlouf, Kshirsagar et al. 2006, Kelly, 
Logue et al. 2010, Kelly 2017). 
Drosophila Pde11 shares a 77% sequence identity with human PDE11 in the 
catalytic domain, and 38% in the rest of the protein (Day, Dow et al. 2005). In 
Drosophila, the Pde11 gene has six annotated transcripts with four unique 3’-UTRs. A 
portion of the 3’-UTR common to all transcripts contains 2 perfect PREs and an 
additional partial (7 nt) PRE. Importantly, these PREs are conserved in human PDE5A 
and PDE11A, the two closest related human PDEs. 
Raf and its human homologs BRAF, ARAF, and Raf1 are serine/threonine 
kinases that act in the Tor, Egfr and sevenless signaling cascades. These pathways are 
crucial for cell growth and proliferation. As the activity of these kinases lead to 
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amplification of downstream events, dysregulation of Raf proteins often lead to cancer. 
As such, their roles as oncogenes have been studied for decades (Nishida, Hata et al. 
1988, Brose, Volpe et al. 2002, Maurer, Tarkowski et al. 2011). 
 In Drosophila, Raf also has roles in memory, where its overexpression leads to 
stabilization of labile memory (Zhang, Li et al. 2018). A large-scale TAP-MS (tandem 
affinity purification-mass spectrometry) study uncovered hundreds of protein interactors 
of Drosophila Raf, highlighting the interconnectivity of this protein in the MAPK signaling 
cascade (Friedman, Tucker et al. 2011). 
Drosophila Raf shares 46% amino acid identity to human RAF1, 44% to ARAF, 
and 43% identity to BRAF (DRSC). The Drosophila Raf gene encodes two transcript 
variants, both of which translate into a single protein isoform. Both transcripts contain 2 
perfect PREs in the 3’ UTR, and the longest transcript contains an additional partial (7 
nt) PRE in the 5’ UTR. The method of post-transcriptional control by Pums is likely 
conserved in humans as well, with all three human Raf homologs (ARAF, BRAF, RAF1) 
possessing at least one PRE in their 3’-UTRs. The human ARAF transcript has also 
been identified in a genome-wide RIP-Chip for binding to both PUM1 and PUM2, and the 
mouse homolog is also bound by Pum (Galgano, Forrer et al. 2008, Zhang, Chen et al. 
2017). Additionally, human RAF1 was shown to functionally compensate for Drosophila 
Raf in mutant flies (Baek, Fabian et al. 1996). 
Chico, first identified in a screen for mutations causing small body size in 
Drosophila, is an insulin receptor substrate, homologous to human IRS1,2, and IRS4. In 
addition to controlling body size by reducing both cell size and number, chico mutants 
also produced nearly double the amount of lipids as WT flies (Böhni, Riesgo-Escovar et 
al. 1999).  The human insulin receptor substrate IRS1 contains 8 PREs in its 3’-UTR.  
Nrv1 (Nervana1) is one of three beta subunits of the sodium-potassium ion 
channel pump (Na+ K+ ATPase). It is orthologous to human beta subunits ATP1B1-B4, 
and ATP4B. The Na+ K+ ATPase ion pumps are essential for maintaining cell polarity, 
which allows for the uptake of molecules and establishes resting membrane potential. 
Nrv1 is expressed in muscle tissues and non-neuronal tissues (Xu, Sun et al. 1999). 
Each of the beta subunits exhibit distinct tissue localization indicating unique functions, 
however the specific roles of Nrv1 in Drosophila have not been well studied (Paul, 
Palladino et al. 2007). 
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Tis11 (TTP, Tristetraprolin in humans) is a conserved RBP that regulates mRNAs 
in a manner similar to Pum. Tis11 binds to AU-rich elements (AREs) in the 3’ UTR of 
target mRNAs via tandem zinc fingers and recruits the CNOT deadenylase complex (Lai, 
Carballo et al. 2000). Tis11 mRNA expression is induced following mitogenic stimulation 
(Sanduja, Blanco et al. 2012).  
Pten (phosphatase and tensin homolog) is a dual specificity phosphatase with 
activity for phosphoinositide lipids and tyrosine or serine/threonine phosphorylated 
residues. Pten inhibits signaling from phosphoinositide 3-kinase (PI3K) by 
dephosphorylating phosphatidylinositol 3,4,5-trisphosphate and negatively regulating the 
insulin receptor pathway (Goberdhan, Paricio et al. 1999). Both Drosophila Pten and its 
mammalian homolog PTEN have been extensively studied for their roles as tumor 
suppressors in regulating cell growth (Shi, Paluch et al. 2012, Texada, Koyama et al. 
2020).  
Pan (Pangolin, also known as dTCF) is a transcription factor in the Wnt signaling 
pathway that acts as a repressor or an activator. Wnt signaling is important for cell-to-
cell communication during development and to maintain cellular homeostasis. Upon 
activation of the pathway, intracellular levels of Armadillo (β-catenin) protein rise and 
bind to Pan, switching Pan from a transcriptional repressor to an activator. Pan thus 
facilitates the transcription of genes in response to the received Wnt signal (Fiedler, 
Graeb et al. 2015). 
Tob (transducer of ERBB2) is most closely related to mammalian TOB1. The Tob 
family of proteins are well known anti-proliferative proteins which also act by recruiting 
the CNOT complex via interactions with Pop2 (human CNOT7/8)  (Winkler 2010, 
Doidge, Mittal et al. 2012). Having no intrinsic RNA binding ability of their own, Tob 
proteins target other RBPs like CPEB or PABP to illicit decay of the transcripts they are 
bound to (Hosoda, Funakoshi et al. 2011). 
Enhancer of polycomb (E(Pc)) was first identified for its ability to suppress 
position-effect variegation in Drosophila (Sato 1983, Elgin and Reuter 2013). It is one of 
the non-catalytic subunits of the NuA4 histone acetyltransferase complex (Doyon and 
Cote 2004). More recently, roles for E(Pc) have been found in hematopoiesis (Owusu-
Ansah and Banerjee 2009), cell cycle control, DNA repair, and cell differentiation (Searle 
and Pillus 2018).  
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4.8. Materials and methods 
 
Cell culture 
Drosophila Dmel2 cells were cultured in Gibco SF-900III media with no additional 
supplements. Cells were passaged every 3 to 4 days and discarded once they reached 
passage 30. Drosophila Dl1 cells were a gift from Eric Wagner. Dl1 cells were cultured in 
Schneider’s Drosophila media (SDM, Gibco) containing additional glutamine (1x 
GlutaMAX, Gibco), 1x anti-microbial/anti-fungal (Anti/anti, Thermo Fisher), and 10% heat 
inactivated fetal bovine serum (FBS, GenClone). FBS was heat inactivated by incubating 
at 56 to 60°C for 30 minutes. DL1 cells were passaged every 3 to 4 days and discarded 
after passage number 40. All Drosophila cells lines were cultured at 25°C in a 
temperature and humidity-controlled incubator. DL1 cells were frozen from 80% density 
in 10-cm dishes, collected and centrifuged in 15 mL tubes at 800 x g for 3 minutes. 2 mL 
of used media was reserved; 500 µL DMSO and 2.5 mL of complete SDM were added to 
the tube and cells were resuspended. Cells were aliquoted into 3 cryogenic storage 




100 µL of Drosophila cells were seeded in 96-well plates at a density of 1.5 x 
10^6 per mL. Four wells in each condition served as biological replicates for luciferase 
measurements, while three wells in each condition were reserved for protein analysis. 
Transfection master mixes were set up using 1 ng of Firefly Luciferase (FF) per well (5 
ng for Dmel2), 1 ng of Nano Luciferase (NLuc) reporter (5 ng for Dmel2), and 98 ng of 
either effector plasmid or balanced with empty pIZ plasmid (90 ng for Dmel2). FuGene 
HD transfection reagent (Promega) was used at a 4:1 ratio (0.4 µL/well) and serum free 
media was added to master mixes to bring the level of master mix transfected per well to 
10 µL. Master mixes were incubated for 5 to 10 minutes before adding to wells of plated 
cells. Plates were incubated for 48 to 72 hours before harvest and analysis. For analysis, 
100 µL of OneGlo Firefly reagent (Promega) was added to each well, mixed and 
incubated at room temperature for 10 minutes. Luminescence was measured on a Glo-
Max instrument under default settings. 100 µL of NanoGlo Stop-n-Glo reagent 
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(Promega) was then added to each well, mixed and incubated at room temperature for 
15 minutes before reading luminescence. 
 
RNAi 
DNA templates for in vitro transcription were made by amplifying from either 
plasmid DNA or cDNA using primers containing T7 RNA polymerase promotor sites. 
Templates for Pum knockdown target a 597 bp region in the RBD and Not1 templates 
target a 536 bp region in the Caf40 binding domain. DNA templates were purified using 
either Qiagen’s QIAquick PCR purification kit or Zymo DNA Clean & Concentrator kit. 
dsRNA was made using 1 µg of template with NEB’s HiScribe T7 RNA polymerase. 
dsRNA was purified using either Zymo RNA Clean & Concentrator or Monarch RNA 
Cleanup kit (NEB). 
Drosophila Dl1 cells were plated in 6-well plates at a density of 1 x 10^6 cells/ mL 
for 4-day knockdowns, or 1.5 x 10^6 cells/mL for 3-day knockdowns. Cells were 
incubated in 10 to 20 µg (20 µg for Not1) dsRNA for 60 minutes in 1 mL serum-free 
media. 2 mL complete media was added after dsRNA bathing step and cells were 
incubated at 25°C for 68 to 90 hours. At harvest, the media was removed and the cells 
were resuspended in 2 mL PBS. 1.5 mL of cells were taken for RNA, and the remaining 
500 µL were processed for protein expression.  
 
Western blotting  
For luciferase assays, three wells of each condition were harvested by pipette-
mixing and transferring cells to 1.5 mL Eppendorf tubes. Cells were centrifuged at 900 x 
g for 4 minutes, media was removed, and the cells were resuspended in 40 µL RIPA 
buffer with additional 2x protease inhibitors (Roche, Sigma). For verification of 
knockdown in tagged cell lines, harvested cells were resuspended in 2 mL PBS. 1.5 mL 
of cells were taken for RNA, and the remaining 500 µL were pelleted and resuspended 
in 75 µL RIPA buffer with 2x protease inhibitors (Roche). Further processing was the 
same. After a 10 minute incubation on ice, lysates were collected by centrifuging at 
21,000 x g for 10 minutes and removing the supernatant. The protein concentration was 




5 µg (from luciferase assays) or 20 µg (for Pum or Not1 knockdown verification) 
of total protein extract was incubated with an equal volume of 2x SDS loading buffer at 
85°C for ten minutes. Samples were loaded on 12% SDS-PAGE gels (either laboratory-
made or purchased precast from BioRad) and run at 120 to 180 volts until dye front 
reached the bottom of the gel. Gels were transferred to PVDF membranes (Millipore) for 
either 1.5 hours at 65 volts or overnight at 35 volts. Following transfer, membranes were 
either blocked in blotto for 1 hour or allowed to dry completely, then primary antibodies 
were applied for one hour at room temperature, or incubated overnight at 4°C. 
Membranes were washed three times for 10 minutes in blotto, then secondary 
antibodies were applied for 1 hour at room temperature. Membranes were washed three 
times for ten minutes each in blotto, then rinsed with 1x PBS before applying 
chemiluminescent substrate (Pierce- Thermo Fisher, or Immobilon- Millipore) Blots were 
imaged using the auto exposure setting on a ChemiDoc Touch (BioRad). 
 
Data analysis 
Luciferase assays: Samples were normalized for potential variation in 
transfection efficiency by calculating the ratio of NLuc to FF. The repression activity of 
each effector was calculated as fold change by dividing each sample well NLuc:FF ratio 
by the average NLuc:FF ratio of the control condition (eGFP, R7 RNA binding mutant, or 
ACA mutant reporter.) Repression activity was then graphed as log(2) fold change. 
Statistics for luciferase assays were performed using Student’s unpaired T-test with 
either equal or unequal variance as dictated by F-test results. Significance calling was 
based on the convention p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***. Each experiment 
consisted of 3 to 4 biological replicates and each experiment was repeated at least 3 
individual times. 
RT-qPCR: Three biological replicates for NTC or WT and 3 biological replicates 
for experimental condition were used for each experiment. Each experimental condition 
was compared to each NTC/WT condition for 3 measurements per biological sample, 
and 9 total measurements per experiment. Fold change for each experiment was 
determined using the Pfaffl method where fold change is represented by the equation 





 . E is defined as primer efficiency for each gene, and ∆Ct is Ct of 
109 
 
the calibrator condition (LacZ) minus the Ct of the test condition (Pum KD or Not1KD.) 
Reference genes were RPL32 for Pum KD and Act5c for Not1 KD. Unpaired Student’s T 
tests with variances determined by F tests were performed using raw ∆Ct values for 
each gene. Each experiment was repeated 3 times, for a total of 27 measurements. 
 
RT-qPCR 
RNA extraction was performed using the Maxwell RSC simply RNA Tissue RNA 
extraction kit and concentration was determined using the NanoDrop spectrophotometer. 
A total of 10 µg RNA was taken from each sample for reverse transcription (RT) using 
GoScript reverse transcriptase (5 µg for RT, 5 µg for noRT samples.) RT reactions were 
primed with random hexamers and carried out according to the manufacturer’s protocol. 
cDNA was then diluted with 100 µL water to approximately 41 ng/µL. Quantitative PCR 
(qPCR) was set up using Promega’s Go-Taq qPCR Master Mix with 2 µL of each 
cDNA/noRT sample in a 20 µL reaction volume using either 100 nM or 200 nM final 
concentration qPCR primers for each gene. Reactions were performed on the Bio-Rad 
CFX96 instrument using the following cycling parameters: 3 min 98°C, [10 sec 95°C, 30 
sec 62/63/64°C, 40 sec 72°C + image] x 39, 60°C-90°C melt curve + image. Individual 
annealing temps for each primer set are listed in Appendix D. 
 
Cloning target reporters 
Endogenous target reporters were created by ordering the 3’-UTR of each 
transcript as a gBlock from IDT to insert into the pAc 5.4 NLuc vector using XhoI and 
NotI restriction sites. For Pde11, nucleotides 5762 to 6368 of transcript variant E were 




Archive number Plasmid name Creator 
ACG864 pIZ Dm Pumilio V5 His6 Aaron Goldstrohm 
CAW003 pIZ Dm Pumilio R7mut SNVVE to 
AAVVA 
Chase Weidmann 
ACG866 pIZ Dm Pumilio RBD Aaron Goldstrohm 
CAW391 pIZ PumΔRD3 V5H6 Chase Weidmann 
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Archive number Plasmid name Creator 
ACG544 pIZ GFP Marzluf Lab 
RMA0008 pIZ Dm Pum RD3-RBD Rene Arvola 
RJH229 pIZ RD3-RBD FF Mut Rebecca Haugen 
CAW004 pIZ Dm Pum RBD R7mut SNVVE to 
AAVVA 
Chase Weidmann 
RJH230 pAc 5.4 NLuc 3xPRE (19 nt) Rebecca Haugen 
RJH231 pAc 5.4 NLuc 3xPRE ACA mt (19 nt) Rebecca Haugen 
CAW061 pIZ MS2CP-GFP V5H6 Chase Weidmann 
RJH232 pAc 5.4 NLuc Chico 3’-UTR Rebecca Haugen 
RJH233 pAc 5.4 NLuc Chico 3’-UTR 2x ACA 
mt 
Rebecca Haugen 
RJH234 pAc 5.4 NLuc Nrv1 3’-UTR Rebecca Haugen 
RJH235 pAc 5.4 NLuc Nrv1 3’-UTR 1x ACA 
mt 
Rebecca Haugen 
RJH236 pAc 5.4 NLuc Pde11 3’-UTR Rebecca Haugen 
RJH237 pAc 5.4 NLuc Pde11 3’-UTR 2xACA 
mt 
Rebecca Haugen 
RJH238 pAc 5.4 NLuc Raf 3’-UTR Rebecca Haugen 
RJH239 pAc 5.4 NLuc Raf 3’-UTR 2xACA mt Rebecca Haugen 
Table 4.2: Plasmids used in Chapter 4. A full list of plasmids can be found in Appendix C. 
Antibodies 
All antibodies used in this study can be found listed in Appendix B. Mouse anti-
V5 primary antibody (Invitrogen, Cat# R960-25) was diluted 1:5000 in blotto. Mouse anti-
Tubulin (CST, Cat# 3873) was diluted 1:1000 in blotto. Rabbit anti-Myc primary antibody 
(CST Cat# 2278S) was diluted 1:5000 in TBST. Mouse anti-Flag (Sigma Cat# F3165-
1MG) was diluted 1:5000 in blotto. Goat anti-rabbit-HRP secondary antibody (CST, Cat# 
7074P2 or Sigma Cat# AP187P) was diluted 1:5000 in blotto. Goat anti-mouse-HRP 
(Thermo Fisher Cat# 31430) was diluted 1:5000 in blotto. 
For total protein detection, Sypro Ruby (Thermo Fisher) was used according to 
the manufacturer’s directions. 
4.8.1. Quantitative western blotting 
Cell culture 
To determine the levels of Pde11 and Raf protein after Pum RNAi, knockdown of 
Pum protein was performed in Pum-myc/V5-Pde11 or Pum-myc/V5-Raf cells, using 10 
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µg Pum dsRNA or LacZ dsRNA in a 4-day experiment. Three wells of each condition 
were used. Cells were plated in 6-well plates at a density of 1 x 10^6 cells/ mL for 4-day 
knockdowns. Cells were incubated in 10 µg dsRNA targeting Pum for 60 minutes in 1 
mL serum-free media. 2 mL complete media was added after dsRNA bathing step and 
cells were incubated at 25°C for 90 hours.  
 
Western blotting 
At harvest, media was removed and cells were washed in 1mL PBS. Cells were 
resuspended in 150µL RIPA buffer with 2x cOmplete protease inhibitors (Roche). Cells 
were incubated on ice for 10 minutes then mechanically disrupted with a pestle for 20 
seconds each. Lysates were collected after a 10 minute 21,000 x g centrifugation step at 
4°C. Protein concentration was determined by Lowry DC with BSA standard (BioRad).  
To determine the linear range of detection for V5-tagged proteins, 5 µg-45 µg 
dilutions were used. For quantitation of Raf and Pde11 protein levels, 5 to 25 µg was 
used for the LacZ samples and 5 to 20 µg was used for Pum RNAi samples. For each 
replicate, titrations of total protein were loaded on a 12% SDS-PAGE gel. Gels were 
electrophoresed at 150 volts until the dye front reached the bottom of the gel, then 
transferred to Immobilon PVDF membrane overnight at 4°C at 35 volts. Membranes 
were dried thoroughly, then Sypro Ruby stain was applied following the manufacturer’s 
directions and detected using the auto-exposure setting on the ChemiDoc. After 
imaging, blots were rocked in 3 changes of blotto for 1 hour to remove residual stain. 
Mouse anti-V5 antibody (Sigma) was applied and incubated overnight at 4°C. Primary 
antibody was washed with 3 changes of blotto, and HRP-labeled goat anti-mouse 
antibody was applied and incubated for 1 hour at room temperature. Secondary antibody 
was washed with two 5-minute washes of blotto followed by two 5-minute washes with 
1x TBS. Blots were incubated briefly in Immobilon substrate (Millipore), quickly rinsed 
with PBS, and imaged using the optimal auto-exposure chemiluminescence setting on a 
ChemiDoc Touch.  
 
Data analysis 
To determine the linear range of detection, acquired images were analyzed using 
Bio-Rad Image Lab software. Titrations of 5 µg to 45 µg each of Pde11-V5 and Raf-V5 
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whole-cell lysates were analyzed via western blots. Three sets of graphs were generated 
to determine sensitivity range. 1) To measure the sensitivity of Sypro Ruby stain, we 
used adjusted total band volume for Sypro Ruby stain (described for housekeeping 
bands below) and graphed it versus total protein loaded. 2) For the V5 antibody, we 
used adjusted total band volume for V5 antibody and graphed it versus total protein 
loaded. 3) To ensure that normalizing V5 antibody to Sypro Ruby would fall within the 
linear range of detection, we also measured normalized V5 antibody band volume 
(normalized to Sypro Ruby) and graphed it versus total protein loaded. For both Pde11 
and Raf detection, 5 to 25 µg total protein lies within the linear range of detection.  
To determine protein level fold change, normalized band volume for each loaded 
protein amount was compared within each blot. For example, the band volume for the 5 
µg Pum KD sample was compared to the 5 µg LacZ sample. Fold change was 
determined as the ratio Pum KD/LacZ. For each individual blot there were a total of 4 
measurements (5 µg, 10 µg, 15 µg, 20 µg). For each experiment with 3 biological 
replicates, this resulted in a total of 12 measurements, and with 3 experimental repeats, 
a total of 36 measurements were made. The average of these measurements is 
represented as a log2 scale value, with error bars as standard error of the mean. To 
generate the standard curve, the adjusted band volume for V5 detection of each µg 
amount loaded in each experiment was graphed against total protein loaded. 
 
Image Lab software analysis 
Multichannel images were created with the chemiluminescent and Sypro Ruby 
images. Lanes were detected manually. Bands for chemiluminescence were detected 
automatically if possible. If manually detected, outer regions of bands were chosen to 
capture the prominent peak and match the profiles of auto-detected bands. The 
normalization channel was set to Sypro Ruby using housekeeping bands, and large 
regions of the lanes in the Sypro channel were selected to represent housekeeping 
bands. If possible, the entire lane was used. This selection method enabled us to avoid 
regions of saturation at the bottom of the blots or regions with large transfer 
imperfections. Each lane on the same blot used the same corresponding region for 
housekeeping band selection. Background subtraction for the Sypro channel was set to 
a 70 mm rolling disk. Background subtraction for the chemiluminescence channel was 
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set to the maximum level possible that did not interfere with band detection. Data for all 
lanes and bands was then exported to Excel, where graphs were generated. For V5-
Pde11, the normalized volume for both bands were added together for graphing. 
 
4.8.2. CRISPR generation of Pum-Myc, Pum KO lines, V5-Pde11, V5-Raf 
Design of CRISPR guides 
For all CRISPR workflows, the NCBI database was used to determine the ideal 
placement for CRISPR-tagging or gene knockout. If available, the N-terminus of each 
protein was chosen so that indels were more likely to result in a knockout. Benchling 
software (2019) was used to identify CRISPR sites with the highest potential efficiency 
for Cas9 cleavage with the lowest potential off-target effects. Gene-specific primers 
(listed in Appendix G) were used to amplify the region of interest and TA-cloned into the 
pGEM T-easy vector to generate a library. Ten clones from each library were mini-
prepped using Promega Mini-prep kits and sequenced to verify the targeted region 
matched the NCBI sequence and that the PAM sites were correct. Single-stranded DNA 
oligos were ordered to match the sgRNA sequence with additional BspQI overhangs for 
cloning into the pAc-sgRNA-Cas9 vector (Bassett, Tibbit et al. 2014). Oligos were 
prepared for cloning by taking 50 pmol of each forward and reverse strand, briefly 
heating them at 90°C, and then slowly cooling them. The annealed oligos were then 
phosphorylated using T4 polynucleotide kinase (PNK, NEB) and used in a ligation 
reaction with a BspQI-digested vector. 
The Drosophila Pum gene is located on the third chromosome and codes for 
eight different transcripts. There are 5 annotated protein isoforms, the largest of which is 
1533 amino acids and approximately 157.5 kDa (via NCBI + FlyBase). It is unclear if 
there is isoform-specific expression in different fly tissues. The canonical 1533 aa form, 
A, is exclusively detected in Dmel2 and Dl1 cells. For this work, all references to amino 
acid positions or nucleotide bases refer to isoform A or transcript variant A.  
For the Pum knockout, the first exon common to all isoforms is exon 9. Primers 
were designed to amplify 463 bp of exon 9 in WT Dl1 cells, and two Cas9 sites were 
chosen to target. Two clones with homozygous knockouts of Pum were recovered.  
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All annotated isoforms of Pum share the same C-terminus, so the C-terminal end 
of Pum was targeted for the addition of a Myc tag in WT Dl1 cells. Primers were 
designed to amplify a 831 bp region in exon 13 and two sgRNA sites were chosen and 
sequence verified. A 200 bp Ultramer oligonucleotide sequence was ordered from IDT 
containing a single Myc tag sequence immediately preceded by a HRV 3C site. The 
homology repair (HR) template was designed to have at least 50 bp of overlapping 
sequence distal and proximal to each cut site. Two verified clones homozygous for the 
Myc tag insertion were isolated. The first carried an in-frame duplication of the HR 
insertion resulting in two tandem HRV 3C and Myc sites. The second clone had an 
appropriate insertion resulting in a functional HRV 3C site and Myc tag. The single 
tagged Pum line was used in all experiments. 
Pum-Myc cell lines were used to create V5-tagged Raf and Pde11. The Pde11 
gene has 6 transcript variants which code for 4 unique proteins with different N- and C-
termini. This work references variant E, where exon 3 is the first common exon for all 
protein isoforms. Primers were designed to amplify a 412 bp region of intron 2 and exon 
3. A single nucleotide polymorphism was detected in the analyzed sequences for Pum-
Myc Dl1 cells where both sgRNAs would bind, and the cloning oligos were changed to 
match. A 200 bp Ultramer was ordered that would insert a V5 tag internally at the N-
terminus of all annotated protein isoforms. For isoforms E, G, and C, this would place 
the V5 tag beginning at position 22, and position 65 for all others. A single V5-Pde11 
clone was isolated. This clone had one allele properly tagged. The other allele contained 
a single nucleotide deletion which changes the methionine at position 57 to a stop 
codon. There were no noticeable effects on growth or Pde11 transcript levels with this 
heterozygous (functionally haploid) line. 
The Drosophila Raf gene encodes two transcript variants, both of which code for 
identical proteins. Primers were designed to amplify a 479 bp region of exon 3 of variant 
E in Pum-Myc Dl1 cells. A 200 bp Ultramer was designed to insert a N-terminal V5 tag at 
position 2. A single homozygous V5-knock-in clone was isolated and verified by 





Generation of CRISPR-tagged cell lines 
Dl1 cells were plated at a density of 1 x 10^6 per mL in 2 mL complete 
Schneider’s Drosophila Medium (SDM) in a six-well dish. Transfection mixes were set up 
using 4 µL FuGene HD (4:1 ratio)(Promega), 1 µg sgRNA-Cas9 plasmid DNA, 40 pmol 
homologous recombination (HR) template, and 100 µL serum free SDM. After a 10 
minute incubation at room temperature, transfection mixes were applied dropwise to 
wells. One well remained untransfected to measure efficacy of Puromycin or Blasticidin 
treatment. Cells were incubated at 25°C for 48 hours, then media was removed and 
Figure 4.7: Characterization of Pum-Myc, V5-Pde11, and V5-Raf cell lines. Aligned 
chromatogram of sequenced amplicons using SnapGene v5.0.4. The inserted tags are shown. 
(Top) C-terminal tagged Pum-Myc with DNA agarose gel of PCR amplicons. (Center) N-terminal 
V5-tagged Pde11 with DNA agarose gel of PCR amplicons. The single base deletion is further 




replaced by media containing 5 µg/mL Puromycin or Blasticidin (Gibco). After 48 to 72 
hours, when untransfected cells had died, selective media was removed and replaced 
with complete SDM. When cells became confluent, they were passaged up to a 10-cm 
dish and allowed to continue growing to 80% density again. At this stage, cells were 
collected as a polyclonal population and approximately half were frozen and stored in 
liquid nitrogen. The remaining cells were diluted to isolate clones in two ways: a limiting 
dilution was made and cells were plated at a density of 1 to 2 cells per 100µL into 3 to 6 
96-well plates, and 10 µL of this dilution was plated into 10-cm plates. Once visible 
colonies grew in the 10-cm plates, they were carefully pipetted out and transferred to 
single wells of a 24-well plate. For all wells of clonal isolates, once cells had achieved 
80% density, they were passaged up sequentially to larger wells. Once cells had 
reached confluency in a 12-well plate, a portion were harvested for genomic analysis. 
Genomic analysis was performed by isolating genomic DNA (gDNA) from the sample 
using the Wizard gDNA isolation kit (Promega) and using gene-specific primers to 
amplify the region of intended template insertion. PCR products were analyzed on a 1% 
agarose gel for correct size, then purified using the Zymo DNA Clean & Concentrator 25 
kit, and verified by DNA sequencing. If contamination of wild type cells was observed, 
cells underwent isolation procedures again until the remaining population appeared to be 
homozygous for the intended insertion. For Pde11-V5 cells, one allele is properly tagged 
but the other contains a single nucleotide deletion resulting in a knockout. 
 
Generation of Pum null cell lines 
Dl1 cells were plated at a density of 1 x 10^6 per mL in 2 mL complete media in a 
6-well dish. Transfection mixes were set up using 8 µL FuGene HD (4:1 ratio), 2 µg 
sgRNA-Cas9 plasmid DNA, and 1 mL serum free SDM. After a 10 minute incubation at 
room temperature, transfection mixes were applied dropwise to wells. Cells were 
incubated at 25°C for 48 hours, then media was removed and replaced by media 
containing 5 µg/mL Puromycin. Cells were isolated in a similar manner as for CRISPR 
tagging, however, Puromycin selection was kept on the cells for twenty days to enforce 
gene knockout. Once clones were isolated and gDNA was sequenced, Synthego ICE 




Characterization of Pum null cell lines  
Two unique homozygous knockout lines were constructed: Pum KO1 and Pum 
KO2. Clone 1 has a 20 bp deletion with an additional 81 bases added, resulting in a net 
gain of 61 bases. This causes a frame shift after glutamine 725 and truncates the 
remaining protein sequence at amino acid 733. Clone 2 has a 10 bp deletion in exon 9, 
causing a frameshift after methionine 726 and truncates the protein at amino acid 764. 
These lines were created prior to the Pum-Myc line, and therefore cannot be detected on 




Figure 4.8: Characterization of Pum KO lines. (A) The full-length Pum protein with CRISPR 
targeting site indicated. The resulting protein products for each Pum KO line are shown, with 
out-of-frame amino acid sections shown in red. Positions of stop codons are marked, along with 
the net gain or loss of nucleotides resulting from CRISPR indels. (B) DNA agarose gel showing 
PCR amplicons from genomic DNA of exon 9. The primers amplify across the CRISPR target 
region. WT Pum amplicon is 463 bp, Pum KO1 is 524 bp, and Pum KO2 is 453 bp. (C) Pum RNA 
level in each KO line as measured by RT-qPCR. qPCR primers bind to either exon 9 (left bar) or 






Figure 4.9: Chromatogram alignment of Pum KO lines. Exon 9 amplicons from WT Dl1 cells 
and Pum KO lines were sequenced and aligned to WT Pum using SnapGene v5.0.4. (Top) Pum 
KO1 has a large insertion and small deletion with a net gain of 61 bases. (Bottom) Pum KO2 has 
a 10 base deletion. 
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Chapter 5: Genome-wide analysis of Pum targets 
 
The RNA seq and data analysis in this chapter were performed in collaboration with the 
laboratory of Dr. Eric Wagner at the University of Texas Medical Branch including 




The repertoire of mRNAs that are functionally regulated by Drosophila Pum has 
not been analyzed on a global scale.  Previous work focused on select mRNAs linked to 
phenotypes in the germline, embryo, and nervous system (Gerber, Luschnig et al. 2006, 
Laver, Li et al. 2015).  As described in the preceding chapter, analysis of the mRNAs 
associated with Pum indicated the potential for a much broader regulatory role, with 
many hundreds of transcripts bound to Pum.  In model organisms (yeast, C. elegans, 
mouse) and human cells, PUMs regulate hundreds of mRNAs (Wickens, Bernstein et al. 
2002). Thus, we set out to analyze the effect of Pum and its CNOT corepressors on the 
Drosophila transcriptome. 
In this chapter, we used two strategies to identify the mRNAs regulated by Pum 
in the DL1 cell line.  DL1 cells were chosen because they are amenable to transfection, 
support efficient RNAi, and are facile for CRISPR-Cas9 genome engineering and clonal 
isolation.  In the first approach, we performed RNAi to transiently deplete Pum protein.  
In the second approach, we used CRISPR-Cas9 editing to create several clonal DL1 
lines with indels that knock out Pum.  
While RNAi does not provide a null background, it is rapid and transient and 
therefore may be less prone to adaptive changes. CRISPR-Cas9 KO offers a complete 
loss of function but may be subject to adaptive changes in the cells during the length of 
selection and clonal isolation.  Here we use a combination of both approaches to 
rigorously analyze Pum regulation. 
We recently showed that the CNOT complex is necessary for Pum repression of 
PRE-containing reporter genes.  RNAi of Pop2 or Not1 reduced translational repression 
and degradation of PRE-containing reporter mRNAs (Arvola, Chang et al. 2020). In 
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Chapter 4 we demonstrated that depletion of Not1 increased the levels of endogenous 
Pum targets. In this study, we extend this approach to analyze the impact of Not1 and 
Pop2 depletion on the transcriptome. We then compare the mRNAs regulated by Pum 
and CNOT as a means to evaluate the impact of the Pum-CNOT axis on the 
transcriptome in flies.  
 
5.2. Pum-CNOT mediated regulation of the transcriptome using PAC-Seq 
To identify mRNAs that are differentially regulated in response to depletion of 
Pum, we used the recently developed form of RNA sequencing, PAC-Seq (Poly-A-Click-
Seq)(Routh, Ji et al. 2017). Library preparation for PAC-Seq consists of annealing an 
oligo dT primer containing a portion of the Illumina p7 adapter to RNA transcripts, then 
performing reverse transcription in the presence of azido-modified A, G, and C 
nucleotides which cause the reaction to stall upstream of the poly(A) tail. Click-chemistry 
is then used to ligate the Illumina p5 adapter to the 3’ end of the first strand. PCR 
amplification is performed using a universal primer and an indexing primer, then the 
library is size selected on an agarose gel to retain amplicons 200 to 400 bp in length. 
PAC-seq has several advantages over traditional RNA sequencing methods: there is no 
need to enrich for poly(A) tails or deplete rRNA, RT termination and size selection 
eliminate the need for RNA fragmentation, and click chemistry avoids the inefficient step 
of linker ligation. In addition, PAC-Seq requires only 2 µg of total RNA.  
To prepare samples for PAC-Seq, we used our knockdown approach to deplete 
Pum, Not1, and Pop2 using RNAi in Pum-Myc Dl1 cells. An optimized protocol was used 
that included treatment of cells with dsRNAs to ensure efficient depletion of the target 
proteins. A non-targeting control dsRNA corresponding to E.coli LacZ was used for 
normalization. Three biological replicates were analyzed for each condition. Depletion of 
Pop2 and Not1 proteins by these dsRNAs was previously reported (Arvola, Chang et al. 
2020) and was confirmed in these samples by RT-qPCR (Figure 5.1 B). Depletion of 
endogenous myc-tagged Pum protein was confirmed by western blotting and RT-qPCR 





 A total of 9,284 genes were measured with a range of 0.02 to 165,116 reads per 
kilobase million (RPKM). We first trimmed this data set to exclude transcripts from the 
mitochondrial genome, pseudogenes, and genes that had withdrawn gene status as of 
FlyBase release 6.38 (February 2021). Other transcripts which could not be mapped 
specifically to a protein-coding gene, ncRNA, miRNA, or annotated miscellaneous RNA 
were also eliminated. After trimming, 9,262 unique genes remained. 
The PAC-Seq data confirm depletion of Pum, Not1, and Pop2 (Figure 5.1 C). 
Not1 and Pop2 showed high levels of depletion, with a 12.4-fold decrease for Not1 and 
Figure 5.1: RNA levels of Pum, Not1 and Pop2 used in sequencing experiments. (A) 
Western blot showing depletion of Pum-Myc in Dl1 cells. Total protein is shown as a loading 
control. Not1 and Pop2 depletion cannot be measured by western. (B) Mean RNA levels of Pum, 
Not1, and Pop2 as measured by RT-qPCR (n = 9). Log(2) fold change is shown relative to LacZ. 
Error bars represent standard error of the mean (SEM). (C) Mean RNA levels of Pum, Not1, and 
Pop2 relative to LacZ, as measured by PAC-seq. Error is SEM. 
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26.2-fold decrease for Pop2. The level of depletion for Pum (1.7-fold decrease) was less 
robust. It is worth noting, however, that this level of Pum depletion resulted in substantial 
stabilization of PRE-containing reporter mRNAs (Arvola, Chang et al. 2020) and 
alleviation of Pum repression in Dmel2 cells (Weidmann and Goldstrohm 2012, Arvola, 
Chang et al. 2020). 
5.2.1. Genes affected by Pum depletion 
 To explore which genes were affected by depletion of Pum, we established a 
biological significance threshold of +/- 1.3-fold change. This change corresponds to the 
level of repression seen in our reporter system in human cells when a single PRE is 
used in a minimal 3’-UTR (Bohn, Van Etten et al. 2018). For statistical significance 
calling we used a p-adjusted value of 0.05.  
 Of the 9,262 genes measured in our PAC-Seq experiment, only 79 were 
significantly upregulated in the Pum RNAi condition (Figure 5.2 A). We performed gene 
ontology (GO) analysis on this set of genes. The most significantly enriched terms 
include protein localization, establishment or maintenance of cell polarity, motor neuron 
axon guidance, cell to cell adhesion, and the Notch signaling pathway. Most of these 
genes also contain one or more perfect PREs (Figure 5.2 B). Approximately 28% of all 
the genes measured contain PREs (2,629 out of 9,262), yet 75% of the upregulated 
genes contain PREs (51 out of 79), indicating that Pum is causing specific regulation of 
the PRE-containing genes (odds ratio 4.67, 95% Credible interval = 2.94, 7.42). 
 Knockdown of Pum also caused a decrease in the RNA level of 51 genes, a 
minority of which contain PREs (Figure 5.2 B). We performed GO analysis on these 
genes and the significantly enriched categories are all involved in stress responses such 





5.2.2. Genes affected by CNOT complex depletion 
Next, we examined the genes affected by Not1 and Pop2 depletion. Since the 
CNOT complex is the major cytoplasmic deadenylase complex in Drosophila, we 
expected a large overall impact on the transcriptome. We used the same biological and 
statistical significance threshold as for Pum targets in our analysis. Over 2000 genes are 
upregulated when either Not1 or Pop2 are knocked down, with 1,790 of these genes 
upregulated in both conditions (Figure 5.3). Additionally, over 2000 genes are 
downregulated, with 1789 shared. Of the genes that were not similarly regulated 
between Not1 and Pop2, most were affected alike but missed our cutoffs for fold change 
(> 1.3-fold) or statistical significance. In fact, only two genes were differentially regulated, 
CDC45L and CG6231. CDC45L, a cell cycle gene, was decreased in the Not1 
knockdown and increased in the Pop2 condition. CG6231 encodes a protein that is 
predicted to be involved in transmembrane transport. It was increased in the Not1 
knockdown but significantly decreased for Pop2.  
Figure 5.2: Genes affected by Pum depletion. (A) Plot showing PAC-seq reads of Pum RNAi 
condition versus Control LacZ. Significantly upregulated genes are shown as red points, while 
downregulated genes are shown in blue. (B) Venn diagram representing the total number of 




We performed GO analysis on the 1790 shared upregulated targets for Not1 and 
Pop2. As expected, the enriched terms cover a wide array of biological processes and 
molecular functions. The most significant terms included protein binding, intracellular 
protein transport, Rab GTPase binding, vesicle-mediated transport, and border follicle 
cell migration. The top Kyoto encyclopedia of genes and genomes (KEGG) pathway 
results were endocytosis, DNA replication, and SNARE interactions in vesicular 
transport. Consistent with the CNOT complex’s role in RNA regulation, GO analysis on 
the downregulated targets showed highly enriched categories in processes such as 
cytoplasmic translation, structural constituent of ribosome, and RNA binding. KEGG 
pathways enriched included the ribosome pathway and oxidative phosphorylation. 
Figure 5.3: Genes affected by knockdown of Not1 and Pop2. (A) Plot of total genes measured 
in Not1 RNAi condition as log(2) counts of control condition versus Not1. Significantly upregulated 
genes are shown as red points, while downregulated genes are shown in blue. (B) Plot of total 
genes measured in Pop2 RNAi condition as described for Not1. (C) Venn diagrams illustrating 
overlap of upregulated genes between Not1 KD and Pop2 KD.  
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Because Pum requires the CNOT complex to repress reporter genes, we 
predicted that the genes upregulated in the Pum knockdown condition should overlap 
with the Not1 and Pop2 knockdowns. We compared all three datasets for both 
upregulated and downregulated genes. Just under half of the genes in the Pum 
downregulated gene sets overlapped for the 3 RNAi conditions. We interpret this to 
represent shared secondary effects that may result from loss of Pum and CNOT 
function. There is a pronounced overlap between the genes in each condition, with 40 
genes upregulated by depletion of Pum, Not1, and Pop2 (Figure 5.4).   
 
Of the 40 shared upregulated genes, 25 contain at least one perfect PRE, 
indicating they could be direct Pum target mRNAs. Further support is provided by RIP-
Chip data, which provide experimental evidence for Pum-binding to these mRNAs 
(Gerber, Luschnig et al. 2006, Laver, Li et al. 2015). These genes are listed in Table 5.1.  
Together, this data supports the importance of CNOT for Pum degradation of PRE-
containing mRNAs. 
Figure 5.4: Overlap of upregulated and downregulated genes between Pum, Not1, and 
Pop2 in the PAC-Seq experiment.  
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wb FBgn0261563 4 1.39  LAMA(1,2,3,5) 
bib FBgn0000180 2 1.31 (2) 
AQP(1-6,8,9), 
MIP 
beat-IV FBgn0039089 1 1.24   
fz2 FBgn0016797 1 1.18  
FZD(5,8), FRZB, 
SFRP4 
CG2150 FBgn0003065 1 1.05   
Msr-110 FBgn0015766 1 1.05   
fend FBgn0030090 5 0.79 (2)  
Tet FBgn0263392 1 0.76  TET(1,2,3) 
CG34347 FBgn0085376 3 0.66 (1) EPB41L4A 
Ppox FBgn0020018 1 0.66 (1), (2) PPOX 
fax FBgn0014163 1 0.63  FAXC 
CG11110 FBgn0034535 1 0.62  
IMMP1L, 
IMMP2L 
CG2200 FBgn0030447 2 0.55 (1), (2)  
pyd FBgn0262614 2 0.54 (1) TJP(1,2,3) 
mlt FBgn0265512 1 0.54  TBCEL 
bbg FBgn0087007 2 0.54  IL16 
CG5056 FBgn0032231 2 0.54 (1), (2) OSER1 
numb FBgn0002973 1 0.51 (2) NUMB, NUMBL 
gukh FBgn0026239 1 0.47  NHS 
COQ7 FBgn0029502 1 0.46 (1), (2) COQ7 
Snx1 FBgn0031534 1 0.45 (1), (2) SNX(1,2,30) 






Eip93F FBgn0264490 5 0.45  LCOR, LCORL 
CG45263 FBgn0266801 3 0.42   
RnrS FBgn0011704 1 0.40 (1), (2) RRM2, RRM2B 
Table 5.1: PRE-containing genes affected by Pum KD and overlapping with Not1 and Pop2. 
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5.3. Pum-CNOT mediated regulation of the transcriptome using Click-Seq 
and Pum knockout cell lines 
 The inefficient knockdown of Pum in the preceding experiment was a potential 
limitation to identification of the full scope of Pum’s effects on endogenous genes, 
including the number of affected genes and the magnitude of the effect. Therefore, we 
knocked out Pum in DL1 cells using CRISPR-Cas9 to introduce indels into exon 9 that 
inactivate the gene. We included three replicates each of two independent Pum null cell 
lines, with WT DL1 cells as a control.  The effects of these Pum KOs on gene expression 
was then compared to Pum RNAi. We further optimized the RNAi conditions to improve 
depletion of Pum, which we confirmed by RT-qPCR and western blotting. A full 
characterization of the Pum knockout (KO) lines is provided in Section 4.8.2. 
We then performed transcriptome analysis of Pum knockout and knockdown, as 
well as Not1 and Pop2 knockdowns. To assess reproducibility, 3 biological replicates 
were performed for each condition. In this experiment, we utilized Click-Seq (Routh, 
Head et al. 2015). This library preparation method is the parent of PAC-Seq and bears 
one major difference. Following poly(A) selection to enrich for mRNA, instead of using 
template reverse primers with oligo dT to target the poly(A) tail of transcripts, Click-Seq 
uses random primers that can anneal anywhere in the transcript. As our focus was to 
identify transcripts regulated by factors that act on poly(A) tails, potential library bias 
toward polyadenylated transcripts was not a concern. In addition, the Click-Seq method 
had the potential to improve our sequencing depth of coverage. 
  For the RNAi samples, Click-Seq measured 8,549 total genes with FKPM values 
from 0.013 to 63969. For the Pum knockout samples, 9,848 genes were measured at 
FPKM values from 0.017 to 55203. The RNA levels in the Pum KO samples were 
decreased 2.9-fold and 1.4-fold for KO1 and KO2, respectively (Figure 5.5 C). For the 
RNAi samples, Pum showed a 3.2-fold decrease, an improvement over the PAC-Seq 
experiment. We also confirmed Pum-Myc depletion via western blot (Figure 5.5 A). Not1 
KD resulted in a 9.6-fold decrease in Not1 RNA levels, while the Pop2 knockdown 




5.3.1. Genes affected by Pum depletion and knockout 
To score differentially expressed genes, we used the same thresholds for 
biological significance (1.3-fold) and statistical significance (p-adj < 0.05). In the Pum 
RNAi condition, 44 genes are significantly upregulated for our Click-Seq experiment 
(Figure 5.6), the majority of which contain PREs. Fourteen genes overlap between the 
PAC-Seq data and the Click-Seq data for Pum RNAi. Thirteen of these overlapping 
genes contain PREs. We performed GO analysis on both up- and down-regulated genes 
Figure 5.5: RNA levels of Pum, Not1 and Pop2 used in sequencing experiments. (A) 
Western blot showing depletion of Pum-Myc in Dl1 cells. Tubulin is shown as a loading control. 
Not1 and Pop2 depletion cannot be measured by western. (B) Mean RNA levels of Pum, Not1, 
and Pop2 as measured by RT-qPCR (n = 9). Log(2) fold change is shown relative to LacZ. Error 
bars represent standard error of the mean (SEM). (C) Mean RNA levels of Pum, Not1, and Pop2 
relative to LacZ, as measured by Click-Seq. RNA levels measured in Pum KO lines are included. 
Error is SEM. 
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for Pum KD. Notch signaling was again one of the most significantly enriched GO terms 
in the Pum upregulated samples. Only one term was enriched for the downregulated 
genes: pyruvate metabolism, represented by two genes, neither of which contain PREs. 
 
  
For the Pum KO lines, over 3,000 genes were differentially expressed. There 
was a strong overlap between Pum KO1 and Pum KO2 for both upregulated and down 
regulated genes (Figure 5.7). Due to the large number of genes regulated in these 
samples, we limited our analysis to these overlapping genes.  
 
Figure 5.6: Genes affected by Pum depletion in Click-Seq experiment. (A) Plot showing 
Click-Seq reads of Pum RNAi condition versus Control LacZ. Significantly upregulated genes are 
shown as red points, while downregulated genes are shown in blue. (B) Venn diagram 





Of the 1247 upregulated genes, 401 of them contain PREs. We performed GO 
analysis on both sets (all upregulated and upregulated PRE-containing). Neurogenesis, 
RNA binding, and mRNA splicing via the spliceosome were some of the highest 
enriched terms for all upregulated genes (Figure 5.8). Neurogenesis was also one of the 
top enriched terms for PRE containing genes, along with transcription, axon guidance, 
protein binding, and the Notch signaling pathway (not pictured).  
We then looked at the genes that were downregulated in the Pum KO lines. 465 
of the downregulated genes contain one or more perfect PREs. GO analysis on all 
downregulated RNAs showed enrichment for many terms such as endocytosis, actin 
binding, neuromuscular synaptic transmission, and oxidoreductase activity (Figure 5.8). 
When we narrowed our focus to PRE-containing genes only, a pattern of neural related 
Figure 5.7: Differential expression of genes in Pum KO cell lines. (A) Plot of total genes 
measured in Pum KO1 lines as log(2) counts of WT versus Pum KO. Significantly upregulated 
genes are shown as red points, while downregulated genes are shown in blue. (B) Plot of total 
genes measured in Pum KO2 as described for Pum KO1. (C) Venn diagrams illustrating overlap 




pathways was prevalent. More than half of the top ten enriched terms pertain to neurons 
or synaptic transmissions (not pictured). 
Figure 5.8: Gene ontology analysis of differentially expressed genes in the Pum KO lines. 
Fold enrichment is shown as full bars corresponding to the upper x axis. P value (as inverse 
log(10)) is shown as small bars and corresponds to the lower x axis. (Top) GO analysis on 
significantly upregulated genes. (Bottom) GO analysis on significantly downregulated genes. Data 
used for the graphs is reported in Appendix F. 
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5.3.2. Genes affected by CNOT depletion 
Similar to our PAC-Seq results, Click-Seq identified thousands of genes that 
were differentially expressed in response to Not1 and Pop2 depletion, with a clear 
overlap of genes between both knockdown conditions (Figure 5.9). The total number of 
genes with changed RNA levels was lower than for our PAC-Seq experiment, which 
could be an effect of lower Not1 and Pop2 depletion levels. However, the overall ratios 
of regulated genes and overlap are similar. GO analysis revealed many of the same 




Figure 5.9: Genes affected by knockdown of Not1 and Pop2. (A) Plot of total genes measured 
in Not1 RNAi condition as log(2) counts of control condition versus Not1. Significantly upregulated 
genes are shown as red points, while downregulated genes are shown in blue. (B) Plot of total 
genes measured in Pop2 RNAi condition as described for Not1. (C) Venn diagrams illustrating 
overlap of upregulated genes between Not1 KD and Pop2 KD. 
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We compared the genes between both PAC-Seq and Click-Seq for Not1 and 
Pop2. Overall, 2,467 unique genes are represented in the upregulated category, while 
1,932 genes are downregulated. 1037 genes are increased in abundance for both Not1 
and Pop2 knockdowns in both datasets, and 1,070 genes are decreased. We performed 
gene ontology analysis on these genes, as these genes represent our highest 
confidence CNOT complex regulated transcripts. The effects of CNOT depletion were 
evident in many different biological processes (Figure 5.10). The GO analysis for 
downregulated genes stresses the importance of the CNOT complex as a central 








Figure 5.10: Gene ontology analysis for high confidence genes in Not1 and Pop2 RNAi 
data. Fold enrichment is shown as full bars corresponding to the upper x axis. P value (as inverse 
log(10)) is shown as small bars and corresponds to the lower x axis. (Top) GO analysis on 
significantly upregulated genes. (Bottom) GO analysis on significantly downregulated genes. Data 
used for the graphs is reported in Appendix F. 
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We then compared the Not1- and Pop2-regulated genes to our Pum-regulated 
genes in the KO lines. As before, there was some overlap of the genes in each condition 
(Figure 5.11). Within the overlapping upregulated genes set, 55 of the 121 genes 
contained PREs, and there were 42 PRE-containing genes in the overlapping 
downregulated condition. Four of the upregulated genes with PREs were also present in 




Another way we evaluated Pum:CNOT targets was by first identifying the PRE-
containing genes that were affected by Pum depletion or knockout. There were 416 
genes in our Click-Seq data upregulated in either Pum condition. Of these genes, 108 
were also upregulated when either Not1 or Pop2 were depleted. 
 
5.4. Analysis of all RNA-seq datasets 
Having compiled our data for PAC-Seq and Click-Seq, we next examined the 
crossover between all the experimental conditions. Since we were focused primarily on 
identifying Pum targets, we first asked what genes were upregulated in all the Pum 
KD/KO samples. Across all three experiments (PAC-Seq RNAi, Click-Seq RNAi, Click-




Seq KO), we measured 9,850 unique Drosophila genes in total. Of those, 2,144 were 
significantly upregulated when Pum protein levels were depleted, 2,094 of which were 
from the KO lines data. These genes were narrowed down further to include only genes 
which contained one or more PREs and could thus be considered direct Pum targets. 
This resulted in 696 genes.  
The best candidates for direct Pum regulation would presumably not only 
possess PREs, but would be upregulated in more than one dataset. Of the 696 PRE-
containing genes, 417 genes fit this criteria. We performed GO analysis on this set of 
genes (Figure 5.12). Hemopoiesis and gene silencing were among the most significantly 
enriched terms, along with chromatin modification, axon guidance and neurogenesis.  
 
Since most of these genes were from both Pum KO lines and we desired to 
obtain a broad sampling of Pum target genes under different conditions, we filtered this 
list of 417 genes further. Fifty-six non-overlapping genes were from the PAC-Seq and 
Click-Seq data. From those 56 genes, we isolated those that were also upregulated in 
either Pum KO line. After filtering, 45 high confidence genes remained. We also cross-
referenced the remaining genes with the RIP-chip datasets to interrogate which of our 45 
Figure 5.12: Genes upregulated in Pum KO/KD experiments. (A) A schematic representation 
of the filtering of genes from all datasets to obtain the highest confidence targets. (B) Gene 
ontology analysis of the 417 genes upregulated in two or more Pum KO/KD datasets. Fold 
enrichment is shown as full bars corresponding to the upper x axis. P value (as inverse log(10)) is 
shown as small bars and corresponds to the lower x axis. Data used to generate graph is 
reported in Appendix F. 
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top Pum targets have evidence of being directly bound by Pum as well (Gerber, 
Luschnig et al. 2006, Laver, Li et al. 2015). This left us with 27 genes. These genes all 
contain PREs, are bound by Pum, and are upregulated when Pum is both depleted with 
RNAi and knocked out with CRISPR. These genes are listed in Table 5.2, along with 
their human homologs. Note that for the average fold change listed, we utilized the data 
for each experiment where the indicated gene was measured, not just the experiments 
where the gene is upregulated. This provides a more complete look at the expression 
level changes under Pum KO or KD.  
Since most of these genes have mammalian homologs, we asked if there was 
evidence of the homologs being bound by Pum as well. We searched murine two 
datasets, one performed using iCLIP (individual nucleotide resolution cross linking 
immunoprecipitation) of Pum1 and Pum2 from mouse whole brain lysates (Zhang, Chen 
et al. 2017), and one using RIP-Chip from mouse testis (Chen, Zheng et al. 2012), and 
two datasets from human, both using RIP-Chip analysis from HeLa cells with PUM1 
(Morris, Mukherjee et al. 2008), or both PUM1 and PUM2 (Galgano, Forrer et al. 2008). 
There were several genes bound by Pum homologs, indicating an evolutionarily 














CG43759 FBgn0264090 3 1.7 (2)  
bib FBgn0000180 2 1.34 (2) 
AQP(1-6,8,9)1,3, 
MIP 
ORMDL FBgn0037110 2 1.13 (1), (2) ORMDL(1-3)3,4 
amx FBgn0000077 2 1.03 (1) TM2D33 
Jheh2 FBgn0034405 1 0.91 (1) EPHX1 
numb FBgn0002973 1 0.87 (2) NUMB1,2, NUMBL 
Best2 FBgn0035696 3 0.82 (1) BEST(1-4) 
MFS16 FBgn0034611 2 0.7 (1) SLC37A(1,2,3)3,4 




CG34347 FBgn0085376 3 0.66 (1) EPB41L4A 
alpha4GT1 FBgn0031491 1 0.65 (1), (2) A4GALT, A4GNT 
Ppox FBgn0020018 1 0.62 (1), (2) PPOX 
cher FBgn0014141 2 0.61 (1) 
FLNA, FLNB, 
FLNC 
RnrS FBgn0011704 1 0.6 (1), (2) RRM2, RRM2B3 
Coq7 FBgn0029502 1 0.6 (1), (2) COQ74 
Raf FBgn0003079 2 0.6 (1), (2) 
BRAF, ARAF2,3, 
RAF1 
Kap-alpha1 FBgn0024889 1 0.59 (1) KPNA(1-7)3,4 
CG2200 FBgn0030447 2 0.59 (1), (2)   
CG4281 FBgn0025626 2 0.59 (1), (2)   
SCAR FBgn0041781 2 0.56 (1), (2) WASF(1,2,3)3 
Ugalt FBgn0024994 3 0.54 (1), (2) SLC35A(1,2,3)2,3,4 
CG18622 FBgn0038460 4 0.5 (1)   
tna FBgn0026160 3 0.49 (1), (2) ZMIZ12, ZMIZ21 
Cdc7 FBgn0028360 2 0.39 (1), (2) CDC74 
Phm FBgn0283509 2 0.36 (1), (2) PAM3 
Got2 FBgn0001125 1 0.34 (1) GOT1, GOT2 
CG7841 FBgn0036502 2 0.34 (1), (2) MCRIP1, MCRIP2 
Table 5.2: Top Pum target genes. Genes listed in this table are upregulated in two or more 
RNA-seq datasets, contain PREs, and are bound by Pum. Log(2) fold change (FC) shown is the 
mean FC from all datasets. Drosophila binding data from (1) (Gerber, Luschnig et al. 2006) and 
(2) (Laver, Li et al. 2015). Homologs identified in mouse or human binding data are indicated by 
superscripts as follows: homolog binding data from 1- (Chen, Zheng et al. 2012), 2- (Zhang, Chen 
et al. 2017), 3- (Galgano, Forrer et al. 2008), 4- (Morris, Mukherjee et al. 2008). 
140 
 
5.5. Summary and discussion 
In this study we utilized PAC-Seq and Click-Seq to interrogate the transcriptome-
wide changes when Pum is depleted. We also analyzed changes when Pum is knocked 
out using CRISPR-Cas9 gene editing. Our combined analyses of genes affected by Pum 
revealed over 2000 upregulated RNAs. 696 of these contain PREs, indicating they are 
direct targets. This data expands the known number of Pum controlled genes 
profoundly. 
Using PAC-seq and Click-Seq, we also measured genome-wide changes with 
depletion of Not1 and Pop2. We found over 1,500 genes upregulated when either Not1 
or Pop2 are knocked down, providing us with new insights into the regulatory network of 
the CNOT complex. Consistent with the CNOT complex’s role in Pum-mediated decay, 
we found that a majority of Pum targets are also upregulated when Not1 and Pop2 are 
depleted. Of the 696 PRE-containing upregulated genes, 261 of these are also 
increased in abundance with Not1/Pop2 RNAi (odds ratio 5.8, 95% credible interval 4.6, 
7.4).  
Curiously, there were 33 genes that were upregulated in the Pum RNAi condition 
but either downregulated or not affected for Not1/Pop2 RNAi. 20 of these genes contain 
PREs. In the Click-Seq data alone, we found that 108 PRE-containing genes were 
upregulated when either Pop2 or Not1 were depleted, out of over 400 PRE-containing 
genes upregulated in the Pum-null lines. This percentage of co-regulated targets was 
lower than we expected. There are several possible explanations for this. First, some of 
the targets failed to meet our cutoffs for either biological or statistical significance in one 
of the datasets. Second, there could be factors with greater influence than Pum or 
CNOT acting on the transcripts. Third, the genes regulated by Pum but not CNOT might 
indicate a CNOT-independent mechanism of Pum-mediated decay. Finally, not all of 
Pum’s targets are degraded. Pum proteins also act through translational inhibition which 
may not necessarily lead to a decrease in RNA levels (Chagnovich and Lehmann 2001, 
Chritton and Wickens 2011, Weidmann, Raynard et al. 2014). 
Gene ontology of upregulated genes reaffirms the known links between Pum 
mutant phenotypical analyses to target RNAs. Wing morphogenesis involves genes from 
many developmental processes, Pum’s most prominent historical role. Other established 
roles for Pum include axon guidance and neurogenesis, discussed briefly in Chapter 1. 
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Cancer phenotypes observed in mammals can be traced to dysregulation of the types of 
genes represented in these categories: transcription factors (Miles, Tschop et al. 2012, 
Oh, Shin et al. 2012, Naudin, Hattabi et al. 2017, Brocard, Khasnis et al. 2018), signaling 
molecules (Bermudez, Jouandin et al. 2011, Maurer, Tarkowski et al. 2011, Chen, 
Zheng et al. 2012), and cell cycle regulators (Belletti and Baldassarre 2015, Sun, 
Zhangyuan et al. 2017). 
GO term analysis of the upregulated gene sets provide us with some new insight 
into processes Pum is involved in. Less is known about Pum’s roles in gene silencing or 
chromatin modification. One of the genes in the gene silencing category is polycomb 
(Pc), a chromatin binding protein. Another is Pipsqueak (psq), a transcription factor that 
mediates the activity of polycomb group proteins and regulates chromatin silencing. We 
evaluated enhancer of polycomb, E(Pc), a subunit of the NuA4 histone acetyltransferase 
complex, and showed that it too is regulated by Pum (Chapter 4).  
The genes populating the GO category hemopoiesis are transcription factors, 
signaling molecules, and other growth regulators. Raf, which we also evaluated in 
Chapter 4, is included in this set. E(Pc), significantly upregulated in both Pum KO lines 
(avg log(2) FC = 1.1), is also involved in hematopoiesis (Owusu-Ansah and Banerjee 
2009). Additionally, human Pums have recently been linked to hematopoietic stem cell 
proliferation through the target FOXP1 (Naudin, Hattabi et al. 2017). 
We also looked at the RNA levels for the targets we identified in Chapter 4. Chico 
was increased an average of 1.34-fold (log(2) 0.43) in the Pum KD conditions, but failed 
to meet the statistical significance cutoff (p > 0.05). Pten was significantly upregulated in 
both Pum KO lines. Raf was significantly increased in one KD condition and both KO 
lines, but both Pde11 and Nrv1 were not significantly upregulated in the Pum KD 
conditions. One explanation for the disparity in regulation seen between the RNAi 
experiments in Chapter 4 and RNA-seq analysis could be the duration of treatment. The 
experiments in Chapter 4 were optimized for Pum depletion and were 90-hour 
knockdowns. The RNA-seq experiments were 48 hours to limit the effects of CNOT 
depletion on cell viability. 
We then examined some of the targets with documented Pum roles in 
Drosophila. Dap, the Drosophila homolog of CDKN1B (p27 protein), is significantly 
upregulated in both Pum KO lines. Egfr was demonstrated to be regulated by Pum (Kim, 
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Kim et al. 2012), and it is significantly upregulated for all Pum conditions. However, it 
does not appear in our top target list because it does not possess a perfect 8 nucleotide 
PRE, the criteria we used to define PRE-containing genes.  
It is worth noting however, that the 8 nucleotide PRE with an adenine in position 
8 is a stringent criteria and newer evidence in mammalian cells suggests the consensus 
sequence may contain either adenine or uracil in position 8 (UGUANAUA and 
UGUANAUU) (Chen, Zheng et al. 2012, Bohn, Van Etten et al. 2018, Wolfe, Schagat et 
al. 2020). Importantly, interactions with other proteins such as Nanos can alter the 
specificity of Pum and potentially increase the pool of targets (Weidmann, Qiu et al. 
2016). 
5.5.1. Biological functions of top targets in Notch signaling 
Many of our top target genes for Pum have roles in signaling pathways, 
especially Notch signaling. Notch signaling is a significantly enriched GO term in all of 
our Pum depletion/knockout analyses. Here we summarize the known function of some 
of the top Pum targets involved in the Notch pathway. 
The Notch signaling pathway is crucial during development for lateral inhibition in 
the neuroectoderm, and for overall homeostasis (Hori, Sen et al. 2013). Notch receptors 
are transmembrane proteins that undergo two internal cleavage events upon activation 
to release an intracellular domain (NICD) which translocates into the nucleus and 
activates the transcription of genes. The second cleavage event is catalyzed by a 
gamma secretase (De Strooper, Annaert et al. 1999, Yang, Zhou et al. 2019). 
Drosophila Amx is thought to function at the level of gamma secretase in the Notch 
pathway as a beta-amyloid peptide binding protein (Michellod and Randsholt 2008). Amx 
is also necessary for the proper localization of Notch receptors during early development 
(Das, Salazar et al. 2020). As gamma secretase is also responsible for cleaving amyloid 
precursor peptide (APP), the human homolog of Amx, TM2D3 has also been implicated 
in late-onset Alzheimer’s disease (Zhang, Li et al. 2014, Jakobsdottir, van der Lee et al. 
2016). 
Lateral inhibition in the developing neuroectoderm results in a select number of 
cells destined to become neural, while the rest are forced toward an epidermal fate. The 
Bib (Big brain) gene encodes a transmembrane ion channel that acts synergistically with 
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Notch receptors to enforce the epidermal fate (Doherty 1997). The mechanism of this 
interaction is still unclear, though it is thought that Bib functions as an adhesive 
molecule, since Bib appears to have no channel activity, despite its homology to 
mammalian aquaporins (Tatsumi, Tsuji et al. 2009). 
Drosophila Numb is a target that was upregulated in every RNA seq dataset for 
Pum, Not1 and Pop2 RNAi, and Pum KO. It is also bound by Pum (Laver, Li et al. 2015), 
and the mammalian homolog is bound by Pum1 and Pum2 (Chen, Zheng et al. 2012, 
Zhang, Chen et al. 2017). Numb is a membrane associated protein asymmetrically 
localized during the lateral inhibition process and contributes to cell fate determination 
(Uemura, Shepherd et al. 1989). Numb is a known antagonist of the Notch signaling 
pathway, interfering with the nuclear translocation of Su(H) and preventing expression of 
Notch target genes (Frise, Knoblich et al. 1996). Of note, Su(H) is also a Pum target 
identified in our data. 
Apart from their roles in cell differentiation, Numb proteins also function as tumor 
suppressors by controlling p53 ubiquitination and degradation (Colaluca, Tosoni et al. 
2008). Numb is the focus of many studies involving breast cancer research (Tosoni, 
Zecchini et al. 2015, Wang, Xiang et al. 2019), prostate cancer (Wang, Yang et al. 
2021), colon cancer (Peng, Wang et al. 2019) and aging (George, Biressi et al. 2013, 
Zhao, Kiss et al. 2020).  
Another significant Pum target involved in the Notch pathway is Tonalli (tna). Tna 
is a member of the protein inhibitor of activated STAT (PIAS) proteins, first identified as 
negative regulators of the Jak-STAT cytokine signaling pathway (Shuai and Liu 2005). 
Tna is a putative E3 ligase in the SUMOylation pathway and interacts with chromatin 
remodeling complexes (Monribot-Villanueva, Juarez-Uribe et al. 2013). Tna is necessary 
for development by controlling expression of Drosophila homeotic (Hox) genes (Rosales-
Vega, Hernandez-Becerril et al. 2018). Both mammalian homologs of tna, Zmiz1 and 
Zmiz2 (previously Zimp10 and Zimp7) also function in the androgen receptor pathway 
(Beliakoff and Sun 2006). Additionally, Zmiz1 can interact directly with the Notch 
intracellular domain and affect the transcription of Notch genes, especially Myc (Pinnell, 
Yan et al. 2015). Zmiz2 has been shown to interact with β-catenin and co-regulate the 




5.6. Materials and Methods 
 




 RNAi was performed in Pum-Myc tagged Drosophila Dl1 cells. 20 µg of prepared 
dsRNA (Pum, Not1, Pop2, or LacZ NTC) was added to a drop of serum free complete 
media (Gibco) in the bottom of a 6-well dish. Cells were counted and diluted to a density 
of 3 x 10^6 cells/mL in 1 mL serum free media, then 1 mL was added to each well. Cells 
were incubated in dsRNA for 60 minutes, then 2 mL complete media containing 5% 
heat-inactivated FBS was added to each well. After 72 hours (PAC-Seq) or 48 hours 
(Click-Seq) cells were harvested. For the 72 hour experiment, viability was assessed 
using trypan blue staining prior to harvest. Then, the media was removed and cells were 
resuspended in 2 mL PBS. 1.5 mL of cells were taken for RNA, and the remaining 500 
µL were processed for protein expression. 
 
Pum KO cell lines 
 Pum KO cell lines and WT Dl1 cells were counted and diluted to a density of 1.5 
x 10^6 cells/mL in complete media (Gibco). 2 mL were plated in 6-well plates in triplicate 
for each cell line. Cells were grown for 72 hours at 25°C then harvested and processed 
as for RNAi samples. 
  For verification of knockdown in tagged cell lines, harvested cells were 
resuspended in 2 mL PBS. 1.5 mL of the cells were taken for RNA, and the remaining 
500 µL was pelleted and resuspended in 75 µL RIPA buffer with 2x protease inhibitors 
(Roche, Sigma). After a 10 minute incubation on ice, lysates were collected by 
centrifuging at 21,000 x g for 10 minutes and removing the supernatant. Protein 
concentration was measured using the Bio-Rad DC protein assay kit according to the 
manufacturer’s directions.  
20 µg of total protein extract was incubated with an equal volume of 2x SDS 
loading buffer at 85°C for ten minutes. Samples were loaded on 12% SDS-PAGE gels 
(laboratory-made) and run at 120 to 180 volts until dye front reached the bottom of the 
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gel. Gels were transferred to PVDF membranes (Millipore) for either 1.5 hours at 65 
volts or overnight at 35 volts. Following transfer, membranes were either blocked in 
blotto for 1 hour or allowed to dry completely, then primary antibodies were applied for 
one hour at room temperature, or incubated overnight at 4°C. Membranes were washed 
three times for 10 minutes in blotto, then secondary antibodies were applied for 1 hour at 
room temperature. Membranes were washed three times for ten minutes each in blotto, 
then rinsed with 1x PBS before applying chemiluminescent substrate (Pierce- Thermo 
Fisher, or Immobilon- Millipore) Blots were imaged using the auto exposure setting on a 
ChemiDoc touch (BioRad). 
 
Antibodies 
All antibodies used in this study are listed in Appendix Mouse anti-Tubulin (CST, 
Cat# 3873) was diluted 1:1000 in blotto. Rabbit anti-Myc primary antibody (CST Cat# 
2278S) was diluted 1:5000 in TBST. Goat anti-rabbit-HRP secondary antibody (CST, 
Cat# 7074P2 or Sigma Cat# AP187P) was diluted 1:5000 in blotto. Goat anti-mouse-
HRP (Thermo Fisher Cat# 31430) was diluted 1:5000 in blotto. Total protein was 




RNA extraction was performed using the Maxwell RSC simply RNA Tissue RNA 
extraction kit (Promega) and concentration was determined using a NanoDrop 
spectrophotometer. A total of 10 µg RNA was taken from each sample for reverse 
transcription (RT) using GoScript (Promega) reverse transcriptase (5 µg for RT, 5 µg for 
noRT samples.) RT reactions were primed with random hexamers and carried out 
according to the manufacturer protocol. cDNA was then diluted with 100 µL water to a 
final concentration of approximately 41 ng/µL. Quantitative PCR (qPCR) was set up 
using Promega’s Go-Taq qPCR Master Mix with 2 µL of each cDNA/noRT sample in a 
20 µL reaction volume using either 100 nM or 200 nM final concentration qPCR primers 
for each gene. Reactions were performed on the Bio-Rad CFX96 instrument using the 
following cycling parameters: 3 min 98°C, [10 sec 95°C, 30 sec 62/63/64°C, 40 sec 72°C 
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+ image] x 39, 60°C-90°C melt curve + image. Individual annealing temps for each 
primer set and primer data are listed in Appendix D. 
 
Data analysis for RT-qPCR  
Fold change for each experiment was determined using the Pfaffl method where 





 . E is defined as primer 
efficiency for each gene, and ∆Ct is Ct of the calibrator condition (LacZ) minus the Ct of 
the test condition (Pum KD or Not1KD). Reference genes were RPL32 for Pum KD and 
Act5c for Not1 KD. Unpaired Student’s T tests with variances determined by F tests 
were performed using raw ∆Ct values for each gene.  
 
PAC-seq library preparation 
PAC-Seq was performed following the method described in (Routh, Ji et al. 2017, 
Elrod, Jaworski et al. 2019). RNA extraction was performed according to manufacturer’s 
protocol using the Maxwell RSC simply RNA Tissue RNA extraction kit (Promega) and 
concentration was determined using the NanoDrop spectrophotometer. RNA samples 
were analyzed by Agilent Tapestation and resulting RIN (RNA integrity number) values 
were all 10. 2 µg of total cellular RNA was used to generate the PAC-Seq library. 
Reverse transcription was performed in a 20 µL reaction following manufacturer’s 
protocol with Superscript III Reverse Transcriptase (Invitrogen) with the following 
components: up to 4 µg RNA, 1 µL of 5 mM AzVTP:dNTPs (at a ratio of 1:5 azido-
nucleotides AzATP, AzCTP, AzGTP (AzVTP) to dNTPs), 1 µL 50 uM 3’ Illumina_4N_21T 
primer (GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNN (21T)), 5x 
Superscript First Strand buffer, DTT, and RNase OUT (Invitrogen). RNA template was 
removed after cDNA synthesis by incubating for 20 minutes at 37°C with 10U RNase H 
(NEB). Azido-terminated cDNA was purified using the Zymo Clean and Concentrator kit 
and eluted in 10 µL of pH 7.2 50 mM HEPES buffer. 
To form the click adapter-linked cDNA, all 10 µL of cDNA was incubated for 30 
minutes at room temperature with 20 µL DMSO, 3 µL of 5 µM Click-Adapter (5’ Hexynyl-
12(N)AGATCGGaaGAGCGTCGTGTAGGGaaAGAGTGTAGATCTCGGTGGTCGCCGT
ATCATT) and 0.4 µL premixed 50mM vitamin C and 2 µL 10 mM Cu-TBTA (Lumiprobe). 
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The alkyne-azide cycloaddition of the adapter was catalyzed twice, then the click-linked 
cDNA was purified with a Zymo DNA column. 
To anneal the remaining Illumina adapters (indexing primer CaaGCAGaaGA 
CGGCATACGAGATnnnnnnGTGACTGGAGTTCAGACGTGT, where nnnnnn is the 
index sequence, and universal primer aaTGATACGGCGACCACCGAG), PCR reactions 
were set up using 2.5 µL each of 5 µM primers, 5 µL click-ligated cDNA, 25 µL 2x 
OneTaq Standard Buffer Master Mix (NEB) in 50 µL total reactions. Optimized cycling 
parameters were 94° 4 min; 53° 30 sec; 68°10 min; [94° 30 sec, 53° 30 sec, 68° 2 min] x 
20–22 cycles; 68° 5 min. Amplicons were size selected at 200 to 300 bp on a 2% 
agarose gel, then gel purified with the Zymo Gel DNA recovery kit. Final yields were 
determined with a QuBit fluorimeter. 
 
Click-Seq library preparation 
 Click-Seq library preparation was performed following the methods developed in 
(Routh, Head et al. 2015). RNA extraction was performed using the Maxwell RSC simply 
RNA Tissue RNA extraction kit (Promega) and concentration was determined using the 
NanoDrop spectrophotometer. RNA samples were submitted for Agilent Tapestation 
analysis and RIN values were 8.7 and higher. Total RNA was poly(A) selected by oligo 
dT using the NEBNext® Poly(A) mRNA Magnetic Isolation Module (NEB Cat#E7490L). 
Library preparation then followed the steps described for PAC-Seq, with the exception of 
the primer sequence used during cDNA first strand synthesis: Illumina 6N p7 adapter 
(GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNN). 
Sequencing was performed on pooled samples using manufacturer’s standard 
operating procedures. Samples were sequenced with single end 75 bp reads on the 
NextSeq 500 (Illumina) with a high density v2.5 flow cell. 
Data processing 
The DPAC pipeline v1.10 (Routh 2019) was used to process the PAC-Seq 
results for differentially expressed genes (DE) in the resulting data. For the Click-Seq 
samples, sequencing adapters were trimmed and unique molecular identifiers (UMIs) 
annotated using fastp (version 0.14.1), then reads were aligned to the UCSC dm6 
genome using hisat2 (version 2.1.0). The alignments were then deduplicated using UMI-
tools (version 1.0.1) and differential expression was analyzed using DEseq2 (1.23.110) 
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and featureCounts (Rsubreads 1.30.9). Significance calling was based on adjusted p 
values (p-adj) and biological significance cutoff was 1.3-fold change. 
 
Determination of PRE-containing genes 
 FlyBase release 6.38 February 2021 was used to download gene annotations for 
coding sequences (CDS), 3’ UTRs, 5’ UTRs, ncRNA, miRNA, and miscRNA. PRE 
processing was performed in R using the seqinR package. Data was then exported to 
Excel and gene matching based on FBgn, gene name, or gene locus was performed to 
assign PRE numbers to each gene from our RNA-seq datasets. Genes in RNA-seq data 
sets that could not be matched to any of the above mentioned FlyBase sequences were 
discarded. These included but were not limited to genes with withdrawn gene status, 








Chapter 6: Conclusions 
 
6.1. Project Summary 
 
 The scope of influence Pum proteins have over an entire organism is broad. Pum 
targets perform myriad functions in the cell. The ongoing investigations of Pum targets in 
both Drosophila and mammals have given us new insights into post transcriptional 
control mechanisms, not just for Pum but for the entire field. 
6.1.1. Understanding Pum function 
 Pum proteins were identified decades ago and much work has been performed 
to understand their structure, function, and targets (Nusslein-Volhard, Frohnhofer et al. 
1987). The initial characterization of the RNA binding domain led to a focus of interest on 
how Pum binds RNA and the importance of the RBD in the regulation of targets 
(Zamore, Williamson et al. 1997). Since the N-terminus of the protein lacks readily 
identifiable domains it had long been ignored, even as it was becoming clear that the 
RBD alone was not the only feature contributing to repression of targets (Wharton, 
Sonoda et al. 1998, Menon, Sanyal et al. 2004, Weston and Baines 2007, Muraro, 
Weston et al. 2008). The identification of the unique repression domains (RDs) of Pum 
and the development of cell-based assays to measure their activity have provided a 
large step forward in elucidating the mechanism of Pum repression (Weidmann and 
Goldstrohm 2012), yet several more questions remain. 
 Evidence in yeast had shown that PUF proteins cause mRNA decay and interact 
with deadenylases (Olivas and Parker 2000, Goldstrohm, Hook et al. 2006) and recent 
work on human Pum proteins indicated that this is a conserved mechanism (Van Etten, 
Schagat et al. 2012, Enwerem, Elrod et al. 2021). Finally, repression by Pum’s RDs 
involves recruitment of the CNOT deadenylase complex in Drosophila (Arvola, Chang et 
al. 2020). From these studies a larger picture was emerging where Pum causes 
repression by interacting with the CNOT complex, not only through the RBD, but via its 
unstructured N-terminal RDs as well.  Despite these advances, the specific interactions 
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with CNOT complex subunits were not identified. The work described in this thesis adds 
to our understanding of Pum function by addressing these gaps in knowledge.  
 
Activity of RD3 depends on two phenylalanine residues. 
 
 The structure-function analysis in Chapter 2 identified several regions of 
conservation within the RD3 of Pum. Each one of these conserved regions (CRs) affects 
repression by RD3 when deleted. Without structural information for RD3, it is not 
possible to be certain if the effects are due to the loss of specific amino acids or an 
overall structural or shape change within the region when the CR is removed. Since RD3 
is predicted to be unstructured, we assume that folding is not a major factor. Deletion of 
certain amino acids likely eliminates an interface used in protein-protein interactions.  
The most important CR for RD3’s activity is CR4. Deleting it alone causes a 
substantial decrease in activity, and when it is deleted in conjunction with CR1, all 
activity is lost. Within CR4 we identified two specific residues, F1033 and F1040, that are 
essential for repression. Additionally, we showed that CR1 and CR4 are both sufficient 
for RD3’s repressive activity when multimerized. A tethered construct consisting of 4 
repeats of CR1+4 can repress a reporter RNA as much as WT RD3, and a 5x CR1+4 
construct has even greater activity than WT RD3. We then mutated the phenylalanine 
residues within this 5x CR1+4 construct to alanine and showed near complete loss of 
activity in their absence. 
We further demonstrated the importance of these phenylalanine residues in 
chapter 4. We expressed constructs of RD3 with the RNA binding domain (RD3-RBD) 
and measured their activity on reporters carrying endogenous target 3’-UTRs. Wild type 
RD3-RBD was able to repress the reporters more than the RBD alone, but the double 
phenylalanine mutants were not.  
 
RD3 interacts with multiple members of the CNOT complex. 
 
 We tested interactions between members of the Drosophila CNOT complex and 
RD3 in chapter 3. We found that Not1, Not2, and Not3 interact with RD3. We further 
isolated the specific region of each protein mediating those interactions. For Not1, the 
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interaction was localized to a region in the N-terminus of the protein where NOT1 is 
known to bind to TTP in humans (Tis11 in Drosophila), amino acids 908 to 1016. If Pum 
and Tis11 compete for binding of the CNOT complex, this could have implications for the 
RNA. A mutually exclusive binding arrangement could potentially affect the fate of a Pum 
or Tis11-bound target. 
RD3 interacts with the C-terminal region of Not2 in the conserved NOT-box 
domain, amino acids 465 to 585. RD3 also interacts with the C-terminal region of Not3. 
Combined with the RD3 interaction with Not1-N, this discovery fits with the model of the 
CNOT complex as a modular assembly with flexible arrangements in vivo.  
 We then showed that the interaction between RD3 and Not1 is dependent on the 
phenylalanine residues in CR4. Mutating either F1033 or F1040 to alanine disrupts the 
interaction with Not1. The deletion of CR4 affects the interaction with Not2, but it is not 
enough to eliminate it. We screened deletions of all 5 identified CRs in RD3 for 
interactions with Not2 but were unable to identify the region of RD3 that Not2 is 
interacting with. We screened RD3 deletions of CRs for interactions with Not3-C and 
found that a double deletion of CR1 and CR4 disrupts the interaction. 
 We demonstrated that RD3 interacts with the CNOT complex in Drosophila cells 
using co-immunoprecipitation. The phenylalanine mutations in CR4 did not disrupt this 
association, which is likely reinforced through multiple contacts with both Not2 and Not3. 
 In addition to strengthening the interaction between Pum and the CNOT 
complex, multiple points of contact might modulate the inherent conformational flexibility 
of CNOT. This could, in turn, affect the deadenylase activity. It is worth noting that 
depletion of Not1, Not2, Not3, or Pop2 all affected RD3’s repressive activity (Arvola, 
Chang et al. 2020). 
6.1.2. Identifying Pum targets 
 RIP-Chip analyses have identified RNAs bound by Pum in Drosophila (Gerber, 
Luschnig et al. 2006, Laver, Li et al. 2015) but the capture and sequencing of bound 
RNA is not 100% efficient and targets of Pum cannot be identified by this manner alone. 
Our RNA sequencing data complements the existing data by adding a functional aspect. 
We identified thousands of genes in our Pum-null lines that were dysregulated in the 
absence of Pum. This not only reflects the biological necessity for Pum in the cell but 
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provides insight inside the mechanisms by which a cell can adjust to the absence of a 
crucial regulator. Using transient depletion of Pum has allowed us to identify some of the 
most responsive Pum targets. Our analysis has vastly expanded the known repertoire of 
Pum targets. 
Gene ontology analysis of regulated Pum targets revealed facets of Pum control 
that have yet to be fully explored, such as gene silencing and hematopoiesis. Many of 
the genes regulated in Drosophila have mammalian homologs, and we noted 
conservation of Pum control in more than a dozen targets. While some of the targets we 
identified have well-known functions, less is known about their regulation. The effects of 
Pum regulating these genes could be a reduction in total protein levels, as is the case for 
Pde11 and Raf (Chapter 4). The discovery of Pum as a repressor of these genes will be 
especially important for research involving disease states that are sensitive to protein 
levels. Another outcome of Pum regulation could be to destabilize the pool of RNA and 
make the system more responsive to transcriptional input. Pum regulation is essential in 
systems where there is little transcriptional control such as neural synapses, or where 
transcription occurs too slowly, such as immediate signaling responses. This is pertinent 
as many of the genes we identified in Chapter 5 are involved in signaling and neural 
pathways.  
 
6.2. Future directions 
6.2.1. Interactions with the CNOT complex 
We demonstrated that the physical interaction between RD3 and the CNOT 
complex is mediated by multiple protein contacts. RD3’s CR4 is responsible for 
contacting Not1. We also identified contacts between RD3 and Not2 that do not depend 
on the CRs. In vitro biochemical assays have also affirmed the interaction between RD3 
and the CNOT complex for Drosophila Pum and human CNOT proteins (Arvola, Chang 
et al. 2020, Enwerem, Elrod et al. 2021). However, these in vitro assays have thus far 
been limited in their ability to determine precise contacts for the individual proteins due 
to stability and expression challenges with single CNOT complex subunits. One pressing 
future goal is to purify a minimal peptide of Pum in complex with a CNOT module for 
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structural analysis via x-ray crystallography. Similar approaches have been used to co-
crystallize Nanos peptides (Bhandari, Raisch et al. 2014) and a TTP peptide (Fabian, 
Frank et al. 2013) with Not1.  
Mapping the protein contacts of the entire Pum protein will be needed to fully 
understand the mechanism of Pum repression. In the absence of structural information, 
the exploration of how Pum is contacting the CNOT complex will have to be completed 
through cell-based assays such as co-IPs and yeast two-hybrid assays. The regions of 
RD3 responsible for binding Not2 have yet to be identified. The Pum N-terminus 
(including RD1 and RD2) also contacts the CNOT complex (Arvola, Chang et al. 2020) 
and these contacts are unknown as well.  
One of our more interesting discoveries was that the phenylalanine mutations 
that destroy the repressive activity of RD3 do not inhibit its association with the CNOT 
complex in Drosophila cells. This could be explored further in two ways. One, using in 
vitro deadenylation assays with recombinant wild type or mutant Pum and purified CNOT 
complex, such as those performed in Raisch et al. 2019, and two, in vivo utilizing a 
transcription shutoff approach with WT and mutant Pum.  We would predict that while 
both WT and mutant Pum could bind and recruit CNOT, only the WT form would 
enhance deadenylation of target mRNAs. 
This work focused on characterizing RD3 and its specific contacts to decay 
factors, especially the CNOT complex. We tested several other decay proteins for 
interactions but the results were negative. For future experiments, the Y2H system can 
be used to screen large libraries of proteins for de novo discovery of Pum partners. This 
analysis would not be limited to decay factors and could uncover links to other regulatory 
networks. 
6.2.2. Pum function 
Our finding in Chapter 3 that functionally inoperative RD3 mutations do not 
prohibit CNOT complex binding has implications for understanding overall Pum 
regulation. The repressive activity of Pum appears to be modulated by the presence of 
auto-regulatory domains, PCMa and PCMb (Weidmann and Goldstrohm 2012). These 
domains show a higher level of conservation than the RDs, which indicates their function 
is crucial to the activity of Pum. One of the possible mechanisms for inhibition of Pum 
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activity to occur could be through occlusion of a Pum-CNOT interaction by PCMb. This 
could inhibit complex binding or prevent potential stimulatory effects conferred by other 
Pum regions. Testing for interference of CNOT complex binding could be performed 
using Y2H assays or co-IPs.  
Additionally, we identified a region of RD3, CR2, that also appears to have a 
regulatory function. Loss of activity resulting from deletions of the Q-P/N region, CR1, or 
CR3 is restored when CR2 is deleted in combination with them. Several observations 
were made that CR2 is a point of phosphorylation in Dmel2 cells (data not shown) but it 
is unclear under what circumstances the phosphorylation occurs and if it is biologically 
relevant. Vertebrate Pums have a highly-conserved insertion in this region that might 
alter or enhance the behavior of CR2. Future experiments could explore the contribution 
of CR2 to the regulation of Pum.  
The N-terminus of Drosophila Pum contains other repression domains, RD1 and 
RD2. Motif analyses similar to the work described here for RD3 was performed for RD2 
but remains incomplete (Joseph Buytendorp, unpublished data). The existing evidence 
that Drosophila RDs interact with the human CNOT complex indicates that each RD 
makes contacts with CNOT (Arvola, Chang et al. 2020). Future experiments can 
complete mapping of these contacts to the CNOT complex using mutational analysis 
and Y2H assays. 
6.2.3. Pum targets 
Our RNA-seq data uncovered many genes that are direct Pum targets. Follow up 
experiments would include verification of PRE-dependent decay using reporter assays, 
similar to the experiments carried out in Chapter 4. For select targets, CRISPR-Cas9 
editing can be used to examine protein level changes with overexpression of Pum or 
Pum depletion. Additionally, the PRE of endogenous targets might be amenable to 
CRISPR editing, presenting the opportunity to engineer genes nonresponsive to Pum.  
We used existing RIP-Chip data to supplement our sequencing results. However, 
many genes differentially expressed in our datasets do not have associated binding 
data. An ideal experiment would use RIP-seq or CLIP-seq with our Pum-Myc cell line to 
identify bound targets. This would provide a complementary dataset that could be 
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compared to the functionally regulated and PRE-containing gene sets to provide an 
extensive list of Pum bound and regulated mRNAs that contain a PRE. 
Many genes in our sequencing datasets are downregulated upon Pum depletion. 
Although these can partially be attributed to secondary effects, that may not hold true for 
all of the decreased genes, some of which contain PREs. Recent evidence in human 
Pums suggests that repression or decay are not the only outcomes of Pum binding to a 
transcript. Indeed, Pum mediated activation of genes has been observed in mammals 
(Naudin, Hattabi et al. 2017, Bohn, Van Etten et al. 2018, Wolfe, Schagat et al. 2020). 
Pum acts to stabilize a certain subset of targets but the mechanism by which this occurs 
is entirely unknown. While there is no documented evidence of this phenomenon in 
Drosophila yet, the high degree of conservation between Pums in these species makes 
it an enticing objective for follow up.  
Our sequencing data also revealed many genes that do not fit with our model of 
Pum-CNOT mediated repression. This could indicate alternative mechanisms of 
regulation. Two of these genes, jheh2 and Phm appear in multiple datasets as being 
upregulated upon Pum depletion but downregulated for both Not1 and Pop2 depletion. 
These genes could serve as a baseline for exploring potential alternative decay 
mechanisms.  
Our experiments in Chapter 4 touched upon a very pressing question: What 
makes a particular PRE more or less functional than another, and how is the outcome of 
Pum binding to a PRE determined?  
One way that this may occur is through interactions with other proteins. The 
interaction with Nanos alters Pum’s binding specificity and increase the pool of potential 
targets (Weidmann, Qiu et al. 2016). This has been documented in detail for cyclin B, 
where Pum alone has low affinity for the cyclin B RNA (Kadyrova, Habara et al. 2007, 
Weidmann, Qiu et al. 2016). Pum also cooperates with Nanos and Brat to regulate 
hunchback and paralytic RNA in early development (Arvola, Weidmann et al. 2017). For 
the regulation of paralytic, the requirement for Brat is cell type specific (Muraro, Weston 
et al. 2008). Pum also has context dependent interactions with CPEB where the number 
and proximity of PREs and CPEs to the polyadenylation sequence can determine the 
fate of the bound transcript. (Pique, Lopez et al. 2008, Campbell, Menichelli et al. 2012)  
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In addition to other proteins, Pum proteins potentially cooperate with the miRNA 
regulatory network (Galgano, Forrer et al. 2008). It has been suggested that Pum 
binding to a transcript can increase accessibility of miRNA seed sites, although the 
reverse might also occur (Kedde, van Kouwenhove et al. 2010, Miles, Tschop et al. 
2012). 
Large data sets such as those generated with RNA-seq present the opportunity 
for mining of motifs or patterns that could provide insight into other cis acting elements 
contributing to the fate of a target. This work has generated several large sets of data for 
such analyses. Follow up experiments could be applied to select targets or engineered 
reporters. Luciferase assays or overexpression/knockdown of regulators coupled to RT-
qPCR can be used to measure regulatory effects. 
While the overall consequence of Pum binding to a PRE is decay, the full extent 
of regulation is likely to be transcript specific, influenced by the full repertoire of cis 
elements, RNA structures, and transacting factors that act on that transcript. It is 
probable that there is no “one size fits all” model for the functionality and outcome of an 
individual PRE. This makes it even more important to understand how Pum functions, 
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Appendix A: ConSurf analysis of RD3 
 
Figure A1: ConSurf conservation analysis of RD3. Analysis generated from an alignment of 
Pum proteins from 45 different species. CRs in RD3 are boxed. PCMb and the RBD are 
indicated. Base image taken from HTML document generated by ConSurf. 
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Dilution used Diluent 
Mouse anti-V5 Invitrogen R960-25 1:5000 Blotto 
Rabbit anti-V5 CST 13202S 1:5000 TBST 
Mouse anti-Flag Sigma F3165-1MG 1:5000 Blotto 
Rabbit anti-Flag Sigma sab4301135 1:5000 Blotto 
Rabbit anti-HA CST 3724s 1:5000 TBST 
Rabbit anti-Myc CST 2278S 1:5000 TBST 
Mouse anti-
Tubulin 










31430 1:5000 Blotto 
Goat anti-rabbit 
HRP 
CST 7074P2 1:5000 Blotto 
Goat anti-rabbit 
HRP 
Sigma AP187P 1:5000 Blotto 
Table B1: Antibodies used in this study. Composition of Blotto: 1x PBS, 0.1% Tween, 5% 
dried milk. TBST: 1x TBS, 5% BSA, 0.1% Tween. 
Appendix C: Plasmids 
Archive 
number 
Plasmid name How cloned Creator Primers 
CAW061 pIZ MS2CP-GFP V5H6 restriction cloned Chase 
Weidmann 
CW115/116 
for insert  
RMA053 pIZ MS2-Dcp1 V5H6 restriction cloned 
from cDNA 
Rene Arvola 
CAW314 pIZ MS2 Pum RD3i 
V5H6 
inverse PCR Chase 
Weidmann 
 
CAW313 pIZ MS2 Pum RD3ii 
V5H6 
inverse PCR Chase 
Weidmann 
 
RMA008 pIZ Dm Pum RD3-RBD inverse PCR Rene Arvola R: CW 055 
F: CW 244 







CAW023 pAc5.1 FFLuc2 minimal 
3’-UTR 
oligo cloned Chase 
Weidmann 
 








Plasmid name How cloned Creator Primers 
RJH64 pIZ MS2 RD3 
▲Q+FA2 






RMA001 pIZ MS2-RD3 -QN INV PCR/PNK/T4 Rene Arvola R: RA 001 
F: RA 002 
RJH66 pIZ MS2 RD3 
▲FA1+CR3 





RJH67 pIZ MS2 RD3 
▲FA2+CR3 






RJH68 pIZ MS2 RD3 
▲FA4+CR3 














RJH77 pIZ MS2 RD3 ▲FA1 invPCR from RD3  Rebecca 
Haugen 
RJH 98+99 




RJH80 pIZ MS2 RD3 1/3 
alone, 1-79 




RJH81 pIZ MS2 RD3 3/3 
alone, 163-243 



















RJH98 pIZ MS2 RD3 2/3 
alone, 80-162 

























































Plasmid name How cloned Creator Primers 








































































RJH158 pIZ MS2 eGFP MCS Inverse PCR to 






RJH161 pIZ MS2 RD3 CR4 
F187+194A 
QuikChange from 
































RJH165 pIZ MS2 RD3 CR1 
SFD+CR4 F187A 
QuikChange from 





RJH166 pIZ MS2 RD3 CR1 
RST+CR4 F187A 
QuikChange from 











RJH172 pIZ MS2 RD3 CR1 
SPS+CR4 F187A 
QuikChange from 





RJH173 pIZ MS2 RD3 CR1  
SAF+CR4 F187A 
QuikChange from 
















Plasmid name How cloned Creator Primers 
RJH241 pIZ MS2-eGFP-link-
CR1-link-CR4 (2x) 
gBlock cloned w/ 









gBlock cloned w/ 









gBlock cloned w/ 









gBlock cloned w/ 









gBlock cloned w/ 








CR1-link-CR4 (5x) FF 
mut 
gBlock cloned w/ 









































































CAW038 pIZ MS2CP-DmPop2 
V5H6 
Amplified from S2 
cDNA w/ CW095, 
096 cut with 









Plasmid name How cloned Creator Primers 




































































































































Plasmid name How cloned Creator Primers 
































CAW018 pIZ HT-V5H6 Amplified RE site 
containing HT w/ 
CW081/082, cut 
with HindIII and 
XbaI, and ligated 








RJH175 pIZ Not1-N FLAG  Amplified from pIZ 
Not1-N V5; 
blunt+SpeI digest 






















ACG864 pIZ Dm Pumilio V5 
His6 
PCR 




CAW003 pIZ DmPumilio R7mut 
SNVVE to AAVVA 
Quickchange PCR  Chase 
Weidmann 
 ACG 864 
CW015, 
016 
ACG866 pIZ Dm Pumilio RBD PCR 













RMA008 pIZ Dm Pum RD3-RBD INV PCR/PNK/T4 Rene Arvola R: CW 055 





Plasmid name How cloned Creator Primers 
RJH229 pIZ RD3-RBD FF Mut restriction cloned Rebecca 
Haugen 
 
CAW004 pIZ DmPumRBD 
R7mut SNVVE to 
AAVVA 













RJH231 pAc 5.4 NLuc 3xPRE 







CAW061 pIZ MS2CP-GFP V5H6 Amplified from 
EGFP / KpnI and 





for insert  







RJH233 pAc 5.4 NLuc Chico 3’-













RJH235 pAc 5.4 NLuc Nrv1 3’-













RJH237 pAc 5.4 NLuc Pde11 













RJH239 pAc 5.4 NLuc Raf 3’-






RMA071 pAc-sgRNA-Cas9    
















RJH246 pAc sgRNA Cas9 
dPum sg1 






RJH247 pAc sgRNA Cas9 
dPum sg2 






RJH248 pAc sgRNA Cas9 Not1 
sg1 










Plasmid name How cloned Creator Primers 
RJH249 pAc sgRNA Cas9 Not1 
sg2 






RJH252 pAc sgRNA Cas9 
∆Flag Pum exon13 sg1 






RJH253 pAc sgRNA Cas9 
∆Flag Pum exon13 sg2 






RJH254 pAc sgRNA Cas9 
∆Flag-Blast Pde11 sg1 






RJH255 pAc sgRNA Cas9 
∆Flag-Blast Pde11 sg2 






RJH256 pAc sgRNA Cas9 
∆Flag-Blast Raf sg1 






RJH257 pAc sgRNA Cas9 
∆Flag-Blast Raf sg2 






     




Appendix D: RT-qPCR primer data 
Reactions for RT-qPCR were performed on the Bio-Rad CFX96 instrument using the 
following cycling parameters: 3 min 98°C, [10 sec 95°C, 30 sec 62/63/64°C, 40 sec 72°C 
+ image] x 39, 60°C-90°C melt curve + image. Individual annealing temps for each 
primer set are listed below, along with primer efficiency and sequences. Primers are 
specific for only the intended target unless specified with an asterisk. The non-specific 
targets for these primers are either not expressed in Dl1 cells (via FlyBase) or have 















Primer sequence F Primer sequence R Amplicon 
length 







































































































































































































































































































































Appendix E: Fold change data for all tested targets in Chapter 4: 
Endogenous targets of Pum. 
 The 23 targets we tested for RNA level changes under Pum depletion are 
described in Chapter 4. These targets were investigated by two methods. In addition to 
the RNAi experiments described in Chapter 4, we also used our CRISPR-Cas9 
engineered Pum KO lines to evaluate the RNA levels of these targets. These targets 
were first examined upon generation of our Pum KO lines by RT-qPCR as described. 
However, after multiple passages of the Pum KO lines, the measured RNA levels did not 
appear to be affected and we assumed the cells had acclimated to the absence of Pum. 
In this table we present the measured average fold changes for the first set of 
experiments in Pum KO lines. Additionally, fold change values are listed for all RNAi 
experiments. Data is compiled from multiple experiments, including the final three 




Pum KO1 Fold 
change (avg, 
n=3) 






n= for RNAi 
Pum 0.678577398 0.525081489 0.181640346 14 
Wac (non-target) 1.559766668 1.048756846 0.911068624 14 
Pgk (non-target)   0.88405044 9 
β-tubulin (non-
target) 
  0.754258575 9 
     
Fs(1)h 1.5609206 1.318678082 1.041977199 14 
Strica 1.2050576 0.670007368   
Larp4B 1.635042 1.396558585 1.059505447 14 
Ches-1-L 1.2144014 1.295067598   
Myc 1.530425 1.258629362 1.069917582 4 
Coa7 1.6316373 1.648109225 1.158389511 5 
Chico 1.316703555 2.122192503 1.213583864 14 
Skd 1.080148177 1.283432295   
E(Pc) 1.512280725 1.984834513 1.19411396 13 
Msi 1.06661805 1.056450538   
Pten 1.406828321 1.456651015 1.153850923 9 
Tob 2.24611848 3.080975635 1.432102831 14 
Tis11 1.680963548 1.56625273 1.152147636 14 
CycK 1.123255273 0.895703324   
Raf 1.998143104 2.444376559 1.709810008 14 
Spoon 1.162615403 1.100030607   
Pan 1.040845778 1.308507525 1.243331993 9 
upSET 1.58110159 1.53039345 1.022308817 5 
Babo 1.346663396 1.368104056 1.284068113 9 
Nrg 1.341054177 1.583092598 1.217768574 11 
Nrv1 1.706321357 1.366139905 1.37710822 11 
Ccm3 1.882039354 1.753311989 1.22458802 14 
Pde11 1.508792832 1.363968501 1.672504459 11 










Appendix F: GO term analyses 
 
Biological Process GO term Count P Value 
Fold 
Enrichment 
GO:0022008~neurogenesis 155 2.28E-39 3.062539868 
GO:0000398~mRNA splicing, via spliceosome 71 1.47E-21 3.507102107 
GO:0006364~rRNA processing 28 1.19E-17 6.946147772 
GO:0009267~cellular response to starvation 36 7.20E-14 4.230360673 
GO:0032543~mitochondrial translation 33 9.00E-13 4.234412743 
GO:0000381~regulation of alternative mRNA 
splicing, via spliceosome 
28 4.72E-11 4.281871914 
GO:0000462~maturation of SSU-rRNA from 
tricistronic rRNA transcript (SSU-rRNA, 5.8S 
rRNA, LSU-rRNA) 
18 5.17E-11 6.698071066 
GO:0006351~transcription, DNA-templated 72 7.55E-10 2.137682255 
GO:0006338~chromatin remodeling 21 1.32E-09 4.884010152 
GO:0016569~covalent chromatin modification 16 3.98E-09 6.159145808 
Molecular Function GO term Count P Value 
Fold 
Enrichment 
GO:0003723~RNA binding 82 2.84E-22 3.199522565 
GO:0003676~nucleic acid binding 93 2.21E-14 2.276354088 
GO:0003677~DNA binding 104 5.62E-12 1.98144021 
GO:0003729~mRNA binding 48 7.39E-12 2.968149303 
GO:0030515~snoRNA binding 12 4.82E-09 8.459225513 
GO:0005515~protein binding 106 1.05E-08 1.732376168 
GO:0000166~nucleotide binding 48 1.75E-08 2.394120428 
GO:0003682~chromatin binding 35 1.95E-08 2.868923381 
GO:0042393~histone binding 14 1.41E-07 5.69370948 
GO:0003899~DNA-directed RNA polymerase 
activity 
14 4.25E-07 5.287015945 
Table F1: Gene Ontology analysis for upregulated genes in Pum KO lines illustrated in 
Figure 5.8. The top ten significantly enriched terms ranked by p-value for each category are 
listed. Count is the number of genes that fall into the listed category. 
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Biological Process Go term Count P Value 
Fold 
Enrichment 
GO:0007476~imaginal disc-derived wing 
morphogenesis 
29 4.64E-11 4.493919 
GO:0006351~transcription, DNA-templated 34 2.13E-08 3.040731 
GO:0022008~neurogenesis 43 3.05E-08 2.559216 
GO:0045892~negative regulation of 
transcription, DNA-templated 
18 8.29E-08 5.044037 
GO:0007411~axon guidance 20 2.37E-06 3.635342 
GO:0030097~hemopoiesis 8 3.07E-06 11.69632 
GO:0006355~regulation of transcription, DNA-
templated 
30 8.16E-06 2.515729 
GO:0000122~negative regulation of 
transcription from RNA polymerase II promoter 
17 8.48E-06 3.836627 
GO:0006338~chromatin remodeling 10 9.58E-06 7.005607 
GO:0006357~regulation of transcription from 
RNA polymerase II promoter 
18 1.46E-05 3.498754 
Molecular Function GO term Count P Value 
Fold 
Enrichment 
GO:0005515~protein binding 44 6.40E-07 2.246866 
GO:0003677~DNA binding 38 3.96E-06 2.26214 
GO:0003682~chromatin binding 14 1.33E-04 3.585644 
GO:0003676~nucleic acid binding 27 5.87E-04 2.064947 
GO:0008375~acetylglucosaminyltransferase 
activity 
4 0.002782 13.21566 
GO:0003723~RNA binding 18 0.003395 2.194482 
GO:0001047~core promoter binding 4 0.003741 12.01423 
GO:0008134~transcription factor binding 9 0.004608 3.417843 
GO:0042393~histone binding 5 0.00717 6.353682 
GO:0003729~mRNA binding 12 0.01437 2.318537 
Table F2: Gene Ontology analysis for PRE-containing upregulated genes in Pum KO lines. 
The top ten significantly enriched terms ranked by p-value for each category are listed. Count is 
the number of genes that fall into the listed category. 
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Biological Process GO term Count P Value 
Fold 
Enrichment 
GO:0006897~endocytosis 21 4.48E-06 3.130088 
GO:0007274~neuromuscular synaptic 
transmission 
19 1.26E-04 2.703258 
GO:0008039~synaptic target recognition 12 3.99E-04 3.414642 
GO:0007616~long-term memory 19 4.13E-04 2.477987 
GO:0007165~signal transduction 34 4.40E-04 1.878053 
GO:0045886~negative regulation of synaptic 
growth at neuromuscular junction 
14 5.89E-04 2.921416 
GO:0055085~transmembrane transport 50 6.83E-04 1.619011 
GO:0000045~autophagosome assembly 10 7.12E-04 3.756106 
GO:0006749~glutathione metabolic process 14 9.28E-04 2.7971 
GO:0035071~salivary gland cell autophagic 
cell death 
19 0.001143 2.287372 
Molecular Function GO term Count P Value 
Fold 
Enrichment 
GO:0003779~actin binding 29 3.67E-05 2.282899 
GO:0016491~oxidoreductase activity 41 9.90E-05 1.872981 
GO:0005215~transporter activity 25 9.67E-04 2.022182 
GO:0003997~acyl-CoA oxidase activity 5 0.002037 7.347262 
GO:0004872~receptor activity 18 0.002737 2.173984 
GO:0019901~protein kinase binding 12 0.003889 2.645014 
GO:0005509~calcium ion binding 38 0.004041 1.595405 
GO:0017137~Rab GTPase binding 16 0.006038 2.137385 
GO:0005089~Rho guanyl-nucleotide 
exchange factor activity 
9 0.006373 3.05194 
GO:0003924~GTPase activity 26 0.007264 1.723568 
Table F3: Gene Ontology analysis for downregulated genes in Pum KO lines illustrated in 
Figure 5.8. The top ten significantly enriched terms ranked by p-value for each category are 
listed. Count is the number of genes that fall into the listed category. 
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Biological Process GO term Count P Value 
Fold 
Enrichment 
GO:0008039~synaptic target recognition 9 8.62E-06 8.261458 
GO:0007274~neuromuscular synaptic 
transmission 
11 5.38E-05 5.048669 
GO:0007165~signal transduction 17 1.52E-04 3.029201 
GO:0007411~axon guidance 16 0.00117 2.61985 
GO:0048675~axon extension 6 0.002327 6.267313 
GO:0007616~long-term memory 9 0.002432 3.786501 
GO:0050770~regulation of axonogenesis 5 0.00245 8.414448 
GO:0007523~larval visceral muscle 
development 
4 0.002564 13.46312 
GO:0098655~cation transmembrane 
transport 
4 0.002564 13.46312 
GO:0055085~transmembrane transport 20 0.003372 2.089104 
Molecular Function GO term Count P Value 
Fold 
Enrichment 
GO:0003779~actin binding 15 2.48E-05 3.922375 
GO:0005509~calcium ion binding 20 9.56E-05 2.789244 
GO:0019901~protein kinase binding 8 3.51E-04 5.857413 
GO:0005089~Rho guanyl-nucleotide 
exchange factor activity 
6 0.001615 6.758554 
GO:0042626~ATPase activity, coupled to 
transmembrane movement of substances 
7 0.003124 4.767662 
GO:0004889~acetylcholine-activated cation-
selective channel activity 
4 0.003922 11.71483 
GO:0005515~protein binding 34 0.012396 1.539042 
GO:0051015~actin filament binding 5 0.014143 5.229833 
GO:0050839~cell adhesion molecule 
binding 
5 0.015977 5.049494 
GO:0005096~GTPase activator activity 8 0.028412 2.693064 
Table F4: Gene Ontology analysis for PRE-containing downregulated genes in Pum KO 
lines. The top ten significantly enriched terms ranked by p-value for each category are listed. 
Count is the number of genes that fall into the listed category. 
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Biological Process GO term Count P Value 
Fold 
Enrichment 
GO:0007476~imaginal disc-derived wing 
morphogenesis 
29 1.08E-10 4.334842 
GO:0006351~transcription, DNA-templated 36 4.25E-09 3.10563 
GO:0022008~neurogenesis 44 3.01E-08 2.526034 
GO:0045892~negative regulation of 
transcription, DNA-templated 
18 1.40E-07 4.865487 
GO:0007411~axon guidance 21 1.00E-06 3.68199 
GO:0006357~regulation of transcription from 
RNA polymerase II promoter 
20 1.47E-06 3.749893 
GO:0030097~hemopoiesis 8 3.91E-06 11.28229 
GO:0006355~regulation of transcription, 
DNA-templated 
31 5.94E-06 2.507566 
GO:0006338~chromatin remodeling 10 1.28E-05 6.75762 
GO:0000122~negative regulation of 
transcription from RNA polymerase II 
promoter 
17 1.33E-05 3.700818 
Molecular Function GO term Count P Value 
Fold 
Enrichment 
GO:0005515~protein binding 47 9.67E-08 2.317585 
GO:0003677~DNA binding 39 3.59E-06 2.241887 
GO:0003682~chromatin binding 14 1.89E-04 3.462426 
GO:0003676~nucleic acid binding 27 9.92E-04 1.993986 
GO:0008375~acetylglucosaminyltransferase 
activity 
4 0.003075 12.76151 
GO:0001047~core promoter binding 4 0.004131 11.60137 
GO:0003723~RNA binding 18 0.004889 2.11907 
GO:0008134~transcription factor binding 9 0.005678 3.300391 
GO:0042393~histone binding 5 0.008102 6.135342 
GO:0003729~mRNA binding 12 0.018201 2.238862 
Table F5: Gene Ontology analysis for the 417 Top Pum targets illustrated in Figure 5.12. 
The top ten significantly enriched terms ranked by p-value for each category are listed. Count is 
the number of genes that fall into the listed category. 
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Biological Process GO term Count P Value 
Fold 
Enrichment 
GO:0007298~border follicle cell migration 41 5.13E-15 4.146381 
GO:0006886~intracellular protein transport 31 1.13E-10 3.874471 
GO:0016567~protein ubiquitination 36 5.00E-10 3.266678 
GO:0043087~regulation of GTPase activity 20 1.24E-09 5.299277 
GO:0032456~endocytic recycling 13 2.23E-09 8.611325 
GO:0016192~vesicle-mediated transport 30 1.27E-08 3.312048 
GO:0006367~transcription initiation from 
RNA polymerase II promoter 
21 2.28E-08 4.347063 
GO:0045746~negative regulation of Notch 
signaling pathway 
18 3.19E-08 4.968072 
GO:0030036~actin cytoskeleton organization 17 7.62E-08 5.004873 
GO:0016322~neuron remodeling 17 2.14E-07 4.692068 
Molecular Function GO term Count P Value 
Fold 
Enrichment 
GO:0005515~protein binding 114 5.26E-17 2.231679 
GO:0005096~GTPase activator activity 28 2.50E-10 4.076336 
GO:0004842~ubiquitin-protein transferase 
activity 
39 1.18E-08 2.759578 
GO:0017137~Rab GTPase binding 22 1.52E-08 4.221919 
GO:0051015~actin filament binding 12 4.19E-06 5.428182 
GO:0001104~RNA polymerase II 
transcription cofactor activity 
13 5.71E-06 4.84279 
GO:0003779~actin binding 23 5.12E-05 2.601004 
GO:0003713~transcription coactivator activity 15 9.97E-05 3.333094 
GO:0004702~receptor signaling protein 
serine/threonine kinase activity 
10 1.03E-04 4.871445 
GO:0004672~protein kinase activity 27 1.44E-04 2.235134 
Table F6: Gene Ontology analysis for upregulated genes in Not1 and Pop2 RNAi 
conditions illustrated in Figure 5.10. The top ten significantly enriched terms ranked by p-value 
for each category are listed. Count is the number of genes that fall into the listed category. 
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Biological Process GO term Count P Value 
Fold 
Enrichment 
GO:0002181~cytoplasmic translation 45 5.72E-24 6.049144 
GO:0006457~protein folding 24 3.32E-06 2.987232 
GO:0005975~carbohydrate metabolic 
process 
23 8.41E-06 2.916778 
GO:0015992~proton transport 11 8.60E-06 5.68723 
GO:0006096~glycolytic process 11 1.28E-05 5.476592 
GO:0045454~cell redox homeostasis 15 1.72E-05 3.877657 
GO:0015986~ATP synthesis coupled proton 
transport 
10 3.12E-05 5.601059 
GO:0006486~protein glycosylation 14 1.48E-04 3.421738 
GO:0006364~rRNA processing 12 3.47E-04 3.584678 
GO:0006488~dolichol-linked oligosaccharide 
biosynthetic process 
5 4.02E-04 11.20212 
Molecular Function GO term Count P Value 
Fold 
Enrichment 
GO:0003735~structural constituent of 
ribosome 
58 1.00E-08 2.223979 
GO:0046933~proton-transporting ATP 
synthase activity, rotational mechanism 
10 3.81E-06 6.795491 
GO:0003723~RNA binding 42 7.76E-05 1.895716 
GO:0019843~rRNA binding 10 1.88E-04 4.530327 
GO:0003729~mRNA binding 29 2.80E-04 2.074413 
GO:0005524~ATP binding 88 4.16E-04 1.433297 
GO:0000030~mannosyltransferase activity 5 0.001263 8.73706 
GO:0046961~proton-transporting ATPase 
activity, rotational mechanism 
11 0.00135 3.281725 
GO:0003756~protein disulfide isomerase 
activity 
7 0.002293 4.756844 
GO:0051287~NAD binding 10 0.002375 3.305915 
Table F7: Gene Ontology analysis for downregulated genes in Not1 and Pop2 RNAi 
conditions illustrated in Figure 5.10. The top ten significantly enriched terms ranked by p-value 
for each category are listed. Count is the number of genes that fall into the listed category. 
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Appendix G: CRISPR data 

















Table G1: HR template sequences. HR templates as ordered from IDT for CRISPR-Cas 9 




Primer name Sequence 
RJH 210 Not1 SG2 Fwd           ttcGCGTCCGACGCTTCTGCCTGG                                     
RJH 211 Not1 SG2 Rev           aacCCAGGCAGAAGCGTCGGACGC                                     
RJH 212 Not1 Sg1 Fwd           ttcgCTCCAGGCAGAAGCGTCGGA                                     
RJH 213 Not1 SG1 Rev           aacTCCGACGCTTCTGCCTGGAGc  
RJH 284 Pum exon 13 sg1 Fwd ttcgAGGAAATAACAAATTAAGCC                                                
RJH 285 Pum exon 13 sg1 Rev aacGGCTTAATTTGTTATTTCCTc                                                
RJH 286 Pum exon 13 sg2 Fwd ttcgAACTATACTGCGATTCGAGA                                                
RJH 287 Pum exon 13 sg2 Rev aacTCTCGAATCGCAGTATAGTTc                                        
RJH 327 Raf sg1 Fwd            ttcgTAGATCGCTGTCGCCTTCGG                                                     
RJH 328 Raf sg1 Rev            aacCCGAAGGCGACAGCGATCTAc                                                     
RJH 329 Raf sg2 Fwd            ttcGGAGCTGCACAACGTCCAGT                                                      
RJH 330 Raf sg2 Rev            aacACTGGACGTTGTGCAGCTCC                                                      
RJH 331 Pde11 sg1 Fwd          ttcGCAGATGCAGGCCTGCAACG                                                      
RJH 332 Pde11 sg1 Rev          aacCGTTGCAGGCCTGCATCTGC                                                      
RJH 333 Pde11 sg2 Fwd          ttcgCCTGCATCTGCGGAGCATCG                                                     
RJH 334 Pde11 sg2 Rev          aacCGATGCTCCGCAGATGCAGGc       
RJH 526 Pum exon 9 crispr 1 Fwd ttcgCACATCGGCAGCGAGTGCTG                                  
RJH 527 Pum exon 9 crispr 1 Rev aacCAGCACTCGCTGCCGATGTGc                                  
RJH 528 Pum exon 9 crispr 2 Fwd ttcGCAACAACAGATGCACATGG                                   
RJH 529 Pum exon 9 crispr 2 Rev aacCCATGTGCATCTGTTGTTGC 
Table G2: Primer sequences for sgRNA used in CRISPR-Cas9 editing. The first “ttc” or “aac” 
are overhangs for BspQI cloning. An additional lowercase “g” or “c” is appended to some 
sequences due to the requirement of the U6 promoter, which requires the first base of the 
transcribed sequence to be guanine. 
